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Abstract
The thesis investigates the effect of surface treatment with various reducing and
oxidizing agents on the quantum yield (QY) of CdSe and CdS quantum dots (QDs). The
QDs, as synthesized by the organometallic method, contained defect sites on their surface
that trapped photons and prevented their radiative recombination, therefore resulting in a
decreased QY. To passivate these defect sites and enhance the QY, the QDs were treated
with various reducing and oxidizing agents, including: sodium borohydride (NaBH4),
calcium hydride (CaH2), hydrazine (N2H4), benzoyl peroxide (C14H10O4), and tert-butyl
hydroperoxide (C4H10O2). It was hypothesized that the reducing/oxidizing agents reduced
the ligands on the QD surface, causing them to detach, thereby allowing oxygen from
atmospheric air to bind to the exposed cadmium. This cadmium oxdide (CdO) layer
around the QD surface satisfied the defect sites and resulted in an increased QY. To
correlate what effect the reducing and oxidizing agents were having on the optical
properties of the QDs, we investigated these treatments on the following factors:
chalcogenide (Se vs. S), ligand (oleylamine vs. OA), coordinating solvent (ODE vs.
TOA), and dispersant solvent (chloroform vs. toluene) on the overall optical properties of
the QDs. The QY of each sample was calculated before and after the various surface
treatments from ultra-violet visible spectroscopy (UV-Vis) and fluorescence spectroscopy
data to determine if the treatment was successful.
From our results, we found that sodium borohydride was the most effective
surface treatment, with 10 of the 12 treatments resulting in an increased QY. Hydrazine,
on the other hand, was the least effective treatments, as it quenched the QD fluorescence
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in every case. From these observations, we hypothesize that the effectiveness of the QD
surface treatments was dependent on reaction rate. More specifically, when the surface
treatment reaction happened too quickly, we hypothesize that the QDs began to
aggregate, resulting in a quenched fluorescence. Furthermore, we believe that the reaction
rate is dependent on concentration of the reducing/oxidizing agents, solubility of the
agents in each solvent, and reactivity of the agents with water. The quantum yield of the
QDs can therefore be maximized by slowing the reaction rate of each surface treatment to
a rate that allows for the proper passivation of defect sites.
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Chapter 1. Introduction
Fluorescent quantum dots (QD) are semiconductor nanocrystals with dimensions
on the order of a few nanometers. At the nano-scale, materials exhibit size-dependent
absorbance and fluorescence emission properties that are not observed in macro-scale
(bulk) semiconductors. The size, shape, and growth conditions of QDs can be tuned by
varying reaction conditions, such as the reaction time, reaction temperature, and
stabilizing ligands used. The ability to tune the size of QDs allows for their potential
application in a number of photonic devices, including: emitters for color displays1, color
modifiers for light emitting diodes (LEDs)2, optical fiber amplifiers3,4, low threshold
lasers5, self-assembled photonic sphere arrays6, polymer-based photovoltaic cells7,
optical temperature probes8, chemical sensors7, and high-speed signal-processing filters9.
Quantum dots, specifically CdSe QDs, are also becoming an important tool in medical
imaging. Regardless of application, QDs with a high quantum yield (QY) are critical to
development of many future technologies. This thesis focuses on developing and
understanding the effect of surface treatments to produce cadmium selenide (CdSe) and
cadmium sulfide (CdS) QDs with a high QY.
The preparation method for the synthesis of CdSe and CdS QDs utilized in this
thesis involves the high temperature thermolysis of organometallic precursors via
microwave heating. During this method, organic precursors are dissolved in a heated
coordinating solvent and bound to unsaturated metal atoms on the QD surface to prevent
the formation of bulk semiconductors.10 The nanoparticles are capped with a monolayer
of organic ligands and are soluble only in non-polar hydrophobic solvents.10 Ligands play
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at least four distinct roles in the overall electronic function of the QDs. First, they are
present during the nucleation process and determine the reactivity and availability of the
crystal precursors and ligands.11 Second, they control the rate of growth and final particle
size distribution11 by keeping the particles isolated and facilitating homogenous growth
during synthesis.12 Third, they provide colloidal stability, preventing aggregation and
growth.11,13,
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Lastly, they interact electronically with surface sites and may passivate

defects on the surface of QDs.12
Quantum dots have a high surface area to volume ratio resulting in a large fraction
of atoms on the surface of the nanocrystals. Incomplete surface coverage can lead to the
formation of inhomogeneous defect sites on the QD surface. These defect sites are
capable of trapping electrons or holes, which in turn prevents radiative recombination and
ultimately degrades their QY. For this reason, proper passivation of the nanocrystal
surface is necessary to achieve a high QY. The goal of this thesis is to develop methods
to effectively passivate these surface defect points via treatment with various reducing
and oxidizing agents. It is expected that treatment with reducing/oxidizing agents will
lead to the formation of a cadmium oxide (CdO) layer around the QDs thereby
passivating the defect sites and resulting in increased QY.16 The reducing agents that will
be investigated include: sodium borohydride (NaBH4), calcium hydride (CaH2), and
hydrazine (N2H4); while the oxidizing agents include: benzoyl peroxide (C14H10O4) and
tert-butylhydroperoxide (C4H10O2).
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To better understand the effect surface reactions of reducing and oxidizing agents
have on the optical properties of the QDs, several variables were investigated more
thoroughly. Specifically, the effect of cadmium precursor in the semiconductor (Se vs. S),
stabilizing ligand (oleylamine vs. oleic acid (OA)), non-coordinating solvent
(octadecence (ODE) vs. trioctylamine (TOA)), and dispersion solvent (chloroform vs.
toluene) was studied. Untreated and treated QDs were subjected to ultra-violet visible
(UV-Vis) spectroscopy, fluorescence spectroscopy, and thermogravimetric analysis
(TGA) to provide information about the QD optical properties, size, and surface coverage
of ligands. The QY of the QDs before and after treatment was used as a measure of
success.
This thesis is organized into 8 chapters. Chapter 2 is a literature review section
that provides an overview of the applications and synthesis methods of QDs and serves as
motivation for the work completed in this thesis. Chapter 3 outlines the experimental
methods used to synthesize and treat the QDs with various reducing/oxidizing agents.
Chapters 4, 5, and 6 present and discuss the results obtained from carrying out these
procedures, and Chapter 7 provides general conclusions from these results. Lastly,
recommendations for future work are summarized in Chapter 8.
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Chapter 2. Background
2.1 Quantum Dots versus Bulk Semiconductors
A bulk semiconductor is a material that has an electrical conductivity between a
metal and an insulator.1 Quantum dots behave similarly to bulk semiconductors but differ
in two distinct ways: (1) the bandgap of QDs can be tuned; and (2) the energy levels of
QDs are considered to be discrete rather than continuous. Electrons in a bulk
semiconductor exhibit different energies and are therefore in different energy levels. The
energy levels are continuous because there is virtually no energy difference between the
levels.2 Some of the energy levels are ‘unavailable’ to electrons and are referred to as the
bandgap.1-3 Electrons occupying levels below the bandgap are in the valence band while
those above the bandgap are in the conduction band (see Figure 2.1 below).1,2,4

Figure 2.1. Electron structure in a semiconductor material.

In most bulk semiconductors, the valence band is occupied by electrons, while the
conduction band is vacant.1,2,4,5 For electrons to move from the valence band to the
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conduction band, they must acquire enough energy to cross the bandgap.1-3,5 To
accomplish this, an external stimulus is required, such as heat, voltage, or photon flux.5
The electrons transferred from the valence band to the conduction band are called ‘free’
electrons because they have been ‘freed’ from the confines of the valence band.1 The
minimum amount of energy a bulk semiconductor absorbs to raise an electron from the
valence band to the conduction band corresponds to the energy of the bandgap (Eg).2,3 For
bulk semiconductors, the bandgap energy is fixed and is dependent on the semiconductor
material. The temporary valence location vacated when an electron moves to the
conduction band is a positively charged ‘hole’.1,3-5 A material rich in holes (or lacking
electrons) is a p-type material whereas an electron-rich material is n-type.1,2
The promoted electrons in the conduction band remain there momentarily before
returning to the valence band. As the electron returns to the valence band, it passes
through the bandgap. Electromagnetic radiation with a wavelength corresponding to the
energy it loses in the transition is emitted.2,3 Typically, electrons fall from the bottom of
the conduction band to the top of the valence band. In other words, they travel from one
edge of the bandgap to the other. Thus, because the bandgap is fixed in bulk
semiconductors, this emission wavelength is also fixed. Often this emitted light is not in
the visible spectrum; instead it is in the infrared (IR) or ultra violet (UV) region.2 The
process of an electron returning to the valence band is known as radiative
recombination.2,3
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Quantum dots are different from bulk semiconductors because their bandgap can
be tuned to emit light at a particular wavelength. The size of the bandgap is dictated by
the size of the particle. More specifically, the nanocrystal bandgap increases with
decreasing size as 1/r2 (where r refers to the QD radius).6 As a result, quantum dots of the
same material can vary in color and optical properties depending on the QD size. The size
may be precisely controlled by the reaction time, temperature, and choice of ligand used
during their synthesis, which will be discussed in detail below. CdSe QDs, for instance,
can be tuned to emit radiation across most of the visible and some of the IR spectrum
(4500 to 6500 Å).6 Experimental observations of CdSe QDs have shown that as the
average radius increases from 0.6 nm to 4.15 nm, the emitted color changes from blue
(centered at 450 nm7) to red (centered at 650 nm7) (see Figure 2.2 below), and the photon
energy of the first absorbance peak decreases from 3.02 eV to 1.88 eV 8and eventually
approaches the bandgap energy of bulk CdSe (Eg = 1.7 eV).9 The electrons of QDs that
are considered ‘blue shifted’ must travel a greater distance in terms of energy and
therefore produce radiation at a shorter, ‘bluer’ wavelength. Because this thesis focuses
on both CdSe and cadmium sulfide (CdS) QD cores, it is important to note that the
bandgap of CdS is higher than that of CdSe (Eg = 2.5 eV9).

Figure 2.2. Schematic of QD particle size and color emitted.
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Another difference between QDs and bulk semiconductors is that the distance
between the electron and ‘hole’ pair (called an exciton) in the bulk material is much
smaller than the dimensions of the semiconductor crystal. With QDs, the exciton is about
the same size as the dimensions of the particle and as a result, their energy levels are
discrete rather than continuous.6 In this context, discrete refers to the finite separation
between energy levels (also referred to as quantum confinement). The separation between
energy levels increases as the particle size decreases. Quantum confinement occurs when
the nanocrystal radius becomes comparable to the bulk exciton Bohr radius (~56
Ǻ for
CdSe).6 Under these conditions, the absorptive and emissive behavior of the
semiconductor is changed because the addition or subtraction of just a few atoms can
alter the boundaries of the bandgap.6

2.2 Applications for Quantum Dots
The ability to tune the size of quantum dots allows for their potential application
in a number of photonic devices, including: emitters for color displays10, color modifiers
for light emitting diodes (LEDs)11, optical fiber amplifiers12,13, low threshold lasers14,
self-assembled photonic sphere arrays15, polymer-based photovoltaic cells16, optical
temperature probes17, chemical sensors16, and high-speed signal-processing filters18.
Quantum dots, specifically CdSe, are also often applied to the medical field. Due to the
known toxicity of Cd and Se to cells, however, in vitro biomedical applications of CdSe
QDs are currently practiced, whereas in vivo applications are still in the research stage.
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Examples of in vitro applications include: laboratory blood tests, urine analysis, tissue
slide staining, and cell culture monitoring.19 Future work of this thesis focuses on the
potential use of QDs in various in vivo applications which are described in detail below.
A primary application of QDs in the medical field involves bioconjugation, or the
coupling of a QD to a small biomolecule, including oligonucleotides, peptides, proteins,
and DNA. In fact, multiple biomolecules can be attached to the surface of a single QD
due to the large surface area of the nanocrystals.20 It has been estimated that two to five
protein molecules and 50 or more small molecules (such as oligonucleotides or peptides)
can be conjugated to a single 4 nm QD.20 These bioconjugations are being used for the
assembly of new materials, for developing homogeneous bioassays, and as multicolor
fluorescent labels for detection and imaging.20 One specific example involves the
attachment of antibodies that have the ability to bind many target proteins to QDs in
order to form new luminescent tags which can help detect the presence of selected
diseased tissues or illuminate the structure of diseased areas.20
A further application of QDs is the multiplexed optical encoding and highthroughput analysis of genes and proteins. This involves embedding polystyrene beads
with multicolor CdSe QDs at various color and intensity combinations.20 It is estimated
that the use of six colors and 10 intensity levels can encode one million protein or nucleic
acid sequences.20 Specific capturing molecules (such as peptides, proteins, and
oligonucleotides) are then covalently linked to the beads and encoded by the bead’s
spectroscopic signature.20 To read all of the QD-encoded beads, a single light source is all
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that is required.20 To then determine whether an unknown analyte is captured or not,
conventional assay methodologies are applied.20 This so-called ‘bar-coding’ technology
can be used for gene profiling and high-throughput drug and disease screening. These
‘bar-coding’ technologies offer significant advantages over planar chip devices, including
improved kinetic binding and dynamic range.20
Quantum dots can also help read DNA sequences.20,21 Recent research has found
that by attaching QDs and antibodies to polymer microspheres, the prevalence of targeted
DNA sequences can be read by a standard flow cytometer.21 The surface of each
microsphere could also be covered with specific antibodies that would bind to particular
protein sequences.21 This method has significant potential as it is currently being
compared to immuno-assay fluorescence arrays.21
Quantum dots can further be used to accurately identify specific types of cancer.
To diagnose a specific cancer type, slides are made from tumor tissue samples and
selective chemical stains highlight one specific feature at a time, such as nuclei or aster
cells.19 Quantum dots can allow for the simultaneous marking of numerous features with
different colors, thus improving the amount and speed of information received by
oncologists.19
Oncologists are also exploring the use of quantum dots to guide cancer surgery.
The intensity of scattered luminescence can guide a surgeon to selectively remove only
tagged diseased tissue beyond the primary tumor.19,22 Traditionally, a radioactive blue
dye is used to track the flow of cancer cells through the lymph system.23 However,
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ionizing radiation is hazardous to both the patient and medical caregivers.23 As a
potentially safer alternative, near-infrared (λ is approximately 850 nm) QDs are being
explored to mark cancerous lymph nodes for surgical removal from mice and pigs.23

2.3 Optical Properties
Despite the large number of potential QD applications in the medical field, the
future work of this thesis focuses on the specific use of QDs in bio-imaging. Quantum
dots are an emerging alternative to traditional organic dyes for solar cells and bioimaging primarily because of their (1) small size, (2) ability to tailor the chemistry of the
QD surface, (3) high quantum efficiency, (4) narrow spectral linewidth, (5) broad
absorption tail, (6) stable emission, and (7) long fluorescence lifetime. The ability to
tailor the QD chemistry is beneficial because varying the size, shape, and composition of
QDs allows for the production of materials with specific emissive, absorptive, and lightscattering properties. This flexibility allows for the production of QDs whose emissive
properties range across the entire visible spectrum from the same material.
The terms quantum yield, quantum efficiency, and photoluminescence are used
interchangeably throughout this thesis to represent the brightness of the QDs. The
quantum yield refers to the existence of nonradiative transition of electrons and holes
between energy levels. In other words, it is the ratio of emitted photons to absorbed
photons.1,25 The quantum yield of QDs is significantly higher than organic dyes causing
them to be advantageous for bio-imaging applications.26 This is because the molar
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extinction coefficients of QDs are about 10-50 times larger than those for organic dyes
(5-10 X 104 M-1cm-1).26 This causes the QD absorption rates to be 10-50 times faster at
the same excitation photon flux than organic dyes.26 Due to this increased rate of light
emission, individual QDs appear to be 10-20 times brighter than dyes.26
One major disadvantage of organic dyes involves their broad, overlapping
emission spectra that prevent their use in multicolor detection applications20,27 without
the use of complex mathematical analysis of the data. Multicolor detection is used to
track multiple molecular targets simultaneously using different colors and intensities, and
is therefore a very important feature. For example, most complex human diseases such as
cancer and atherosclerosis involve a large number of genes and proteins and would
therefore require this type of detection.26 Quantum dots exhibit a narrow spectral
linewidth6,28, typically one third that of a conventional organic dye, therefore making
them very attractive for these types of applications (see Figure 2.3).29 A narrow spectral
linewidth means that the QDs can only be excited within a narrow window of
wavelengths.30 Consequently, QDs of different sizes and colors can be excited by a single
wavelength shorter than their emission wavelengths, with minimum signal overlap.
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Figure 2.3. Excitation (dotted line) and fluorescence (solid line) spectra of fluorescein (top) and a typical
water-soluble QD (bottom).30

The fluorescence peak of traditional organic dyes is very close to their absorption
peak.19 This causes each dye to require its own expensive, carefully-tuned, sharp-cutoff
filter to block the excitation background from the imaging camera.19 In contrast, QDs
have a broad absorption tail over wavelengths shorter than the peak emission
wavelength.19 A single common long pass filter and a single excitation source are
therefore all that is required for QDs that emit in several distinct wavelength ranges.31
QDs offer another advantage over organic dyes because their emission
wavelengths can be continuously tuned by varying the particle size and chemical
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composition. Additionally, QDs are about 100 times more stable against photobleaching
(also called fading) than organic dyes.28,30 Moreover, QDs show long-term stability
against photochemical and current-induced degradation.6 This extreme stability reflects
the strong chemical bonding found in QDs and makes them very attractive for the
imaging of thick masses over long periods of time.30 It also allows for the acquisition of
real-time20 images that are bright and well contrasted.32
Another interesting characteristic of QDs is their long fluorescence lifetime on the
order of several to tens of nanoseconds.29 This allows time-delayed fluorescence
measurements, which can be used to suppress the autofluorescence of biological
matricies.29 Additionally, the long fluorescence lifetime facilitates the use of time-gated
detection to separate their signal from that of shorted lived species.32 More specifically,
time-gated detection provides a technique to separate the QD fluorescence from
background fluorescence.

2.4 Synthesis
2.4.1 Synthetic Methods
Since QD emission is size dependent, the synthesis process must be carefully
controlled to achieve the targeted radius with a narrow size distribution. There are two
main approaches for the synthesis of QD cores depending on the nature of the solvent: (1)
the wet chemistry method, and (2) high temperature thermolysis of organometallic
precursors.6,19,20,33,34 The wet-chemistry method uses low-temperature polar solvents such
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as water or methanol, whereas the organometallic synthesis method uses high
temperature, non-polar solvents such as trioctylphosphine oxide (TOPO). Typically, the
wet chemistry method produces lower quality QDs with smaller and wider emission
peaks as compared to those produced by the organometallic method.19,35 The QDs
produced in this thesis were synthesized via the latter method.

2.4.1.1 Wet Chemistry Method
The wet chemistry method involves the deposition of a precursor material with a
surfactant in a coordinating organic solvent.36 As the QDs grow, the organic solvent is
naturally coordinated to the surface of the QDs and acts as a dispersant.36 Accordingly,
the organic solvent allows the initial nucleus to grow to the level of nanometers.36 The
wet chemistry method allows for the control of QD core size by varying the organic
solvents used, reaction temperature, and reaction time.36,37
The type of organic solvent used in the wet chemistry method is of the utmost
importance. The ideal solvent should: (1) have the ability to be coordinated to the surface
of the QD36, (2) be sufficiently bulky to the extent that it can control the growth rate of
the cores36, (3) be stable at the crystal growth temperature36, and (4) be able to disperse
the QDs in a state where the solvent is coordinated to the surface of the core.36 For
example, in a study by Masala et al.35, two different solvents were investigated:
ethylenediamine and pyridine. The QDs produced in the presence of ethylenediamine
were small and uniform (approximately 4 nm – 6 nm in diameter), whereas QDs with
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poor crystallinity and low yield resulted in the presence of pyridine.35 From these results,
ethylenediamine was recommended as the organic solvent of choice for this QD synthesis
method.
Unfortunately, the synthesis temperature is limited by the boiling point of the
organic solvent.35 When grown at a low temperature, QDs often have a poor degree of
crystallinity35 as well as a high defect concentration19 leading to a low quantum
efficiency. It is therefore necessary to choose a solvent with a higher boiling point to
ensure that a high enough reaction temperature can be used to produce high quality QDs.
The particle size distribution of QDs synthesized from the wet chemistry method
is usually so wide that size-selective precipitation is required to separate a distribution
into sections with narrow emission peaks.19,35 Additionally, this method typically yields
QDs with very poor crystallinity35 and low quantum yield. For these reasons, the wet
chemistry method was not investigated in this thesis.

2.4.1.2 Thermoylsis of Organometallic Precursors
The decomposition of molecular precursors at high temperatures in a coordinating
solvent is one of the most successful and popular routes to prepare high-quality QDs.35
This approach was first developed in 1993 by Bawendi et al. who prepared CdE QDs
(E = Se, S, and Te) through separate, rapid injections of a solution of cadmiumdimethyl
(CdMe2) in trioctylamine (TOA) and a solution of trioctylphosphine (TOP) and the
corresponding chalcogenide (Se, S, or Te) into tri-n-octylphosphine oxide (TOPO) at
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high temperatures (200 °C to 300 °C).7,8,35,38 The capping agent allowed particle stability
in organic solvents, prevented particle aggregation, and electronically passivated the
semiconductor surface.35
This method, although successful at producing high-quality QDs, is hindered by
the toxicity of the starting materials as well as the high temperature required by the
reaction. In particular, the alkyl metal (CdMe2) is pyrophoric, explosive at high
temperatures, and emits highly toxic gases of metal oxide.35 It was later found that
cadmium oxide (CdO) and cadmium salts with an anion of a weak acid, such as cadmium
acetate (Cd(Ac)2) and cadmium carbonate (CdCO3A), proved to be adequate
substitutes.35,38-40 Compared to the highly unstable CdMe2, the cadmium salt substitutes
offer several advantages, including: (1) the injection temperature can be much lower
(220 °C to 300 °C), (2) both nucleation and growth are almost independent of injection
therefore guaranteeing great reproducibility, and (3) the slow nucleation implies that the
injection can be completed within a longer time, therefore allowing large amounts of
stock solutions to be added to the reaction vessel, making the process more feasible for
scale-up productions.35
Today, a typical reaction involves the dissolution of the cadmium salt in a mixture
of TOPO and another solvent (for example, amines such as n-dodecylamine, or fatty
acids such as stearic acid) at 300 °C or below, followed by the addition of a solution of
the chalcogenide (Se, S, or Te) in tri-n-octylphosphine (TOP).35,40 The chalcogenide and
cadmium precursor combine to form stable nuclei that subsequently grow as the reaction

18
proceeds.40 At the growth temperature, surfactant molecules adsorb and desorb rapidly
from the QD surface, enabling the addition (as well as removal) of atoms from the
nanocrystal, while aggregation is suppressed by the presence of one monolayer of
surfactant at the nanocrystal surface.41 The QDs resulting from this method are typically
monodisperse, with sizes ranging from 2 nm to 25 nm and quantum efficiencies of up to
85%.35
Tri-n-octylphosphine is used as both a surfactant and selenium-delivery solvent
when in the form of a trioctylphosphine selenium (TOPSe) solution during QD
synthesis.42 During the synthesis process, TOP (a cationic precursor) coordinates to the
chalcogenide (Se or S) ion.42 The phosphine then undergoes nucleophilic attack from
either the carboxylic acid/phosphonic acid counter ion or excess TOP in solution,
cleaving the P=Se bond.42 In this thesis, the cadmium precursor used was cadmium
acetate (Cd(Ac)2) therefore the carboxylic acid provided the counter ion. The presence of
a ligand during synthesis (especially oleic acid (OA)) induces P=Se cleavage.42 The
presence of TOP on selenium rich surfaces has also been shown to be the source of
enhanced fluorescence.42
The organometallic synthesis method was developed8 to produce superior
crystallinity and higher quantum yield43,44 from higher temperature reactions, and to
provide better size control and surface passivation44,45 than other synthesis methods. At
these higher temperatures, there is more thermal energy to help each add-atom find more
energetically favorable bonding positions in the crystal lattice, therefore reducing defects
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by annealing during growth, leading to increased overall quantum efficiency.19 Another
advantage associated with the organometallic method is that a narrower size distribution
of QDs may be achieved compared to other techniques because effective separation of
the two synthesis stages (nucleation and growth) is achieved by the ‘hot injection
technique.’34 The ‘hot injection technique’ involves the rapid injection of organometallic
reagents into a hot coordinating solvent causing nucleation to immediately take place and
continue until the temperature and ligand concentration drop below a critical
threshold.8,46 The depletion of reagents through nucleation and the sudden temperature
drop associated with the introduction of room temperature reagents prevents further
nucleation8, thus yielding particles of one size.46 It is estimated that the diameter of CdSe
QDs immediately after nucleation is about 1.75 nm and the fluorescence peak is around
500 nm.47 The subsequent growth of the QD, however, resulted in the red shift of the
fluorescence peak to green, yellow, and red as the size of the QD continued to
increase.47,38 The ‘hot injection technique’ was utilized in this thesis.

2.4.2 Impact of Reaction Parameters on the Synthesis of QDs
For any method, experimental conditions are of the utmost importance when
trying to produce QDs with consistent shape, crystal structure, and size. Alisvisatos et al.
explored the CdSe system extensively to demonstrate that parameters such as
temperature, ligand concentration, and growth rate significantly influence QD size and
morphology.35,41,46 The size of the QDs can easily be tuned by controlling the reaction
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temperature, with larger particles forming at higher temperatures.35 Spherical QDs were
found to form at high ligand concentrations and slow growth rates, whereas rod-,
teardrop-, and tetrapod-like shaped QDs formed at lower ligand concentrations and
increased growth rates.35 It is most desirable to produce spherical QDs because they can
achieve the highest quantum efficiency (85% for CdSe QDs7) as compared to
significantly lower quantum efficiencies for the other morphologies (for example, rodshaped CdSe QDs can achieve a quantum efficiency as low as 1%41).
As mentioned above, the temperature necessary to maintain steady growth
increases with increasing QD size. More specifically, as the size distribution narrows, the
reaction temperature must be raised to maintain steady growth.8 At these higher
temperatures, the CdSe cores begin to grow via Ostwald ripening, and their size
distribution deteriorates, leading to broader spectral line widths.33 In Ostwald ripening,
the higher surface free energy of small QDs makes them less stable to dissolution in a
solvent than larger QDs.8,20 This difference in stability results in the sacrifice of small
particles to larger particles.8 In other words, larger particles grow and smaller particles
dissolve, thus widening particle size distributions. When the size distribution begins to
broaden, the temperature necessary for slow, steady growth drops.8 These lower
temperatures can lead to the incomplete decomposition of the precursors or to reduced
crystallinity of the surface monolayer of ligands.33 It is therefore necessary to determine
the ideal growth temperature individually for each CdSe core size to ensure that the size
distribution of the cores remains constant and that surface ligand layers with a high
degree of crystallinity are formed.33
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Ligand concentration also affects both the shape and size distribution of QDs. For
diffusion-controlled growth, the distribution of incoming diffusion flux toward each
nanocrystal depends strongly on the ligand concentration in the bulk solution.48 At high
ligand concentrations, the chemical potential of the bulk solution is equally as high as the
overall chemical potential of the entire crystal.48 In this type of environment, there is no
net diffusion flux between the bulk solution and the diffusion sphere. To minimize the
total surface energy of the nanocrystal, the ligands on each nanocrystal surface adjust
their position which means a rod-shaped crystal will turn into a dot-shaped one.48 Ligand
concentration also affects the size distribution of QDs. At higher ligand concentrations,
the smaller particles grow faster than the larger ones, resulting in a nearly monodisperse
size distribution.41 If the ligand concentration drops below a critical threshold, small QDs
are depleted as larger ones grow and the distribution broadens41 similar to Ostwald
ripening. Thus, the preparation of nearly monodisperse spherical QDs is best achieved at
a high ligand concentration.
Manipulation of the growth kinetics can offer further control over the shape of
QDs. This is possible because the growth of CdSe QDs is highly anisotropic when the
system is kinetically over-driven by a high ligand concentration.41 In addition to being
anisotropic, CdSe has a unique c-axis which leads to faster growth along this axis when
the overall growth rate is fast.41 When the growth rate is slow, a nearly spherical shape
that minimizes surface area is favored.41 A slow reaction rate is preferred because it
forms the thermodynamically favored sphere rather than the kinetically favored rod.

22
In addition to the experimental conditions discussed above, the precursor ratio
(amount of Cd compared to amount of Se) plays a significant role in determining the
emission properties of the synthesized QDs. In a study by Qu and Peng, Cd:Se ratios
were varied between 2:1 and 1:10 to determine effect of initial precursor concentrations.7
From their study it was concluded that the highest quantum yields resulted when there
was an excess of one of the precursors.7 When either one of the precursors was initially in
excess, the concentration of the reacting species in the solution was considered constant
after the growth reaction proceeded for a short period of time.7 This provided a desirable
condition for the construction of the most favorable surface structure/reconstruction for
the QDs in solution.7 Thus, an excess of one of the precursors, either Cd or Se, is required
to produce QDs with high quantum efficiency.

2.4.3 Effect of Ligands on the Synthesis of QDs
The quality of QD cores produced is also dependent on the molecule that binds to
the central metal atom of the QD core by some attractive interaction, (chemisorption,
electrostatic attraction, or hydrophobic interaction).31 This molecule is called a ligand.
Typical CdSe QDs have a diameter between 2 nm to 5 nm, with approximately 100 to
1600 CdSe ion pairs, and approximately 40 to 250 capping ligands on the QDs surface.49
Ligands play at least four distinct roles in the overall electronic function of the QDs.
First, they are present during the nucleation process and determine the reactivity and
availability of the crystal precursors and ligands.50 Second, they control the rate of
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growth and final particle size distribution50 by keeping the particles isolated and
facilitating homogenous growth during synthesis.19 Third, they provide colloidal stability,
preventing aggregation and growth.31,50,51 Lastly, they interact electronically with surface
sites and may passivate defects on the surface of QDs.19
Defects exist on the surface of QDs due to the large surface-to-volume ratio of
QDs45,52,53 which causes the formation of dangling bonds from some of the surface
atoms.7 Ligands serve to donate electrons to, or accept electrons from, these dangling
bonds of incompletely coordinated metal ions (Cd2+ sites are electron acceptors, and Se2are electron donors) in order to preserve the core character of the QD.53,54 The surface
defects often act as nonradiative recombination sites for electron-hole pairs produced by
incident excitation light, thereby reducing the quantum efficiency of the QDs.7,55 In CdSe
QDs, these nonradiative traps are positioned above the valence band.45 Ligands passivate
varying amounts of these surface defects to influence the quantum efficiency of the QDs.
If the surface ligand provides good passivation of surface defects, high quantum
efficiency is expected.
The nature and density of the surface trapping sites depends strongly on the
surface structure and shape of the QD, along with the nature of the defect sites on the QD
surface.7,31 Furthermore, the atomic configuration of the QD surface significantly affects
the degree of passivation provided by the ligands.7 This can be visualized by considering
the steric effect of the surface configuration of the QDs on the packing of the surface
ligands.7 Thus, the surface structure of QDs also plays a role in determining quantum
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yield. The shape of the QD dictates the number of atoms on the QD surface and therefore
the number of potential surface trapping sites. Figure 2.4 below illustrates the fraction of
surface atoms on a CdSe QD for different shapes. Spherical QDs have the smallest
number of total surface atoms and are thermodynamically the most stable.56 It is
estimated that approximately 56% of the atoms in a 3 nm spherical QD are at the
surface.54 On the other hand, elongated structures, such as rods and wires, maintain a
larger fraction of their constituent atoms on their surfaces. Thus, spherical particles have
the least amount of potential defect sites on their surface causing them to have the highest
quantum yield potential and therefore be the most desirable.

Figure 2.4. Fractions of atoms on the CdSe QD surface plotted against the total number of atoms. The wires
(purple) are 1 μm in length, the disks (green) are 20 nm in length, and the spheres (blue) and rods (red) are
4 nm in diameter.56

Because ligands play such a vital role on the overall quality of QDs, numerous
efforts have been made to synthesize high quality spherical CdSe QDs using different
capping ligands. Although there are several different types of ligands, this thesis
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investigates the effect of two, oleic acid (OA) and oleylamine, which are discussed in
further detail below.

2.4.3.1 Oleic Acid (OA)
As described above, a popular method of producing QD cores via the
organometallic method involves the use of tri-n-octylphosphine oxide (TOPO) as the
ligand of choice. Although nearly monodisperse QDs with high quantum yield were
obtained with TOPO, it is expensive, hazardous, and toxic.57 Additionally, due to varying
amounts of impurities in commercially obtained TOPO, it is difficult to consistently
produce high-quality QDs using various TOPO batches. Oleic acid (OA) was chosen
instead of TOPO as one of the ligands investigated in this thesis as it is an
environmentally friendly, cheaper, and a safer capping ligand.57
Research has shown that OA can yield much more stable QDs than other
saturated fatty acids.58,59 This higher stability is attributed to the amorphous structure of
the ligand layer which is less permeable to oxygen than a crystalline ligand layer.58 More
specifically, crystalline packing of the hydrocarbon chains of the ligand creates gaps
between each crystalline domain.58 These gaps act as the diffusion channels for oxygen
molecules, consequently making the QDs less stable if they are coated with ligands with
a saturated hydrocarbon chain.58 The stability of OA is also attributed to the double bond
and associated ‘kink’ in its alkyl chain which serves to impart colloidal stability.42 Oleic
acid further provides better protection against oxidation and emission loss than other
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ligands with 18 carbons, including stearic acid and octadecylamine (ODA).19 This higher
stability of QDs capped with OA was attributed to the amorphous structure of the OA
ligand layer.19

2.4.3.2 Oleylamine
In a study conducted by Talapin et al. it was found that smaller QDs with better
size distributions were achieved when amines (such as oleylamine) were used as
stabilizing and size-regulating ligands than the commonly used TOPO.45 Additionally,
amines provided much better passivation of the defects on the surface of QDs leading to
non-radiative recombination.45 Research has consistently shown that for both CdS and
CdSe QDs, direct interaction between the QD surface and amine ligand effectively
passivates the QD surface and blocks the trapping of electrons at the defect sites therefore
leading to high quantum efficiecy.60 The use of amines as capping ligands on CdSe QDs
has also been shown to result in a surface reconstruction, specifically a lattice contraction
during growth, which also may contribute to the elevated quantum efficiency.42
The proper choice of amine is important in producing high quality QDs. In
general, less sterically hindered amines create higher capping densities, which leads to
improved surface capping and, hence, better passivation of traps.45 The boiling point of
the chosen amine is also of importance as it can potentially limit its use. For example, the
relatively low boiling point (~175 °C) of octylamine prevents its use in CdSe QD
reactions, as they require a temperature of approximately 300 °C.45 Octylamine was
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further ruled out as a capping ligand because QDs were found to have a tendency to
partially precipitate from solution during heating.45 The use of secondary amines
(including dioctylamine) was also found to be inadequate for QD synthesis because they
resulted in a very weak stabilization and poorly controlled growth of the QDs.45 For this
thesis, the amine ligand of choice was oleylamine because it has been shown to produce
high quality QDs, is cost effective, and safe to handle.
During the synthesis of QDs, the trioctylphosphine (TOP) and chalcogenide
(either Se or S) solution is rapidly injected into the ligand and cadmium precursor
solution to begin the growth process of the QD core. After this injection, the solution
color may change based on ligand stability. For example, the TOPSe/TOPS solution is
very stable in oleylamine due to hydrogen bonding, therefore the color is not expected to
change.61 Because oleylamine is a very stable ligand, the growth rate of the QDs is much
slower, resulting in spherical nanoparticles with a uniform size distribution.61 FTIR
spectra on oleylamine-capped CdSe QDs suggested that oleylamine binds through
donation of the lone pair of electrons from the nitrogen atom to both cadmium and
selenium surface sites.42 Amines are expected to bind to selenium sites preferentially over
cadmium sites due to the higher binding energy for selenium terminated sites over
cadmium terminated sites, 1.05 eV compared to 0.91 eV, respectively.42

28
2.4.4 Effect of Solvent
2.4.4.1 Non-Coordinating Solvent
The non-coordinating solvent mixture strongly affects nucleation, which in turn
affects QD growth. This thesis investigates the effect of the coordinating properties of
two different solvents when coupled with oleic acid: non-coordinating octadecene
(ODE), and weakly-coordinating trioctylamine (TOA).
Octadecene is a non-coordinating solvent that provides an environment for
particle nucleation and growth.40,62 ODE has a relatively low melting point (below
20 °C), relatively high boiling point (about 320 °C), low cost, low toxicity, low reactivity
to precursors, and excellent solvation power for many compounds at elevated
temperatures.62,63 Each of these factors makes ODE an ideal solvent for the growth of
high-quality QDs. Research has shown that nucleation of CdSe QDs from ODE is very
fast and stops almost immediately after precursor injection.40,62 It is estimated that when
ODE is used, nucleation and growth is completed within the first 100 s of the reaction.40
Because nucleation and growth happen so fast, QDs with a very narrow size distribution
are formed in the presence of ODE. Additionally, it has been found that QDs prepared in
ODE had a spherical shape.61
In a study where CdS QDs were formed in the presence of OA coupled with
ODE, the amount of nuclei formed during the reaction could be controlled.42 When too
many nuclei were formed, the size distribution of QDs was defocused due to Ostwald
ripening.42 Conversely, when there were too few nuclei, particle growth was too fast to
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reach the required size distribution.42 The balance between these two extremes was able
to be achieved by altering the concentration of the capping ligand (OA) and thus the
amount of metal complex available for the reaction through control of the amount of
ODE.42 Using ODE as a solvent also allows control over particle size, making it further
advantageous.42
Unlike ODE, TOA is a weakly-coordinating solvent61, therefore it contains some
coordinating groups. Similar to ODE, research has shown that in the presence of TOA,
spherical QDs formed.61 Although little literature exists on TOA, this thesis sets out to
compare the quantum yield of QDs prepared in the presence of TOA to those prepared in
ODE.

2.4.4.2 Dispersion Solvent
Depending on the application, QDs may need to be suspended in a particular
solvent. For example, biomedical applications typically require aqueous environments.
Quantum dots synthesized from the wet chemistry method are soluble in water and other
polar solvents. Those made from the organometallic synthesis, on the other hand, are
soluble in a variety of volatile non-polar organic solvents because of the residual nonpolar organic ligands bonded to the QD surface.19 The QDs studied in this thesis were
synthesized via the organometallic method, therefore the focus of this section will be on
non-polar solvents, specifically chloroform and toluene.
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The dispersion solvent has an effect on the optical properties of the QDs. In a
study conducted by Bullen et al., it was observed that chloroform yielded greater
photoluminescence intensity than toluene.50 This difference in photoluminescence may be
due to changes in the dissolved oxygen concentration in the different solvents.50 Oxygen
is more soluble in chloroform than toluene.50 The concentration of oxygen at 20 °C is
8.63 mM in toluene and 11.6 mM in chloroform.50 This suggests that the primary effect
of solvent changes is to alter the degree of adsorption of passivating ligands on the QD
surfaces.50 When the solvent in which the QDs are dissolved is altered, the adsorption
isotherm adjusts.50 If the ligand is more soluble in the new medium, desorption occurs.50
If the ligand is less soluble, it will tend to adsorb from solution and may enhance the
luminescence even further.50 The as synthesized QDs with OA and oleylamine as the
capping ligands are non-polar. Consequently, QDs are more soluble in nonpolar solvents
such as toluene, hardly soluble in chloroform, and insoluble in n-butanol and water.64,65
In other words, because the QDs are less soluble in chloroform than toluene, it is
expected that they will exhibit higher quantum efficiency when dissolved in chloroform.
Quantum dot concentration in a dispersion solvent affects quantum efficiency. In
general, the more concentrated the QD concentration, the higher the quantum efficiency.
This trend is explained by the effect of dilution on the surface chemistry of the QD.
Assuming a simple reversible equilibrium exists between ligands adsorbed to the QD
surface and free ligands in solution, a proposed reaction is66:
[Cd–L]

[Cd] + [L]

(1)
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where [Cd–L] is the concentration of Cd sites bound to ligand in solution, [Cd] is the
concentration of empty binding sites, and [L] is the concentration of free ligand in
solution.66 Because the proposed reaction is reversible, after dilution in a solvent the QDs
and ligands should re-establish equilibrium and the fraction of bound surface sites should
decrease.66 For this reason, decreased quantum efficiency is expected with decreasing QD
concentration.66

2.4.5 Separation of Cores from Reaction Solution
After synthesis, it is possible to precipitate QDs of a specific size from solution
through the addition of methanol. The addition of methanol increases the average polarity
of the solvent and reduces the energetic barrier to flocculation.8 Flocculation differs from
precipitation because the colloids are suspended in a liquid prior to separation rather than
actually dissolved in the solution. The largest particles in a dispersion experience the
greatest attractive forces and therefore have a higher probability of overcoming the
reduced barrier.8 For this reason, the large particles are enriched in the flocculate
produced and it is possible to remove a specific subset of particles from the solution.8 In
this thesis, methanol was used to precipitate cores of a specific size distribution.

2.5 Surface Treatment
As previously explained, the surface of QDs is coated with passivating ligands
that stabilize the growing particle, sustain their dispersion in solution, and minimize the
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number of surface atoms with reduced coordination number.67 Often, the surface
coverage is incomplete and the unbound surface atoms constitute a distribution of
localized sites that carry slight positive or negative charge.67 These sites act as
inhomogeneous defects and are capable of trapping electrons or holes, preventing their
radiative recombination32 and lowering the quantum efficiency.67,68 In addition to proper
choice of ligand, these defect sites can be passivated through the addition of a reducing or
oxidizing agent.
In a specific instance, Jang treated cadmium sulfide (CdS) QDs with sodium
borohydride (NaBH4). Sodium borohydide is a widely used reducing agent that is both
inexpensive and safe with regards to storage and handling.69 The quantum efficiency of
the CdS QDs increased from 1.4 % to 78 % after treatment, which is a 54 fold
improvement.70 Additionally, they found that the shape and size of the QDs did not
change after treatment, according to transmission electron microscopy (TEM) images.70
Figure 2.5 illustrates these findings. Jang and coworkers concluded that treatment of the
QDs with NaBH4 caused oxidation of the QD surfaces. The NaBH4 reduced the oleic acid
surfactants to the corresponding alcohols or sodium salts which caused the ligands to lose
their coordinating properties and detach from the nanocrystal surface.70 Oxygen (from
atmospheric air) then diffused to the exposed cadmium on the QD surface to form a
cadmium oxide (CdO) layer around the CdS QD surface.70 This CdO layer effectively
passivated the surface defects, resulting in a nanocrystal with an enhanced quantum
yield.70 They further concluded that because the treatment was independent of reaction
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conditions and reagents, it would have similar effects for other II-VI QDs (including
CdSe).70

Figure 2.5. UV absorbance spectra and photoluminescence spectra of the original and NaBH4 treated CdS
QDs excited at 365 nm. Inset: photos taken under a 365 nm UV lamp (left, original; right, treated with
NaBH4) and HR-TEM images (left, original; right, treated with NaBH4) of the QDs in toluene.70

Jang et al. expanded on their work to include cadmium telluride (CdTe) QDs
produced via the wet-chemistry method. Ma et al. found that after NaBH4 surface
treatment, the photostability of the QDs as well as the quantum efficiency were
improved.71 These results successfully demonstrated that the NaBH4 treatment can be
extended to water-soluble QDs because NaBH4 is also water-soluble.71 With their data,
they generated an XPS spectrum which confirmed that a CdO layer formed around the
QD surface, as proposed by Jang.71 Due to the formation of this CdO layer, the surface
defects were effectively passivated and the quantum efficiency of the treated cores was
double that of the untreated cores.71 This increased quantum efficiency was justified due
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to the fact that CdO has a valence binding energy of 5.4 eV, which is higher than the
CdTe bandgap energy (Eg = 1.44 eV), therefore resulting in effective surface
passivation.71 Surface treatment did not change the size of the QDs (and therefore color
emitted), however, as confirmed by the consistency of the peak wavelength (585 nm) and
bandwith (40 nm) of the treated and untreated cores.71
The CdO layer formed on the QD surface was also shown to shield the oxygen
molecules from interacting with the QD core and preventing photo-oxidation.71 A total
internal reflection fluorescence microscope (TIRFM) quantitatively illustrated that the
original QDs were notably photobleached, while those treated with NaBH4 were much
more photostable.71 The decay times were estimated to be 5.4 s and 32.7 s, for untreated
and treated QDs, respectively, providing further evidence of the photostability of QDs by
surface treatment.71 Good photostability of QDs is required for their application as
fluorescent probes to label targets in biological systems, specifically for experiments with
long-term imaging.71
In the surface treatment of QDs, the amount of NaBH4 added as well as the
reaction time is very important. An excess amount of NaBH4 and/or prolonged reaction
time can result in the detachment of ligands from the QD core, resulting in the
aggregation and precipitation of QDs.71 Because of this strong dependence, these two
reaction parameters will be explored in this thesis. Additionally, this thesis will evaluate
the effect of other reducing agents (including calcium hydride (CaH2) and hydrazine
(N2H4)), as well as two oxidizing agents (including benzoyl peroxide (C14H10O4) and tert-

35
butyl hydroperoxide (C4H10O2)) to develop more robust methods to alter the surface
chemistry of CdSe and CdS QDs.
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Chapter 3. Materials and Methods
Chapter 3 will summarize the materials used and experimental methods practiced
to complete the experimental work of this thesis. Specifically, this chapter is divided into
several sections that will present the procedures used to synthesize CdSe and CdS QDs
from two different ligands (oleylamine and oleic acid) as well as two non-coordinating
solvents (octadecence (ODE) and trioctylamine (TOA)). Methods used to treat the
surface of the as-synthesized QDs with various reducing/oxidizing agents will then be
presented followed by the characterization techniques applied to evaluate the effect of
each surface treatment. Lastly, the methods which quantum yield and bandgap energy
(Eg) were calculated are presented.

3.1 Materials
3.1.1 Quantum Dot Core Synthesis with Oleylamine
The materials used to synthesize quantum dot cores include a glass vial (5 mL),
plastic cap for the vial, a 50 mL round-bottom flask, a 50 mL centrifuge tube, 5 mL
Norm-Ject® disposable syringes, syringe needles (21 G x 1½ in from Becton-Dickinson),
stir bars, selenium (Acros Organics, 99.5+%), sulfur (E.M. Science), dihydrate cadmium
acetate (Sigma-Aldrich, reagent grade, 98%), trioctylphosphine (TOP) (Sigma-Aldrich,
90%), oleylamine (Aldrich Chemical Company), and methanol (Aldrich Chemical
Company, 99+%). A CEM microwave (Discover System Model, 908005) was used to
heat the solution and facilitate the reaction. A Thermo Electron Corporation centrifuge
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(Centra CL5R) and centrifuge tubes were used to separate the cores from solution, an
Entela ultraviolet light (UVGL) was used to provide a long-wave (365 nm) ultraviolet
light to test sample fluorescence, and a Shel Lab vacuum oven was used to dry the
sample.

3.1.2 Quantum Dot Core Synthesis with Oleic Acid and ODE
The materials used to synthesize quantum dot cores include a glass vial (5 mL),
plastic cap for the vial, a 50 mL round-bottom flask, a 50 mL centrifuge tube, 5 mL
Norm-Ject® disposable syringes, syringe needles (21 G x 1½ in from Becton-Dickinson),
stir bars, selenium (Acros Organics, 99.5+%), sulfur (E.M. Science), dihydrate cadmium
acetate (Sigma-Aldrich, reagent grade, 98%), trioctylphosphine (TOP) (Sigma-Aldrich,
90%), oleic acid (Aldrich Chemical Company), octadecene (ODE) (Sigma-Aldrich,
technical grade, 90%), and methanol (Aldrich Chemical Company, 99+%). A CEM
microwave (Discover System Model, 908005) was used to heat the solution and facilitate
the reaction. A Thermo Electron Corporation centrifuge (Centra CL5R) and centrifuge
tubes were used to separate the cores from solution, an Entela ultraviolet light (UVGL)
was used to provide a long-wave (365 nm) ultraviolet light to test sample fluorescence,
and a Shel Lab vacuum oven was used to dry the sample.
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3.1.3 Quantum Dot Core Synthesis with Oleic Acid and TOA
The materials used to synthesize quantum dot cores include a glass vial (5 mL),
plastic cap for the vial, a 50 mL round-bottom flask, a 50 mL centrifuge tube, 5 mL
Norm-Ject® disposable syringes, syringe needles (21 G x 1½ in from Becton-Dickinson),
stir bars, selenium (Acros Organics, 99.5+%), sulfur (E.M. Science), dihydrate cadmium
acetate (Sigma-Aldrich, reagent grade, 98%), trioctylphosphine (TOP) (Sigma-Aldrich,
90%), oleic acid (Aldrich Chemical Company), trioctylamine (TOA) (Aldrich, 98%), and
methanol (Aldrich Chemical Company, 99+%). A CEM microwave (Discover System
Model, 908005) was used to heat the solution and facilitate the reaction. A Thermo
Electron Corporation centrifuge (Centra CL5R) and centrifuge tubes were used to
separate the cores from solution, an Entela ultraviolet light (UVGL) was used to provide
a long-wave (365 nm) ultraviolet light to test sample fluorescence, and a Shel Lab
vacuum oven was used to dry the sample.

3.1.4 Surface Treatment with Reducing/Oxidizing Agents
The materials used to treat the QD cores with various reducing and oxidizing
agents include 7 mL glass vials, a 1,000 µL Eppendorf pipette, pipette tips, spectroscopic
grade toluene (J.T. Baker), and spectrophotometric grade chloroform (Sigma-Aldrich,
99.8%). The reducing agents used include sodium borohydride (NaBH4) (Sigma-Aldrich,
98.5%), benzoyl peroxide (C14H10O4) (Aldrich, 97%), calcium hydride (CaH2) (SigmaAldrich, 90-95%), tert-butyl hydroperoxide (C4H10O2) (Aldrich, 70 wt% in water), and
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hydrazine (N2H4) (Sigma-Aldrich, 98%). Ultra-violet visible spectroscopy (UV-Vis) and
fluorescence spectroscopy were performed using a Spectramax M5 Multi-Mode
Microplate Reader (Molecular Devices) to measure sample absorbance and fluorescence,
respectively. A Rotovapor R-210 (Buchi) was used to remove various solvents to isolate
the cores. Lastly, a Entela ultraviolet light (UVGL) was used to provide a long-wave
(365 nm) ultraviolet light to test sample fluorescence.

3.2 Methods
3.2.1 CdSe Quantum Dot Core Synthesis with Oleylamine
The first step in the synthesis of CdSe quantum dot cores with oleylamine
involves carrying out two reactions in parallel. The first reaction is between selenium and
trioctylphosphine (TOP); the second is cadmium acetate with oleylamine (Figure 3.1).

Figure 3.1. Synthetic scheme for the synthesis of CdSe quantum dot cores with oleylamine.
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The Se/TOP reaction was carried out in a flame-dried 5 mL glass vial while the
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were
capped to ensure that the environment was rid of oxygen and water. The liquids were
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject®
disposable syringes and syringe needles. The quantity of reactants used in the reactions
was dependent on the batch size (see Table 3.1 below).
Table 3.1. Quantity of reactants required for various batch sizes.

Batch Size

Selenium

TOP

Cadmium Acetate

Oleylamine

g

mol x 104

mL

mol x 104

g

mol x 104

mL

mol x 102

1X

0.008

1.06

0.04

0.897

0.025

0.94

1.50

0.46

2X

0.015

1.87

0.70

15.7

0.050

1.88

3.30

1.00

5X

0.039

4.88

2.00

44.8

0.125

4.69

7.50

2.28

10X

0.077

9.75

4.00

89.7

0.250

9.38

15.0

4.56

The solids in both solutions were dissolved by gently swirling with heating. It was
important not to boil the solution during this step. Once the solids completely dissolved, a
stir bar was added to the vial containing the Se/TOP mixture and placed in the CEM
microwave at the settings summarized below. The settings of the CEM microwave were
controlled by Synergy software.
a. Temperature: 120 °C
b. Power: 300 Watts
c. Ramp Time: 2 min
d. Hold Time: 30 s
e. Stirring: High
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Once the reaction was complete, the vial was removed from the microwave. A stir
bar was added to the round-bottom flask containing the oleylamine and cadmium acetate
mixture and placed in the microwave. As with reactant quantities, the microwave settings
were adjusted with batch size (see Table 3.2). During the reaction, the round-bottom flask
was purged with dry nitrogen.
Table 3.2. Microwave settings for various batch sizes.

Batch Size
1X

2X

5X

10X

Step
1

Power (W)
300

Temperature (°C)
100

Ramp (min)
2:00

Hold (min)
0:10

2

300

160

1:30

0:30

1

300

100

2:00

0:10

2

300

160

1:30

0:30

1

300

100

3:00

0:10

2

300

150

2:00

1:30

1

300

100

3:00

0:10

2

300

150

2:00

1:30

When the temperature of the reaction reached 120 °C during the second heating step, the
microwave was paused and the pre-heated Se/TOP mixture was injected into the roundbottom flask using a disposable syringe and needle. After the reaction was complete and
the round-bottom flask cooled to room temperature, the solution was examined under the
UV long-wave light to ensure that it fluoresced. Based on the settings specified in the
above table, the cores will fluoresce a yellow or reddish color.
The excess oleylamine and unreacted cadmium precursor were separated from the
QDs by extraction of the reaction solution with a volume of methanol equivalent to 4
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times the reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The
centrifuge tube was gently shaken to start this precipitation before being placed in the
Thermo Electron Corporation centrifuge. A centrifuge tube containing water of an equal
volume was placed opposite the solution in the blue centrifuge tube holder. The
centrifuge was run for 5 min at a 25 °C and a speed of 4500 relative centrifugal force
(RCF). Once the separation was complete, the QD cores were visibly separated from the
methanol. The methanol was then poured from the tube and disposed. Finally, the newly
synthesized cadmium selenide cores were dried over night under vacuum (4000 Pa) at
room temperature.

3.2.2 CdS Quantum Dot Core Synthesis with Oleylamine
The first step in the synthesis of CdS quantum dot cores with oleylamine involves
carrying out two reactions in parallel. The first reaction is between sulfur and
trioctylphosphine (TOP); the second is cadmium acetate with oleylamine (see Figure
3.2).

Figure 3.2. Synthetic scheme for the synthesis of CdS quantum dot cores with oleylamine.
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The S/TOP reaction was carried out in a flame-dried 5 mL glass vial while the
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were
capped to ensure that the environment was rid of oxygen and water. The liquids were
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject®
disposable syringes and syringe needles. The quantity of reactants used in the reactions
was dependent on the batch size (see Table 3.3 below).
Table 3.3. Quantity of reactants required for various batch sizes.

Batch Size

Sulfur
g
mol x 104

TOP
mL
mol x 104

Cadmium Acetate
g
mol x 104

Oleylamine
mL mol x 102

1X

0.008

2.62

0.040

0.897

0.025

0.94

1.50

0.456

2X

0.015

4.61

0.700

15.7

0.050

1.88

3.30

1.00

5X

0.039

12.0

2.00

44.8

0.125

4.69

2.00

0.608

10X

0.077

24.0

4.00

89.7

0.250

9.38

15.0

4.56

The solids in both solutions were dissolved by gently swirling with heating. It was
important not to boil the solution during this step. Once the solids completely dissolved, a
stir bar was added to the vial containing the S/TOP mixture and placed in the CEM
microwave at the settings summarized below. The settings of the CEM microwave were
controlled by Synergy software.
a. Temperature: 120 °C
b. Power: 300 Watts
c. Ramp Time: 2 min
d. Hold Time: 30 s
e. Stirring: High

48
Once the reaction was complete, the vial was removed from the microwave. A stir
bar was added to the round-bottom flask containing the oleylamine and cadmium acetate
mixture and placed in the microwave. As with reactant quantities, the microwave settings
were adjusted with batch size (see Table 3.4). During the reaction, the round-bottom flask
was purged with dry nitrogen.
Table 3.4. Microwave settings for various batch sizes.

Batch Size

Step

Power (W)

Temperature (°C)

Ramp (min)

Hold (min)

1X

1

300

100

2:00

0:10

2

300

160

1:30

0:30

1

300

100

2:00

0:10

2

300

160

1:30

0:30

1

300

100

3:00

0:10

2

300

175

2:00

1:30

1

300

100

3:00

0:10

2

300

200

2:00

1:30

2X

5X

10X

When the temperature of the reaction reached 120 °C during the second heating step, the
microwave was paused and the pre-heated S/TOP mixture was injected into the roundbottom flask using a disposable syringe and needle. After the reaction was complete and
the round-bottom flask cooled to room temperature, the solution was examined under the
UV long-wave light to ensure that it fluoresced. Based on the settings specified in the
above table, the cores will fluoresce a yellow color.
The excess oleylamine and unreacted cadmium precursor were separated from the
QDs by extraction of the reaction solution with a volume of methanol equivalent to 4
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times the reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The
centrifuge tube was gently shaken to start this precipitation before being placed in the
Thermo Electron Corporation centrifuge. A centrifuge tube containing water of an equal
volume was next placed opposite the solution in the blue centrifuge tube holder. The
centrifuge was run for 5 min at a 25 °C and a speed of 4500 relative centrifugal force
(RCF). Once the separation was complete, the QD cores were visibly separated from the
methanol. The methanol was then poured from the tube and disposed. Finally, the newly
synthesized CdS cores were dried over night under vacuum (4000 Pa) at room
temperature.

3.2.3 CdSe Quantum Dot Core Synthesis with Oleic Acid and Octadecene
The first step in the synthesis of CdSe quantum dot cores with oleic acid (OA)
and octadecene (ODE) involves carrying out two reactions in parallel. The first reaction
is between selenium and trioctylphosphine (TOP); the second is cadmium acetate, OA,
and ODE (see Figure 3.3).

Figure 3.3. Synthetic scheme for the synthesis of CdSe quantum dot cores with OA and ODE.
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The Se/TOP reaction was carried out in a flame-dried 5 mL glass vial while the
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were
capped to ensure that the environment was rid of oxygen and water. The liquids were
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject®
disposable syringes and syringe needles. The quantity of reactants used in the reactions
was dependent on the batch size (see Table 3.5 below).
Table 3.5. Quantity of reactants required for various batch sizes.

Batch
Size

Selenium

TOP

0.04

OA

ODE

1X

0.008

mol
x 104
1.06

2X

0.015

1.87

0.70

15.7

0.050

1.88

2.00

0.634

1.00

3.13

5X

0.039

4.88

2.00

44.8

0.125

4.69

5.00

1.58

2.50

7.81

10X

0.077

9.75

4.00

89.7

0.250

9.38

10.0

3.15

5.00

15.6

g

mol
x 104
0.897

Cadmium
Acetate
mol
g
x 104
0.025 0.938

mL

1.00

mol
x 102
0.317

0.50

mol
x 103
1.56

mL

mL

The solids in both solutions were dissolved by gently heating. It was important
not to boil the solution during this step. Once the solids completely dissolved, a stir bar
was added to the vial containing the Se/TOP mixture and placed in the CEM microwave
at the settings summarized below. The settings of the CEM microwave were controlled
by Synergy software.
a. Temperature: 120 °C
b. Power: 300 Watts
c. Ramp Time: 2 min
d. Hold Time: 30 s
e. Stirring: High
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Once the reaction was complete, the vial was removed from the microwave. A stir
bar was added to the round-bottom flask containing the OA, ODE, and cadmium acetate
mixture and placed in the microwave. As with reactant quantities, the microwave settings
were adjusted with batch size (see Table 3.6). During the reaction, the round-bottom flask
was purged with nitrogen.
Table 3.6. Microwave settings for various batch sizes.

Batch Size

Step

Power (W)

Temperature (°C)

Ramp (min)

Hold (min)

1X

1

300

100

2:00

0:10

2

300

160

1:30

0:30

1

300

100

2:00

0:10

2

300

160

1:30

0:30

1

300

100

3:00

0:10

2

300

150

2:00

1:30

1

300

100

3:00

0:10

2

300

150

2:00

1:30

2X

5X

10X

When the temperature of the reaction reached 120 °C, the microwave was paused and the
pre-heated Se/TOP mixture was injected into the round-bottom flask using a disposable
syringe and needle. After the reaction was complete and the round-bottom flask cooled to
room temperature, the solution was examined under the UV long-wave light to ensure
that it fluoresced. Based on the settings specified in the above table, the cores will
fluoresce a yellowish color.
The excess OA and unreacted cadmium precursor were separated from the QDs
by extraction of the reaction solution with a volume of methanol equivalent to 4 times the
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reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The centrifuge
tube was gently shaken to start the precipitation, the cap was removed from the tube, and
the solution was left until it separated into two distinct layers. The top layer composed of
methanol and excess unreacted ligand was removed from the centrifuge tube and
discarded using a pipette. Following the same procedure, the QD cores were washed a
second time with methanol. Finally, the newly synthesized CdSe cores were dried over
night under vacuum (4000 Pa) at room temperature.

3.2.4 CdS Quantum Dot Core Synthesis with Oleic Acid and Octadecene
The first step in the synthesis of CdS quantum dot cores with oleic acid (OA) and
octadecene (ODE) involves carrying out two reactions in parallel. The first reaction is
between sulfur and trioctylphosphine (TOP); the second is cadmium acetate, OA, and
ODE (see Figure 3.4).

Figure 3.4. Synthetic scheme for the synthesis of CdS quantum dot cores with OA and ODE.
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The S/TOP reaction was carried out in a flame-dried 5 mL glass vial while the
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were
capped to ensure that the environment was rid of oxygen and water. The liquids were
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject®
disposable syringes and syringe needles. The quantity of reactants used in the reactions
was dependent on the batch size (see Table 3.7 below).
Table 3.7. Quantity of reactants required for various batch sizes.

Batch
Size

Sulfur

TOP

0.04

OA

ODE

1X

0.008

mol
x 104
2.62

2X

0.015

4.61

0.70

15.7

0.050

1.88

2.00

0.634

1.00

3.13

5X

0.039

12.0

2.00

44.8

0.125

4.69

5.00

1.58

2.50

7.81

10X

0.077

24.0

4.00

89.7

0.250

9.38

10.0

3.15

5.00

15.6

g

mol
x 104
0.897

Cadmium
Acetate
mol
g
x 104
0.025 0.938

mL

1.00

mol
x 102
0.317

0.50

mol
x 103
1.56

mL

mL

The solids in both solutions were dissolved by gently swirling with heating. It was
important not to boil the solution during this step. Once the solids completely dissolved, a
stir bar was added to the vial containing the S/TOP mixture and placed in the CEM
microwave at the settings summarized below. The settings of the CEM microwave were
controlled by Synergy software.
a. Temperature: 120 °C
b. Power: 300 Watts
c. Ramp Time: 2 min
d. Hold Time: 30 s
e. Stirring: High
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Once the reaction was complete, the vial was removed from the microwave. A stir
bar was added to the round-bottom flask containing the OA, ODE, and cadmium acetate
mixture and placed in the microwave. As with reactant quantities, the microwave settings
were adjusted with batch size (see Table 3.8). During the reaction, the round-bottom flask
was purged with nitrogen.
Table 3.8. Microwave settings for various batch sizes.

Batch Size

Step

Power (W)

Temperature (°C)

Ramp (min)

Hold (min)

1X

1

300

100

2:00

0:10

2

300

160

1:30

0:30

1

300

100

2:00

0:10

2

300

160

1:30

0:30

1

300

100

3:00

0:10

2

300

185

2:00

1:30

1

300

100

3:00

0:10

2

300

190

2:00

1:30

2X

5X

10X

When the temperature of the reaction reached 120 °C during the second heating step, the
microwave was paused and the pre-heated S/TOP mixture was injected into the roundbottom flask using a disposable syringe and needle. After the reaction was complete and
the round-bottom flask cooled to room temperature, the solution was examined under the
UV long-wave light to ensure that it fluoresced. Based on the settings specified in the
above table, the cores will fluoresce a yellowish color.
The excess OA and unreacted cadmium precursor were separated from the QDs
by extraction of the reaction solution with a volume of methanol equivalent to 4 times the
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reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The centrifuge
tube was gently shaken to start the precipitation, the cap was removed from the tube, and
the solution was left until it separated into two distinct layers. The top layer composed of
methanol and excess unreacted ligand was removed from the centrifuge tube using a
pipette and discarded. Following the same procedure, the QD cores were washed a
second time with methanol. Finally, the newly synthesized cadmium sulfide cores were
dried over night under vacuum (4000 Pa) at room temperature.

3.2.5 CdSe Quantum Dot Core Synthesis with Oleic Acid and Trioctylamine
The first step in the synthesis of CdSe QD cores with oleic acid (OA) and
trioctylamine (TOA) involves carrying out two reactions in parallel. The first reaction is
between selenium and trioctylphosphine (TOP); while the second is cadmium acetate,
OA, and TOA (see Figure 3.5).

Figure 3.5. Synthetic scheme for the synthesis of CdSe quantum dot cores with OA and TOA.
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The Se/TOP reaction was carried out in a flame-dried 5 mL glass vial while the
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were
capped to ensure that the environment was rid of oxygen and water. The liquids were
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject®
disposable syringes and syringe needles. The quantity of reactants used in the reactions
was dependent on the batch size (see Table 3.9 below).
Table 3.9. Quantity of reactants required for various batch sizes.

Batch
Size

Selenium

TOP

0.04

OA

TOA

1X

0.008

mol
x 104
1.06

2X

0.015

1.87

0.70

15.7

0.050

1.88

2.00

0.634

1.00

2.29

5X

0.039

4.88

2.00

44.8

0.125

4.69

5.00

1.58

2.50

5.72

10X

0.077

9.75

4.00

89.7

0.250

9.38

10.0

3.15

5.00

11.4

g

mol
x 104
0.897

Cadmium
Acetate
mol
g
x 104
0.025 0.938

mL

1.00

mol
x 102
0.317

0.50

mol
x 103
1.14

mL

mL

The solids in both solutions were dissolved by gently swirling with heating. It was
important not to boil the solution during this step. Once the solids completely dissolved, a
stir bar was added to the vial containing the Se/TOP mixture and placed in the CEM
microwave at the settings summarized below. The settings of the CEM microwave were
controlled by Synergy software.
f. Temperature: 120 °C
g. Power: 300 Watts
h. Ramp Time: 2 min
i. Hold Time: 30 s
j. Stirring: High
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Once the reaction was complete, the vial was removed from the microwave. A stir
bar was added to the round-bottom flask containing the OA, TOA, and cadmium acetate
mixture and placed in the microwave. As with reactant quantities, the microwave settings
were adjusted with batch size (see Table 3.10). During the reaction, the round-bottom
flask was purged with nitrogen.
Table 3.10. Microwave settings for various batch sizes.

Batch Size
1X

2X

5X

10X

Step
1

Power (W)
300

Temperature (°C)
100

Ramp (min)
2:00

Hold (min)
0:10

2

300

160

1:30

0:30

1

300

100

2:00

0:10

2

300

160

1:30

0:30

1

300

100

3:00

0:10

2

300

150

2:00

1:30

1

300

100

3:00

0:10

2

300

150

2:00

1:30

When the temperature of the reaction reached 120 °C during the second heating step, the
microwave was paused and the pre-heated Se/TOP mixture was injected into the roundbottom flask using a disposable syringe and needle. After the reaction was complete and
the round-bottom flask cooled to room temperature, the solution was examined under the
UV long-wave light to ensure that it fluoresced. Based on the settings specified in the
above table, the cores will fluoresce a reddish color.
The excess OA and unreacted cadmium precursor were separated from the QDs
by extraction of the reaction solution with a volume of methanol equivalent to 4 times the
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reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The centrifuge
tube was gently shaken to start the precipitation, the cap was removed from the tube, and
the solution was left until it separated into two distinct layers. The top layer composed of
methanol was then removed from the centrifuge tube and discarded using a pipette.
Following the same procedure, the QD cores were washed a second time with methanol.
To separate the washed QD cores from methanol, the Thermo Electron Corporation
centrifuge was used. A centrifuge tube containing water of an equal volume was placed
opposite the solution in the blue centrifuge tube holder. The centrifuge was run for 5 min
at a 25 °C and a speed of 4500 relative centrifugal force (RCF). Once the separation was
complete, the QD cores were visibly separated from the methanol. The methanol was
then poured from the tube and disposed. Finally, the newly synthesized CdSe cores were
dried over night under vacuum (4000 Pa) at room temperature.

3.2.6 CdS Quantum Dot Core Synthesis with Oleic Acid and Trioctylamine
The first step in the synthesis of CdS quantum dot cores with OA and
trioctylamine (TOA) involves carrying out two reactions in parallel. The first reaction is
between sulfur and trioctylphosphine (TOP); while the second is cadmium acetate, OA,
and TOA (see Figure 3.6).
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Figure 3.6. Synthetic scheme for the synthesis of CdS quantum dot cores with OA and TOA.

The S/TOP reaction was carried out in a flame-dried 5 mL glass vial while the
other reaction was carried out in a 50 mL round-bottom flask. Both reaction vessels were
capped to ensure that the environment was rid of oxygen and water. The liquids were
transferred from storage bottles to their respective glassware using 5 mL Norm-Ject®
disposable syringes and syringe needles. The quantity of reactants used in the reactions
was dependent on the batch size (see Table 3.11 below).
Table 3.11. Quantity of reactants required for various batch sizes.

Batch
Size

0.04

mol
x 104
0.897

Cadmium
Acetate
mol
g
x 104
0.025 0.938

Sulfur

TOP

1X

0.0084

mol
x 104
2.62

2X

0.0148

4.61

0.70

15.7

0.050

5X

0.0385

12.0

2.00

44.8

10X

0.077

24.0

4.00

89.7

g

mL

Oleic Acid

1.0

mol
x 102
0.317

1.88

2.0

0.125

4.69

0.250

9.38

TOA

0.5

mol
x 103
1.14

0.634

1.0

2.29

5.0

1.58

2.5

5.72

10.0

3.15

5.0

11.4

mL

mL

The solids in both solutions were dissolved by gently swirling with heating. It was
important not to boil the solution during this step. Once the solids completely dissolved, a
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stir bar was added to the vial containing the S/TOP mixture and placed in the CEM
microwave at the settings summarized below. The settings of the CEM microwave were
controlled by Synergy software.
f. Temperature: 120 °C
g. Power: 300 Watts
h. Ramp Time: 2 min
i. Hold Time: 30 s
j. Stirring: High

Once the reaction was complete, the vial was removed from the microwave. A stir
bar was added to the round-bottom flask containing the oleic acid, TOA, and cadmium
acetate mixture and placed in the microwave. As with reactant quantities, the microwave
settings were adjusted with batch size (see Table 3.12). During the reaction, the roundbottom flask was purged with nitrogen.
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Table 3.12. Microwave settings for various batch sizes.

Batch Size
1X

2X

5X

10X

Step
1

Power (W)
300

Temperature (°C)
100

Ramp (min)
2:00

Hold (min)
0:10

2

300

160

1:30

0:30

1

300

100

2:00

0:10

2

300

160

1:30

0:30

1

300

100

3:00

0:10

2

300

175

2:00

1:30

1

300

100

3:00

0:10

2

300

175

2:00

1:30

When the temperature of the reaction reached 120 °C during the second heating step, the
microwave was paused and the pre-heated S/TOP mixture was injected into the roundbottom flask using a disposable syringe and needle. After the reaction was complete and
the round-bottom flask cooled to room temperature, the solution was examined under the
UV long-wave light to ensure that it fluoresced. Based on the settings specified in the
above table, the cores will fluoresce a yellowish color.
The excess OA and unreacted cadmium precursor were separated from the QDs
by extraction of the reaction solution with a volume of methanol equivalent to 4 times the
reaction volume (reaction solution:methanol = 1:4) in a centrifuge tube. The centrifuge
tube was gently shaken to start the precipitation, the cap was removed from the tube, and
the solution was left until it separated into two distinct layers. The top layer composed of
methanol and unreacted ligand was then removed from the centrifuge tube using a pipette
and discarded. Following the same procedure, the QD cores were washed a second time
with methanol. To separate the washed QD cores from methanol, the Thermo Electron
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Corporation centrifuge was used. A centrifuge tube containing water of an equal volume
was placed opposite the solution in the blue centrifuge tube holder. The centrifuge was
run for 5 min at a 25 °C and a speed of 4500 relative centrifugal force (RCF). Once the
separation was complete, the QD cores were visibly separated from the methanol. The
methanol was then poured from the tube and disposed. Finally, the newly synthesized
CdS QDs were dried over night under vacuum (4000 Pa) at room temperature.

3.2.7 Treatment with a Reducing/Oxidizing Agent
The CdSe and CdS cores were treated with various reducing/oxidizing agents to
increase their quantum efficiency. This step was completed by dissolving the dried cores
in spectrophotometric grade chloroform. It is important to note that regular grade
chloroform resulted in negative fluorescence peaks, therefore spectrophotometric grade
was required. The absorbance of the QD solution was measured via ultra-violet visible
spectroscopy (UV-Vis) using a Spectramax M5 Multi-Mode Microplate Reader. For
dilute solutions, the solution absorbance is linearly proportional to QD concentration. The
lower the arbitrary units (a.u.), the more dilute the solution. A solution absorbance
between 0.08 and 0.10 a.u. was desirable for this investigation, therefore the volume of
chloroform added to each batch of QD cores was varied to adjust the absorbance to this
range.
Once absorbance of the QD solution was between 0.08 and 0.10 a.u., the master
batch was divided into 16 different sub-batches in 7 mL glass sample vials. The volume
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of each sample was approximately 5 mL. This thesis investigates the effect of 5 different
reducing/oxidizing agents: (1) sodium borohydride (NaBH4), (2) calcium hydride (CaH2),
(3) hydrazine (N2H4), (4) benzoyl peroxide (C14H10O4), and (5) tert-butyl hydroperoxide
(C4H10O2). To determine the optimal quantity of agent to be used for each batch, these 16
prepared samples were used to test 3 different concentrations of each of the 5 agents. One
additional sample was left untreated and used as a reference throughout the treatment
process. For solid agents, the masses investigated were: 0.001 g, 0.003 g, and 0.006 g.
For liquid agents, the volumes investigated were: 0.05 mL, 0.10 mL, and 0.15 mL.
Preliminary results showed that QDs fluoresced brighter in chloroform than toluene,
therefore, chloroform was used as the solvent when determining concentration. The
optimum quantity of reducing/oxidizing agents for each of the batch types was defined as
the quantity at which the highest quantum yield was achieved. These quantities are
summarized in Table 3.13 below, while the plots and pictures supporting the chosen
quantities can be found in Appendix A.
Table 3.13. Optimal quantity of reducing/oxidizing agents.

CdSe

NaBH4
CaH2
N2H4
C14H10O4
C4H10O2

CdS

Oleylamine

OA/ODE

OA/TOA

Oleylamine

OA/ODE

OA/TOA

0.006 g
0.159 mmol
0.001 g
0.024 mmol
0.150 mL
4.74 mmol
0.001 g
0.004 mmol
0.050 mL
0.519 mmol

0.006 g
0.159 mmol
0.001 g
0.024 mmol
0.050 mL
1.58 mmol
0.006 g
0.025 mmol
0.150 mL
1.56 mmol

0.001 g
0.026 mmol
0.001 g
0.024 mmol
0.150 mL
4.74 mmol
0.003 g
0.012 mmol
0.100 mL
1.04 mmol

0.003 g
0.079 mmol
0.001 g
0.024 mmol
0.150 mL
4.74 mmol
0.001 g
0.004 mmol
0.150 mL
1.56 mmol

0.003 g
0.079 mmol
0.001 g
0.024 mmol
0.050 mL
1.58 mmol
0.003 g
0.012 mmol
0.100 mL
1.04 mmol

0.006 g
0.159 mmol
0.003 g
0.071 mmol
0.050 mL
1.58 mmol
0.001 g
0.004 mmol
0.100 mL
1.04 mmol
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After the concentration for each of the reducing/oxidizing agents was determined,
6 additional 7 mL glass vials were filled with 5 mL aliquots of the QD solution. To 5 of
these samples, the optimum amount of reducing/oxidizing agents as summarized in Table
3.13 was added. The additional sample was left untreated and used as a reference
throughout the treatment process. An absorbance and fluorescence spectrum of each of
the 5 treated samples was measured 1 min, 1 d, 5 d, and 10 d after treatment. These
spectra were compared to those of the untreated sample and used to evaluate the effect
each reducing/oxidizing agent had on the quantum yield of the various QD batches.
The rotary evaporator was then used to evaporate the remaining chloroform from
the QD solution. The isolated solid QD cores were then resuspended in photrex grade
toluene. The volume of toluene added was varied until a solution absorbance between
0.08 a.u. and 0.10 a.u. was achieved as measured by the SpectraMax M5. Similar to
chloroform, photrex grade toluene was required to eliminate negative fluorescence peaks
that appeared in fluorescence spectra of QDs dissolved in regular grade toluene. The QD
and toluene solution was divided into 6, 5 mL samples. Following the same procedure as
described above, these toluene samples were treated with each of the 5
reducing/oxidizing agents and the absorbance and fluorescence of these samples was
measured at the specified time intervals. Preliminary results showed that QDs fluoresced
brighter in chloroform than toluene, therefore chloroform was used as the solvent when
determining the optimum amount of reducing/oxidizing agents to be used. It was
assumed that the optimum amount of agents was not dependent on solvent, therefore,
Table 3.13 was applied to the toluene samples as well.
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3.3 Characterization Techniques
Following synthesis and treatment, QD samples were analyzed for absorbance,
fluorescence, and ligand surface coverage using the techniques described in detail below.

3.3.1 Ultra-Violet Visible (UV-Vis) Spectroscopy
Ultra-violet visible (UV-Vis) spectroscopy is a technique used to analyze
compounds in the ultraviolet (UV) and visible (Vis) regions. UV-Vis measures electronic
transitions and can be used to determine the wavelength and maximum absorbance of
compounds. Spectra are produced when electrons in atoms or molecules move from one
energy level to another higher energy level. In doing so, they absorb energy equal to the
gap between the two energy levels. Compounds that absorb light in the visible region
have color (such as QDs), while those that absorb only in the UV region are colorless.
Inside a UV-Vis spectrophotometer, there are two light sources: one giving off
UV light and one giving off visible light. Typically, a tungsten light bulb is used as the
visible light source while a deuterium light is used for UV light. The light sources
produce white light that includes energies of all wavelengths (or colors) of light. A mirror
directs this light into the diffraction grating which splits the colors into their constituent
wavelengths. The instrument scans through the spectrum, sending different wavelengths
of light through the sample in sequence. The single beam of light passing through the
sample is then directed to a detector by mirrors. This detector compares the sample’s
intensity to the reference intensity and sends a signal proportional to their ratio to the
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computer that controls the instrument. The logarithm of this ratio gives the absorbance of
the sample. Absorbance is a measure of how much light is being absorbed by the sample
at a particular wavelength.
In this thesis, UV-Vis was used to measure the absorbance of the QD solution
samples using a Spectramax M5 Multi-Mode Microplate Reader (Molecular Devices).
SoftMax Pro software was used to collect the absorbance data from 350 nm to 750 nm
and generate plots of absorbance units (a.u.) versus wavelength (nm). As previously
mentioned, sample absorbance is proportional to the QD concentration. The lower the
a.u., the more dilute the sample. Absorbance data was therefore used as a measure of
sample concentration. Additionally, the intensity of the absorbance peak at 365 nm was
used in calculating the quantum yield of each sample as described in detail in the
following section. Lastly, the absorbance value corresponding to 365 nm was used to
normalize the fluorescence data, as described in detail below.

3.3.2 Fluorescence Spectroscopy
Fluorescence spectroscopy is a type of electromagnetic spectroscopy used to
analyze the fluorescence from a sample. This technique involves using a beam of
ultraviolet light to excite the electrons in molecules of certain compounds and causes
them to emit light of a lower energy. In this thesis, fluorescence spectroscopy was used to
measure the fluorescence of the QD samples using a Spectramax M5 Multi-Mode
Microplate Reader (Molecular Devices). The optimum excitation wavelength is defined
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as the excitation wavelength that yields an emission wavelength that is separated from the
excitation peak wavelength by more than 80 nm.1 As seen in Figure 3.7 below, an
excitation wavelength of 365 nm resulted in an approximate 200 nm separation between
the emission wavelength (560 nm) and the excitation peak wavelength (365 nm). The
optimum excitation wavelength was therefore found to be 365 nm for all samples in this
thesis.

Figure 3.7. Sample fluorescence spectrum with excitation wavelength of 365 nm and no cutoff.

As seen in Figure 3.7 above, the intensity of the excitation light peak (at 365 nm)
is significantly greater than that of the emitted light peak (at 560 nm). This difference in
intensity is caused by interference due to scattered or stray light and background
interference.1,2 Sources of background include stray excitation light, sample constituents,
and solvents.1 To restrict these interferences, a long-pass emission cutoff filter is
necessary.1 The optimum emission cutoff filter should block as much of the residual
excitation light as possible without reducing the fluorescence signal.1 The cutoff
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wavelength value should be between the excitation wavelength and the maximum
emission wavelength.1 For this thesis, the cutoff wavelength was chosen to be 420 nm.
Figure 3.8 below illustrates the effect of using an emission cutoff filter. This figure
includes a fluorescence spectrum of the same sample as shown in Figure 3.7 excited at
365 nm with a cutoff filter at 420 nm.

Figure 3.8. Sample fluorescence spectrum with excitation wavelength of 365 nm and cutoff at 420 nm.

Solutions of QDs were loaded into quartz cuvettes for fluorescence
measurements. The cuvettes were made of quartz to allow passage of the UV excitation
radiation, and were transparent on all four sides. It was necessary that the sides be
transparent, since the fluorescence emission is detected in a direction perpendicular to the
direction of the incident excitation radiation.3 SoftMax Pro software was used to collect
the fluorescence data of the reference solution (which in this case was the blank solvent)
as well the fluorescence of the QD solutions from 350 nm to 750 nm and generate plots
of relative fluorescence units (RFU) versus wavelength (nm). The reference fluorescence
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data was subtracted from the QD fluorescence data to correct for the solvent effect. To
normalize this fluorescence data to absorbance data, the fluorescence values
corresponding to a specific sample were divided by the absorbance of the same sample at
the excitation wavelength of 365 nm. The area of the normalized fluorescence peak was
used in calculating the quantum yield of each sample as described in detail in the
following section.

3.3.3 Thermogravimetric Analysis (TGA)
Thermogravimetric analysis (TGA) measures the weight change of a sample as it
is heated to the temperature at which it degrades. A thermal degradation profile of a
sample can be determined by plotting the residual mass versus temperature. In this thesis,
TGA was utilized to measure the ligand surface coverage of the QDs. TGA was
performed using a TA Instruments SDT-Q600, which employs two cantilever balances in
a furnace purged with nitrogen. An aliquot of a QD sample solution was placed in an
alumina ceramic pan and placed in an oven at a temperature of 70 °C until the solvent
evaporated. This step was repeated until the bottom of the ceramic pan was covered with
a layer of the QD powder. The alumina ceramic pan filled with this QD powder was
placed on one cantilever. A second, empty ceramic pan was placed on the other cantilever
as a reference. The sample was then heated from 30 °C to 600 °C at a constant rate of
10 °C/min. The mass remaining after heating to the set temperature was believed to be
that of the metal core without organic ligands. The mass lost due to heating was therefore
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assumed to be that of the ligands, thereby allowing for the estimation of ligand surface
coverage.

3.4 Calculating Quantum Yield
The quantum yield (QY) of a compound is defined as the fraction of molecules
that emit a photon after direct excitation by the source. This value is of importance as it is
a measure of the extent of interferences and therefore is a quantitative measure of a
compound’s brightness. The QY of untreated QD cores and those treated with a
reducing/oxidizing agent was calculated by comparison with a known reference. In this
thesis, Rhodamine 6G (Rh6G) was chosen as the reference because its QY is known
(0.95), and it emits a photon at a similar wavelength as the QDs synthesized in this thesis
(~ 530 nm) when excited at 365 nm. Reference solutions were made by dissolving Rh6G
in water until the absorbance of each solution was between 0.08 a.u. and 0.10 a.u., as
measured using the SpectraMax M5. A solution absorbance within this range was desired
so that the concentration of the reference solution was comparable to the concentration of
the QD sample solutions. The fluorescence of the reference solutions was also measured
using the SpectraMax and peaks were generated. A custom MATLAB script was
developed to calculate the area under each measured fluorescence peak. The QY of each
QD sample was calculated using the following relation:
 FLQDs
QYQD = QYRh 6G 
 AB
 QDs

 ABRh 6G

 FL
 Rh 6G

2
 η sol
 2
 η H 2O






(1)
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Where QYRh 6G is the quantum yield of the reference solution, Rh6G (0.95); FLQDs and
FLRh 6G are the areas under the fluorescence peaks of the quantum dot and reference
(Rh6G) solutions, respectively; ABQDs and ABRh 6G are the intensities of the absorbance
peaks of the quantum dot and reference (Rh6G) solutions at 365 nm, respectively; η sol is
the refractive index of the solvent (η toluene = 1.497 and η chloroform = 1.446) ; and η H 2O is
the refractive index of water ( η H 2O = 1.333) .

3.5 Calculating Band Gap Energy (Eg)
The bandgap energy (Eg) is the energy between the valence and conduction band
in a semiconductor. As described in the background section, the Eg is the minimum
amount of energy required to promote an electron from the valence band to the
conduction band. When the electron returns to the valence band, energy corresponding to
the energy of the bandgap is emitted. This value is of importance when referring to QDs
because, unlike in bulk semiconductors, the Eg can be tuned to emit light of a particular
wavelength. In other words, QDs of the same material can emit light at an array of
wavelengths. The size of the bandgap is dictated by the size of the particle. For this
reason, the Eg will be used throughout this thesis to quantitatively account for changes in
QD size after surface treatment with various reducing and oxidizing agents.
To calculate Eg, the absorbance data for each sample was plotted versus energy.
The bandgap energy was defined as the minimum energy required for radiative
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recombination from the valence band to the conduction band and was simply read off
each graph (see Figure 3.9).4 To convert wavelength to energy, the following relation was
used:

E=

hc

λ

(2)

Where E is energy in eV (1 eV = 1.602 x 10-19 J); h is Planck’s constant (6.63 x 10-34 J•s);
c is the speed of light (3.00 x 108 m/s); and λ is wavelength in m.

Figure 3.9. Typical absorbance spectra used to estimate the bandgap energy (Eg).4
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Chapter 4. Results and Discussion: CdSe
Chapter 4 will present and discuss the results of the experimental work performed
on CdSe QDs. This chapter will be divided into three sections: (1) CdSe QDs synthesized
with oleylamine, (2) CdSe QDs synthesized with oleic acid (OA) and octadecene (ODE),
and (3) CdSe QDs synthesized with OA and trioctylamine (TOA). Each section will
summarize the effect of treating the surface of the various QD batches with three
reducing and two oxidizing agents. More specifically, the effect of each treatment on the
quantum yield (QY) of the QDs will be investigated. The QY refers to the nonradiative
transition of electrons and holes between energy levels, and is therefore a measure of
brightness. The QY reported for each treatment was calculated following the procedures
presented in Chapter 3 of this thesis. Rhodamine 6G (Rh6G) was chosen as the reference
in the QY calculation because its QY is known (0.95), and it emits a photon at a similar
wavelength as the QDs synthesized in this thesis (~ 530 nm) when excited at 365 nm.
It is important to note that the calculated QY is representative of the entire QD
mixture, not just the QDs because the QD solution was not purified after treatment. For
this reason, a major limitiation of this study is that the measured absorbance and
fluorescence spectra of each sample were of the mixture, not the pure components. For
example, the absorbance of the mixture (Amixture) can be represented by the following
equation:
𝐴𝑚𝑖𝑥𝑡𝑢𝑟𝑒 = 𝐴𝑄𝐷𝑠 + 𝐴𝑙𝑖𝑔𝑎𝑛𝑑 + 𝐴𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 + 𝐴𝑠𝑜𝑙𝑣𝑒𝑛𝑡

(3)
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Where Amixture is the intensity of the absorbance peak of the QD mixture at 365 nm; AQDs
is of the QDs; Aligand is of the ligand; Atreatment is of the reducing/oxidizing agents; and
Asolvent is of the solvent.
When performing UV-Vis on the reaction mixture, the blank solvent was used as
the reference and subtracted from the total absorbance, therefore the absorbance of the
solvent can be neglected in the equation 3 (Asolvent = 0). Furthermore, UV-Vis was
performed on a mixture containing each ligand and solvent combination. Again, the blank
solvent was used as the reference, therefore the measured absorbance was representative
of only the ligand. Figure 4.1 below contains the absorbance spectra of a sample QD
mixture (CdSe QDs capped with oleylamine in chloroform) represented by the solid line
and a solution of ligand (oleylamine) and chloroform represented by the dashed line.

365
Figure 4.1. Absorbance spectra of a CdSe (oleylamine) QDs dissolved in chloroform (solid) and a solution
of oleylamine and chloroform (dashed).

Absorbance is directly related to concentration via Beer’s Law:
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𝐴 = 𝜀𝐶𝐿

(4)

Where A is the intensity of the absorbance peak; ε is the molar absorbtivity (L/mol·cm) C
is the molar concentration (mol/L) of the component in solution; and L is the path length
(cm) of the radiation beam used for measuring the absorbance spectrum. As seen in
equation 3, the absorbance of the QD mixture (Amixture) is the sum of the intensities of the
absorbance peaks at 365 nm of each component. The absorbance of the ligand is
significantly less than that of the QD mixture at 365 nm (see Figure 4.1), therefore we
can conclude that there is a small concentration of ligand in the QD mixture.
Furthermore, even though the intensity of the absorbance peaks in Figure 4.1 were both
approximately 0.06, indicating that the concentration of the components in the solutions
were approximately the same, there were more components in the QD mixture solution
than the solution comprised of only ligand and solvent. For this reason, we can conclude
that the concentration of ligand in the QD mixture was orders of magnitude less than that
in the solution only composed of ligand and solvent. The absorbance of the ligand
(Aligand) in equation 3 can therefore be assumed to be negligible (Aligand = 0). The
absorbance measured for each QD mixture as summarized in the following sections is
therefore representative of the mixture of the absorbance of the QDs and that of the
treatment, or:
𝐴𝑚𝑖𝑥𝑡𝑢𝑟𝑒 = 𝐴𝑄𝐷𝑠 + 𝐴𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡

(5)

The measured fluorescence spectra included in this study are also representative
of the QD mixture rather than just the QDs. For this reason, when the fluorescence of the
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QDs was quenched, we were unable to conclude what caused this quenching. For
example, if the quenching was caused by excess free ligand in the QD solution, it may be
possible to restore the fluorescence by purifying the QDs after treatment and removing
this residual ligand. In a study by Tansakul et al. it was found that the quenched QD
fluorescence could be restored, therefore proving that quenching may be reversible.24 It is
recommended that future work performed on this study explore whether the quenching is
reversible by purifying the QDs after treatment.
In addition to comparing the QY of the QDs before and after surface treatment, a
change in QD size distribution was also investigated. In a study by Zezza et al., it was
concluded that the sharpness of the absorbance peak is indicative of the particle size
distribution.1 Specifically, the sharper the absorbance peak, the narrower the size
distribution.1 Furthermore, Bullen et al. found that a high full-width half-maximum
(FWHM) value indicates the onset of Ostwald ripening which causes a slow “defocusing”
of the size distribution.2 It can therefore be concluded that a sharp absorbance peak and
low FWHM value is indicative of a narrow size distribution.
Lastly, the bandgap energy (Eg) was calculated before and after each surface
treatment following the procedure provided in Chapter 3. The bandgap energy is the
minimum amount of energy a QD absorbs to raise an electron from the valence band to
the conduction band. The electron remains in the conduction band momentarily before
returning through the bandgap to the valence band at which time it emits electromagnetic
radiation with a wavelength corresponding to the bandgap.3,4 The size of the bandgap is
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therefore dictated by the size of the QD. Specifically, Eg increases with decreasing
particle size.5 Furthermore, QD size is representative of the color emitted, with smaller
QDs emitting blue and large QDs emitting red.
The reducing agents to be investigated include: sodium borohydride (NaBH4),
calcium hydride (CaH2), and hydrazine (N2H4), while the oxidizing agents include:
benzoyl peroxide (C14H10O4) and tert-butyl hydroperoxide (C4H10O2). Three different
concentrations

of

each

reducing/oxidizing

agent

were

investigated

prior

to

experimentation to determine which concentration yielded the highest calculated QY for
each batch of QDs (see Appendix A). This concentration was defined as the optimum
concentration and was used to treat each batch of QDs, as described in the following
sections.

4.1 CdSe (Oleylamine) Quantum Dot Cores
4.1.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform
Figure 4.2 displays the absorbance and fluorescence spectra of a CdSe
(oleylamine) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a
1.99 x 10-5 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Figure
4.2 below. From these values, it can be seen that the QY of the QDs increased slightly
after treatment with NaBH4 and reached a maximum 1 d after treatment before
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decreasing to below that of the untreated QY 10 d later. Figure 4.2e confirms this
decrease in QY 10 d after treatment as the treated QDs (right) are less bright than the
untreated QDs (left). Additionally, no notable change in the sharpness of the absorbance
peak or FWHM value was observed therefore ruling out a significant broadening of the
QD size distribution after treatment. Lastly, the Eg did not change after treatment
indicating that there was no change in the size of the QDs. In conclusion, treatment of
CdSe (oleylamine) QDs dissolved in chloroform with NaBH4 resulted in a 66.7 %
increase in the QY of the QDs 1 d after treatment.

Figure 4.2. Absorbance spectra (a) and fluorescence spectra (b) of a 6.39 x 10-7 M solution of CdSe
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow),
1 d (red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (1.99 x 10-5 molar ratio of QDs to
NaBH4). Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light
(c) 1 d, (d) 5 d, and (e) 10 d after treatment.
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Table 4.1. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(oleylamine) QD and NaBH4 solution dissolved in chloroform at a 1.99 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.003

38.7

2.19

Initial

0.003

40.3

2.19

1d

0.005

42.5

2.19

5d

0.004

45.7

2.19

10 d

0.002

49.4

2.20

4.1.2 Treatment with Sodium Borohydride (NaBH4) in Toluene
Figure 4.3 displays the absorbance and fluorescence spectra of a CdSe
(oleylamine) QD and sodium borohydride (NaBH4) solution dissolved in toluene at a
3.27 x 10-5 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table
4.2 below. From these values, it can be seen that the QY of the QDs increased
immediately after treatment with NaBH4 before decreasing to below that of the untreated
QY 10 d later. The pictures in Figure 4.3 confirm these results as the treated sample
(right) is brighter than the untreated sample (left) 1 d after treatment (c) and less bright 10
d after treatment (e). Additionally, the absorption edge continued to become less sharp
and the FWHM continued to increase with time, indicating a broadening of the QD size
distribution after treatment. Lastly, the Eg did not change after treatment indicating that
there was no change in the size of the QDs. In conclusion, treatment of CdSe
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(oleylamine) QDs dissolved in toluene with NaBH4 resulted in a 64.0 % increase in the
QY of the QDs immediately after treatment.

Figure 4.3. Absorbance spectra (a) and fluorescence spectra (b) of a 1.04 x 10-6 M solution of CdSe
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (3.27 x 10-5 molar ratio of QDs to NaBH4).
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 4.2. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(oleylamine) QD and NaBH4 solution dissolved in toluene at a 3.27 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.050

39.3

2.15

Initial

0.082

39.7

2.16

1d

0.025

39.3

2.15

5d

0.046

46.2

2.17

10 d

0.029

47.5

2.18
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4.1.3 Treatment with Calcium Hydride (CaH2) in Chloroform
Figure 4.4 displays the absorbance and fluorescence spectra of a CdSe
(oleylamine) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 1.33 x
10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 4.3
below. From these values, it can be seen that the QY of the QDs decreased after treatment
with CaH2. Additionally, the spectra in Figure 4.4 illustrate that the fluorescence peak
flattened and the absorbance increased after treatment. In a study by Mandal et al., an
increase in absorbance was found to be indicative of aggregation because absorbance
measurements are sensitive to scattering from colloidal suspensions that form as QD
aggregates grow in size.6 Furthermore, they found that a significant decrease in QD
fluorescence also resulted from aggregation.6 It can therefore be concluded that the
flattening of the fluorescence peak coupled with the significant increase in absorbance
observed 10 d after treatment with CaH2, indicates that the QDs began to aggregate at this
time. Furthermore, because the QDs were no longer fluorescent 10 d after treatment (see
Figure 4.4e), it can be concluded that the QDs precipitated out of solution.7 Lastly, the Eg
did not change after treatment indicating that there was no change in the size of the QDs.
In conclusion, treatment of CdSe (oleylamine) QDs dissolved in chloroform with CaH2
caused the QDs to stop fluorescing 10 d after treatment.
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Figure 4.4. Absorbance spectra (a) and fluorescence spectra (b) of a 6.39 x 10-7 M solution of CdSe
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1
d (red), 5 d (green), and 10 d (purple) after treatment with CaH2 (1.33 x 10-4 molar ratio of QDs to CaH2).
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.

Table 4.3. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of of a CdSe
(oleylamine) QD and CaH2 solution dissolved in chloroform at a 1.33 x 10-4 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.003

40.0

2.19

Initial

0.003

43.7

2.19

1d

0.003

40.6

2.19

5d

0.002

43.3

2.20

10 d

---

---

---
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4.1.4 Treatment with Calcium Hydride (CaH2) in Toluene
Figure 4.5 displays the absorbance and fluorescence spectra of a CdSe
(oleylamine) QD and calcium hydride (CaH2) solution dissolved in toluene at a 2.17 x
10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 4.4
below. From these values, it can be seen that the QY of the QDs steadily decreased with
time after treatment with CaH2. The pictures included in Figure 4.5 confirm this expected
decrease in QY, as the treated sample (right) is less fluorescent than the untreated sample
(left). Additionally, the absorption edge continued to become less sharp and the FWHM
increased with time, indicating a broadening of the QD size distribution after treatment.
Lastly, the Eg increased slightly after treatment indicating that there was a slight decrease
in the size of the QDs. In conclusion, treatment of CdSe (oleylamine) QDs dissolved in
toluene with CaH2 resulted in a quenching of the QDs fluorescence.
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Figure 4.5. Absorbance spectra (a) and fluorescence spectra (b) of a 1.04 x 10-6 M solution of CdSe
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with CaH2 (2.17 x 10-4 molar ratio of QDs to CaH2).
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.

Table 4.4. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(oleylamine) QD and CaH2 solution dissolved in toluene at a 2.17 x 10-4 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.057

39.1

2.15

Initial

0.042

40.3

2.15

1d

0.026

39.9

2.15

5d

0.020

46.6

2.19

10 d

0.023

53.6

2.23

86
4.1.5 Treatment with Hydrazine (N2H4) in Chloroform
Figure 4.6 displays the absorbance and fluorescence spectra of a CdSe
(oleylamine) QD and hydrazine (N2H4) solution dissolved in chloroform at a 6.74 x 10-7
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 4.5
below. From these values, it can be seen that the QY of the QDs decreased after treatment
with N2H4. A possible explanation for the observed decrease in QY involves the
solubility of N2H4 in chloroform. Specifically, N2H4 is nearly insoluble in chloroform8
and is a liquid at room temperature. Therefore, an emulsion formed immediately after the
addition of N2H4 to the untreated QD solution, as seen in Figure 4.6c where N2H4 formed
large droplets that were poorly dispersed in the continuous chloroform phase. We
hypothesize that oleylamine was able to act as a surfactant and stabilize the hydrazine
droplets, as its surface tension (31.4 mN/m9) is in between that of N2H4 (66.39 mN/m9)
and chloroform (27.5 mN/m9). As mentioned above, N2H4 formed large, unevenly
dispersed droplets in the chloroform which led to the assumption that oleylamine was a
poor surfactant. This assumption was confirmed as the hydrophilic-lipophilic balance
(HLB) of oleylamine was found to be approximately 1010, indicating that it is a
hydrophilic surfactant.11 Chloroform is a hydrophobic solvent, therefore a hydrophobic
surfactant with a low HLB value is required to yield a stable emulsion with small, evenly
dispersed droplets of N2H4.
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When the reducing/oxidizing agents were soluble in a given solvent, it was
assumed that the reduction/oxidation of the QDs happened immediately. Because N2H4 is
nearly insoluble in chloroform, an emulsion formed immediately after treatment.
Immediately after addition, a small amount of soluble N2H4 reacted with the QDs and
reduced their surface to etch and destroy the QDs thereby quenching the QD
fluorescence. The remainder of the N2H4 formed large, unevenly dispersed N2H4 droplets
stabilized by the residual oleylamine. The solution appeared blue-green when excited by
a 365 nm UV lamp because the oleylamine emits light at 450 nm upon excitation (see
Figure 4.7). After 10 d a visible layer forms at the top of the chloroform solution,
presumably due to instability of the emulsion (see Figure 4.6e). In conclusion, CdSe
(oleylamine) QDs dissolved in chloroform died immediately after the addition of N2H4.
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Figure 4.6. Absorbance spectra (a) and fluorescence spectra (b) of a 6.39 x 10-7 M solution of CdSe
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1
d (red), 5 d (green), and 10 d (purple) after treatment with N2H4 (6.74 x 10-7 molar ratio of QDs to N2H4).
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.

Table 4.5. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(oleylamine) QD and N2H4 solution dissolved in chloroform at a 6.74 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.006

39.5

2.19

Initial

0.001

---

---

1d

0.003

107

2.37

5d

0.004

107

2.40

10 d

0.004

106

2.40
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Figure 4.7. Normalized fluorescence spectrum of a solution composed of chloroform, oleylamine, and
N2H4.

4.1.6 Treatment with Hydrazine (N2H4) in Toluene
Figure 4.8 displays the absorbance and fluorescence spectra of a CdSe
(oleylamine) QD and hydrazine (N2H4) solution dissolved in toluene at a 1.10 x 10-6
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 4.6
below. From these values, it can be seen that the QY of the QDs was quenched
immediately after treatment with N2H4. This quenching of the fluorescence was
confirmed by the flattening of the fluorescence spectrum and the pictures in Figure 4.8
where the treated samples (right) no longer fluoresce. Hydrazine is soluble in toluene,
therefore it was assumed that the reducing agent reacted with the QDs immediately after
treatment and the concerns discussed in section 4.1.5 above were not applicable. In
conclusion, treatment of CdSe (oleylamine) QDs dissolved in toluene with N2H4 caused
the QDs to stop fluorescing immediately after treatment.
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Figure 4.8. Absorbance spectra (a) and fluorescence spectra (b) of a 1.04 x 10-6 M solution of CdSe
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with N2H4 (1.10 x 10-6 molar ratio of QDs to N2H4).
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.

Table 4.6. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(oleylamine) QD and N2H4 solution dissolved in toluene at a 1.04 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.041

39.6

2.15

Initial

0.003

42.3

2.05

1d

0.001

70.9

---

5d

0.001

---

---

10 d

---

---

---
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4.1.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform
Figure 4.9 displays the absorbance and fluorescence spectra of a CdSe
(oleylamine) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a
7.99 x 10-4 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table
4.7 below. From these values, it can be seen that the QY of the QDs decreased after
treatment with C14H10O4. Although the QY was calculated to be at a maximum 10 d after
treatment, a decrease in fluorescence was actually observed (see Figure 4.9e).
Similar to treatment with N2H4 (as described in section 4.1.5 above), the
fluorescence peak centered at 560 nm in Figure 4.10 represents the true emission of the
QDs. The peaks centered at 450 nm, on the other hand, are representative of the mixture
of chloroform, oleylamine, and C14H10O4, not the QDs. Focusing on the peak
representing the QDs, it can therefore be seen that the fluorescence of the QDs decreased
immediately after treatment, decreased further and experienced a blue-shift 5 d after
treatment, and was completely quenched 10 d after treatment. Figure 4.9e illustrates this
quenching of the QD fluoescence 10 d after treatment, as the treated sample (right) is not
fluorescent. Additionally, the absorption edge continued to become less sharp with time
and the FWHM increased, indicating a broadening of the QD size distribution after
treatment. Lastly, the Eg increased 5 d after treatment indicating that there was a slight
decrease in the size of the QDs at this time. In conclusion, treatment of CdSe
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(oleylamine) QDs dissolved in chloroform with C14H10O4 caused the QDs to stop
fluorescing 10 d after treatment.

Figure 4.9. Absorbance spectra (a) and fluorescence spectra (b) of a 6.39 x 10-7 M solution of CdSe
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow),
1 d (red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (7.99 x 10-4 molar ratio of QDs to
C14H10O4). Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

Table 4.7. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(oleylamine) QD and C14H10O4 solution dissolved in chloroform at a 6.39 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.005

39.3

2.19

Initial

0.003

39.7

2.19

1d

0.002

39.3

2.19

5d

0.003

53.3

2.23

10 d

0.007

102

2.40
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Figure 4.10. Normalized fluorescence spectrum of a solution composed of chloroform, oleylamine, and
benzoyl peroxide (C14H10O4).

4.1.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene
Figure 4.11 displays the absorbance and fluorescence spectra of a CdSe
(oleylamine) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at a 1.30
x 10-3 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 4.8
below. From these values, it can be seen that the QY of the QDs increased 1 d after
treatment with C14H10O4 before decreasing to below that of the untreated QY 5 d later.
This increase in QY 1 d after treatment is illustrated in Figure 4.11c as the treated sample
(right) is brighter than the untreated sample (left).
Similar to treatment with C14H10O4 in chloroform (as described in section 4.1.7
above), the fluorescence peak centered at 550 nm in Figure 4.11 represents the emission
of the QDs. The peaks measured 5 d (green) and 10 d (purple) after treatment, on the
other hand, are centered at 450 nm and are therefore representative of the mixture of
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toluene, oleylamine, and C14H10O4, not the QDs (see Figure 4.12 below). Focusing on
the peak representing the QDs, it can therefore be seen that the fluorescence of the QDs
increased 1 d after treatment and was completely quenched 5 d after treatment. Figure
4.11d and e confirm these observations as the treated sample (right) is not fluorescent 5 d
and 10 d after treatment, respectively. Additionally, the absorption edge continued to
become less sharp with time and the FWHM increased, indicating a broadening of the
QD size distribution after treatment. In conclusion, treatment of CdSe (oleylamine) QDs
dissolved in toluene with C14H10O4 resulted in a 22.9 % increase in the QY of the QDs
1 d after treatment, however, the fluorescence of the QDs was quenched 5 d after
treatment.
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Figure 4.11. Absorbance spectra (a) and fluorescence spectra (b) of a 1.04 x 10-6 M solution of CdSe
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (1.30 x 10-3 molar ratio of QDs to
C14H10O4). Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

Table 4.8. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(oleylamine) QD and C14H10O4 solution dissolved in toluene at a 1.30 x 10-3 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.035

40.4

2.15

Initial

0.013

39.5

2.15

1d

0.043

41.0

2.19

5d

0.028

84.5

2.35

10 d

0.007

71.6

2.40

96

Figure 4.12. Normalized fluorescence spectrum of a solution composed of toluene, oleylamine, and
C14H10O4.

4.1.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform
Figure 4.13 displays the absorbance and fluorescence spectra of a CdSe
(oleylamine) QD and tert-Butyl Hydroperoxide (C4H10O2) solution dissolved in
chloroform at a 6.14 x 10-6 molar ratio. From these spectra, quantum yield (QY), fullwidth half-maximum (FWHM), and bandgap energy (Eg) were calculated before
treatment, as well as immediately, 1 d, 5 d, and 10 d after treatment. These results are
summarized in Table 4.9 below. From these values, it can be seen that the QY of the QDs
decreased immediately after treatment with C4H10O2 before ceasing to fluoresce 1 d later.
Figure 4.13c illustrates this quenching of the QD fluoescence 1 d after treatment, as the
treated sample (right) is not fluorescent.
Similar to treatment with C14H10O4 (as described in sections 4.1.7 and 4.1.8
above), the fluorescence peak centered at 550 nm in Figure 4.10 represents the true
emission of the QDs. The peaks measured after treatment, on the other hand, are centered
at 450 nm and are therefore representative of the mixture of chloroform, oleylamine, and
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C4H10O2, not the QDs. For this reason, the quenching of the fluorescence of the QDs 1 d
after treatment was confirmed. In conclusion, treatment of CdSe (oleylamine) QDs
dissolved in chloroform with C4H10O2 resulted in a quenching of the QD fluorescence 1 d
after treatment.

Figure 4.13. Absorbance spectra (a) and fluorescence spectra (b) of a 6.39 x 10-7 M solution of CdSe
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1
d (red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (6.14 x 10-6 molar ratio of QDs to
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.
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Table 4.9. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(oleylamine) QD and C4H10O2 solution dissolved in chloroform at a 6.14 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.002

44.0

2.19

Initial

0.001

48.0

2.19

1d

0.001

32.8

2.40

5d

0.003

43.5

2.38

10 d

---

---

2.35

Figure 4.14. Normalized fluorescence spectrum of a solution composed of chloroform, oleylamine, and
tert-butyl hydroperoxide (C4H10O2).

4.1.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene
Figure 4.15 displays the absorbance and fluorescence spectra of a CdSe
(oleylamine) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in toluene at
a 1.00 x 10-5 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These values, as summarized in Table
4.10, show that the QY of the QDs decreased immediately after treatment with C4H10O2.

99
This decrease in QY is illustrated in Figure 4.15c where the treated QDs (right) are less
bright than the untreated QDs (left).
Similar to treatment with C4H10O2 in chloroform (as described in section 4.1.9
above), the fluorescence peak centered at 550 nm in Figure 4.15 represents the true
emission of the QDs. The peak measured 5 d (green) and 10 d (purple) after treatment, on
the other hand, is centered at 450 nm and is therefore representative of the mixture of
toluene, oleylamine, and C4H10O2, not the QDs (see Figure 4.16 below). Focusing on the
fluorescence peak representing the QDs, it can therefore be seen that the fluorescence
was quenched 5 d after treatment. Figure 4.15d and e confirm this quenching of the QD
fluoescence as the treated sample (right) is not fluorescent 5 d and 10 d after treatment,
respectively. Additionally, the absorption edge continued to become less sharp with time
and the FWHM increased, indicating a broadening of the QD size distribution after
treatment.1,12 In conclusion, treatment of CdSe (oleylamine) QDs dissolved in toluene
with C4H10O2 resulted in a quenching of the QD fluorescence 5 d after treatment.

100

Figure 4.15. Absorbance spectra (a) and fluorescence spectra (b) of a 1.04 x 10-6 M solution of CdSe
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (1.00 x 10-5 molar ratio of QDs to
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

Table 4.10. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(oleylamine) QD and C4H10O2 solution dissolved in toluene at a 1.00 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.052

46.6

2.15

Initial

0.002

---

2.15

1d

0.021

52.4

2.23

5d

0.062

75.6

2.35

10 d

0.097

76.9

2.39
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Figure 4.16. Normalized fluorescence spectrum of a solution composed of toluene, oleylamine, and
C4H10O2.

4.1.11 Summary of CdSe/Oleylamine Treatments
Figure 4.17 compares the effect of treating CdSe (oleylamine) QDs with various
reducing and oxidizing agents in chloroform versus toluene. From these photographs, it
can be seen that the QDs dissolved in toluene were visibly brighter than those in
chloroform. This observation was confirmed as the QY of the QDs before treatment in
chloroform was approximately 0.004 while the QY in toluene was approximately 0.050.
Because both sets of QDs came from the same master batch of cores, this difference in
QY may be due to the solubility of the oleylamine in the various solvents. Thuy et al.
have shown that the QY is higher when the capping ligand is less soluble in a given
solvent.13 Because the QY was higher in toluene than chloroform, we therefore
hypothesize that oleylamine is less soluble in toluene than chloroform. The Eg of the
untreated QDs in chloroform and toluene were 2.19 eV and 2.15 eV, respectively, which
suggests that the QD size and therefore color emitted is independent of solvent.
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Figure 4.17. Photos of CdSe (oleylamine) QDs that are from left to right: untreated, treated with NaBH4,
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were
suspended and treated in chloroform while those in the right column were suspended and treated in toluene.
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment.

The effect of reducing and oxidizing agents on the QY of CdSe (oleylamine) QDs
was found to be independent of solvent for 4 of the 5 treatments. More specifically, it was
found that the QY of the QDs declined after treatment with CaH2, N2H4, and C4H10O2 and
improved after treatment with NaBH4 in both chloroform and toluene. Treatment with
C14H10O4, on the other hand, increased the QY of the QDs when dissolved in toluene, but
not in chloroform. The reason for this dependence on solvent is not known, however, a
possible explanation focuses on the solubility of the oxidizing agent in the dispersion
solvent, as explained in detail below.
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Treatment of QDs with a reducing/oxidizing agent is expected to reduce the
surface ligands thereby causing them to lose their coordinating properties and detach
from the QD surface.14 Oxygen from atmospheric air is then able to diffuse to the
exposed cadmium on the QD surface to form a cadmium oxide (CdO) layer around the
QDs.14This CdO layer serves to passivate defects on the QD surface, thereby enhancing
the QY of the QDs.14 A possible explanation for the observed decrease of the QY after
treatment with C14H10O4 in chloroform is that the oxidizing agent reacted with the QDs at
a rate so fast that oxygen was not able to diffuse to the QD surface and form a CdO layer.
Instead, C14H10O4 caused the oleylamine ligands to quickly detach from the QD surface
and therefore caused aggregation in chloroform (as measured by the increase in
absorbance), and resulted in a quenched QY.7 In toluene, however, the reaction rate was
slowed down significantly because C14H10O4 is less soluble in toluene than chloroform.15
Because the reaction rate was slowed, after the C14H10O4 reduced the oleylamine on the
QD surface, oxygen was able to form the CdO layer and therefore passivate the defect
sites on the QD surface. To confirm this theory, additional testing is required. A possible
experiment involves treating the QDs with a lower concentration of C14H10O4 in
chloroform to see if the reaction rate slows enough to allow for the formation of a CdO
layer and therefore increased QY.
As mentioned above, treatment of CdSe (oleylamine) QDs with NaBH4 resulted
in an enhanced QY, while treatment with CaH2 decreased the QY of the QDs. We
hypothesize that this result can be explained by a difference in the reducing agents
reactivity with water. Specifically, we hypothesize that the reducing agents react with the

104
residual water present in each of the solvents to form hydrogen. The hydrogen then reacts
with the surface ligands, causing them to detach from the QD surface, and allowing
oxygen from the atmospheric air to diffuse to the exposed cadmium. The resulting CdO
layer around the QDs serves to passivate the defect sites located on the QD surface and
therefore improves the QY of the QDs. If the reducing agent reacts too fast with the
residual water, the QDs will aggregate and the QY will be quenched. In a study by Kong
et al., the reaction rate of NaBH4 with water vapor was found to be ten times slower than
that of CaH2.16 For this reason, it is hypothesized that CaH2 reacted very fast with the
residual water present in the QD solution, causing the QDs to aggregate, and the QY to
be quenched. This aggregation was confirmed by an increase in the measured absorbance.
NaBH4, on the other hand, reacted with the water at a slow enough rate that the hydrogen
produced was able to effectively detach ligands on the QD surface and allow for the
formation of the CdO layer.
In each of the 10 preceding subsections, a fluorescence peak centered at
approximately 450 nm was observed. To account for this peak, fluorescence spectroscopy
was

performed

on

solutions

consisting

of

each

oleylamine,

solvent,

and

reducing/oxidizing agent combination. Several of these spectra are included in the above
section. From these spectra, the peak at 450 nm was consistently found to represent the
ligand, solvent, and reducing/oxidizing agent combination, not the QDs. In 8 of the 10
cases summarized above, an increase in this peak centered at 450 nm was observed with
time. A possible explanation for this increase is that the solvent evaporated over time, as
seen by the decrease in solution volume in the pictures included in the figures above. As
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the solvent evaporated, the concentration of the precursor solution increased, and an
increase in fluorescence was therefore observed.

4.2 CdSe (OA and ODE) Quantum Dot Cores
4.2.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform
Figure 4.18 displays the absorbance and fluorescence spectra of a CdSe (OA &
ODE) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a 2.02 x
10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table
4.11 below. These values show that the QY of the QDs increased after treatment with
NaBH4 and reached a maximum 5 d after treatment. Additionally, the Eg decreased
slightly with time, indicating a minor increase in QD size and slight red-shift in emission
color. Figure 4.18d illustrates this increase in QY and red-shift in emission color 5 d after
treatment as the treated sample (right) is significantly brighter and slightly more red than
the untreated sample (left). Lastly, the FWHM decreased significantly 5 d and 10 d after
treatment, indicating a significant narrowing of the QD size distribution.
A possible explanation for the observed red-shift in emission is explained by the
measured increase in absorbance 10 d after treatment (see Figure 4.18a). Absorbance is
related to the concentration of QDs in solution, therefore an increase in absorbance is
indicative of a higher density of particles packed in the QD solution. When the space
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between QDs is small, it is possible for the wave function of the electrons in an
individual QD to ‘leak out’ and overlap with the wave function of a neighboring QD.7
This formation of collective electronic states due to electron overlap interactions results
in a spectral red-shift of QD emission.7 In conclusion, treatment of CdSe (OA & ODE)
QDs dissolved in chloroform with NaBH4 resulted in a 170 % increase in the QY of the
QDs and a red-shift in emission 5 d after treatment.

Figure 4.18. Absorbance spectra (a) and fluorescence spectra (b) of a 6.43 x 10-7 M solution of CdSe (OA
& ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (2.02 x 10-5 molar ratio of QDs to NaBH4).
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.
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Table 4.11. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & ODE) QD and NaBH4 solution dissolved in chloroform at a 2.02 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.060

217

2.23

Initial

0.061

217

2.23

1d

0.061

217

2.23

5d

0.162

172

2.18

10 d

0.130

154

2.20

4.2.2 Treatment with Sodium Borohydride (NaBH4) in Toluene
Figure 4.19 displays the absorbance and fluorescence spectra of a CdSe (OA &
ODE) QD and sodium borohydride (NaBH4) solution dissolved in toluene at a 9.21 x 10-5
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table
4.12 below. These values show that the QY of the QDs increased slightly after treatment
with NaBH4 before decreasing to below that of the untreated QDs 1 d later. Additionally,
the Eg decreased slightly with time, indicating a minor increase in QD size and red-shift
in emission color. The pictures included in Figure 4.19 illustrate this decrease in QY and
red-shift, as the treated sample (right) is less fluorescent and more red than the untreated
sample (left).
Similar to the previous section, a possible explanation for the observed red-shift is
explained by the measured increase in absorbance 5 d and 10 d after treatment (see
Figure 4.19a). Absorbance is related to the concentration of QDs in solution, therefore an
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increase in absorbance is indicative of a higher density of particles packed in the QD
solution. When the space between QDs is small, it is possible for the wave function of the
electrons in an individual QD to ‘leak out’ and overlap with the wave function of a
neighboring QD.7 This formation of collective electronic states due to electron overlap
interactions results in a spectral red-shift of QD emission.7 In conclusion, treatment of
CdSe (OA & ODE) QDs dissolved in toluene with NaBH4 resulted in a 0.05 % increase
in the QY of the QDs immediately after treatment as well as a red-shift in emission.

Figure 4.19. Absorbance spectra (a) and fluorescence spectra (b) of a 2.93 x 10-6 M solution of CdSe (OA
& ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with NaBH4 (9.21 x 10-5 molar ratio of QDs to NaBH4).
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.
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Table 4.12. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & ODE) QD and NaBH4 solution dissolved in toluene at a 9.21 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.204

157

2.52

Initial

0.205

156

2.52

1d

0.165

155

2.52

5d

0.103

159

2.50

10 d

0.066

166

2.49

4.2.3 Treatment with Calcium Hydride (CaH2) in Chloroform
Figure 4.20 displays the absorbance and fluorescence spectra of a CdSe (OA &
ODE) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 1.34 x 10-4
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table
4.13. These values show that the QY of the QDs reached a maximum 5 d after treatment
with CaH2 before decreasing to below that of the untreated QY 10 d later. Additionally,
the absorbance value increased significantly between 5 d and 10 d after treatment. In a
study by Mandal et al., an increase in absorbance was found to be indicative of
aggregation because absorbance measurements are sensitive to scattering from colloidal
suspensions that form as QD aggregates grow in size.6 Furthermore, they found that a
decrease in QD fluorescence also resulted from aggregation.6 Similar to treatment of
CdSe (oleylamine) QDs with CaH2 as described in section 4.1.3 above, the observed
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increase in absorbance and flattening of the fluorescence peak (see Figure 4.20) indicates
that the QDs began to aggregate 10 d after treatment.

Figure 4.20. Absorbance spectra (a) and fluorescence spectra (b) of a 6.43 x 10-7 M solution of CdSe (OA
& ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with CaH2 (1.34 x 10-4 molar ratio of QDs to CaH2).
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.
Table 4.13. Quantum yield (QY) and full-width half-maximum (FWHM) of a CdSe (OA & ODE) QD and
CaH2 solution dissolved in chloroform at a 1.34 x 10-4 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.070

156

2.23

Initial

0.038

218

2.23

1d

0.071

163

2.24

5d

0.165

155

2.25

10 d

0.040

163

2.21
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From the above results, a slight red-shift in emission was also observed 10 d after
treatment as confirmed by the slight red-shift of the fluorescence peak, minor decrease in
Eg, and in Figure 4.20e where the treated QDs (right) appeared slightly more red than the
untreated QDs (left). Several other research groups have reported observing a red-shift in
conjunction with aggregation.7,17-19 This red-shift is attributed to the tight packing of the
QDs contained in the aggregates. Similar to treatment with NaBH4 as described in the
preceding sections, when QDs are tightly packed, the wave function of the electrons in an
individual QD is believed to ‘leak out’ and overlap with the wave function of a
neighboring QD.7 This formation of collective electronic states due to electron overlap
interactions results in a spectral red shift of QD emission.7 In conclusion, treatment of
CdSe (OA & ODE) QDs dissolved in chloroform with CaH2 resulted in a 136 % increase
in the QY of the QDs 5 d after treatment and a red-shift due to aggregation 10 d after
treatment.

4.2.4 Treatment with Calcium Hydride (CaH2) in Toluene
Figure 4.21 displays the absorbance and fluorescence spectra of a CdSe (OA &
ODE) QD and calcium hydride (CaH2) solution dissolved in toluene at a 6.10 x 10-4
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table
4.14 below. These values show that the QY of the QDs steadily decreased with time after
treatment with CaH2. Furthermore, a significant increase in absorbance was observed
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10 d after treatment (see Figure 4.21a). As explained in detail in section 4.2.3 above, an
increase in absorbance was found to be indicative of aggregation because absorbance
measurements are sensitive to scattering from colloidal suspensions that form as QD
aggregates grow in size.6 Furthermore, aggregation also results in a decrease in QD
fluorescence.6 It is therefore hypothesized that the observed increase in absorbance
coupled with a decrease in fluorescence 10 d after treatment indicates that the QDs began
to aggregate at this time.
In Table 4.14 below, the FWHM was reported to increase and Eg to decrease
slightly 5 d and 10 d after treatment, indicating a broadening of the size distribution and
slight red-shift in emission color. This red-shift was confirmed in Figure 4.21 where the
treated sample (right) is more red than the untreated sample (left) 5 d (d) and 10 d (e)
after treatment. Similar to the preceding section, a possible explanation for the observed
red-shift in emission is attributed to the tight packing of the QDs contained in the
aggregates. When QDs are tightly packed, the wave function of the electrons in an
individual QD is believed to ‘leak out’ and overlap with the wave function of a
neighboring QD.7 This formation of collective electronic states due to electron overlap
interactions results in a spectral red shift of QD emission.7 In conclusion, treatment of
CdSe (OA & ODE) QDs dissolved in toluene with CaH2 resulted in a decline in the QY
of the QDs and a red-shift in emission due to aggregation.
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Figure 4.21. Absorbance spectra (a) and fluorescence spectra (b) of a 2.93 x 10-6 M solution of CdSe (OA
& ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with CaH2 (6.10 x 10-4 molar ratio of QDs to CaH2). Photos of
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.

Table 4.14. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & ODE) QD and CaH2 solution dissolved in chloroform at a 6.10 x 10-4 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.177

156

2.52

Initial

0.119

154

2.53

1d

0.165

156

2.55

5d

0.068

173

2.51

10 d

0.038

196

2.50
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4.2.5 Treatment with Hydrazine (N2H4) in Chloroform
Figure 4.22 displays the absorbance and fluorescence spectra of a CdSe (OA &
ODE) QD and hydrazine (N2H4) solution dissolved in chloroform at a 2.03 x 10-6 molar
ratio. Because the fluorescence of the QDs was quenched immediately after treatment, it
was not possible to calculate the quantum yield (QY), full-width half-maximum (FWHM)
or bandgap energy (Eg) of the QDs. Similar to treatment of CdSe (oleylamine) QDs in
chloroform (as described in section 4.1.5 above), the addition of N2H4 resulted in an
emulsion. We hypothesize that OA was able to act as a surfactant and stabilize the
hydrazine droplets, as its surface tension (32.5 mN/m9) was in between that of N2H4
(66.39 mN/m9) and chloroform (27.5 mN/m9). The hydrophilic-lipophilic balance (HLB)
of OA was found to be 120, indicating that it is a hydrophobic surfactant.11 Chloroform is
a hydrophobic solvent, therefore OA was found to be a good surfactant that yielded a
stable emulsion with small, evenly dispersed droplets of N2H4.
Immediately after adding N2H4 to the chloroform, a small amount of soluble N2H4
reacted with the QDs and reduced their surface to etch and destroy the QDs thereby
quenching the QD fluorescence. The fluorescence spectrum included in Figure 4.22b
confirms this quenching of the fluorescence as the peak completely flattened immediately
after treatment. The residual OA in the solution then stabilized the remaining N2H4 into
small, evenly dispersed N2H4 droplets. These droplets scattered the light, causing the
solution to appear cloudy in visible light. When a 365 nm UV lamp was used as the
incident light, the evenly dispersed droplets of N2H4 in the QD solution scattered the light
causing the solution to appear purple (see pictures in Figure 4.22). In conclusion,
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treatment of CdSe (OA & ODE) QDs dissolved in chloroform with N2H4 caused the QDs
to stop fluorescing immediately after treatment.

Figure 4.22. Absorbance spectra (a) and fluorescence spectra (b) of a 6.43 x 10-7 M solution of CdSe (OA
& ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with N2H4 (2.03 x 10-6 molar ratio of QDs to N2H4).
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.

Table 4.15. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & ODE) QD and N2H4 solution dissolved in toluene at a 2.03 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.069

159

2.23

Initial

---

---

---

1d

---

---

---

5d

---

---

---

10 d

---

---

---
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4.2.6 Treatment with Hydrazine (N2H4) in Toluene
Figure 4.23 displays the absorbance and fluorescence spectra of a CdSe (OA &
ODE) QD and hydrazine (N2H4) solution dissolved in toluene at a 9.27 x 10-6 molar ratio.
From these spectra, quantum yield (QY), full-width half-maximum (FWHM), and
bandgap energy (Eg) were calculated before treatment, as well as immediately, 1 d, 5 d,
and 10 d after treatment. These results are summarized in Table 4.16 below. As
illustrated in Figure 4.23b, immediately after treatment with N2H4, the fluorescence peak
centered at 550 nm flattened completely and a peak centered at 460 nm was observed.
This peak was found to be representative of the solution of toluene, OA, ODE, andN2H4,
not the QDs (see Figure 4.24 below). We therefore hypothesize that immediately after
treatment with N2H4 the fluorescence of the QD solution was quenched. The blue color
observed in the pictures included in Figure 4.23 is therefore representative of the
precursor solution, not the QDs. Because N2H4 is soluble in toluene, the issues explained
in section 4.2.5 above are not applicable to this system. In conclusion, treatment of CdSe
(OA & ODE) QDs dissolved in toluene with N2H4 resulted in the quenching of the QD
fluorescence immediately after treatment.
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Figure 4.23. Absorbance spectra (a) and fluorescence spectra (b) of a 2.93 x 10-6 M solution of CdSe (OA
& ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with N2H4 (9.27 x 10-6 molar ratio of QDs to N2H4). Photos of
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.

Table 4.16. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & ODE) QD and N2H4 solution dissolved in toluene at a 9.27 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.173

155

2.52

Initial

0.004

133

2.71

1d

0.003

121

2.74

5d

0.008

121

2.74

10 d

0.006

117

2.83
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Figure 4.24. Normalized fluorescence spectrum of a solution composed of toluene, OA, ODE, and N2H4.

4.2.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform
Figure 4.25 displays the absorbance and fluorescence spectra of a CdSe (OA &
ODE) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a 1.29 x
10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, which are summarized in
Table 4.17 below, show that the QY of the QDs increased significantly after treatment
with C14H10O4 and reached a maximum 5 d after treatment before decreasing to slightly
below that of the untreated QY 10 d later. Additionally, the FWHM was at a minimum
5 d after treatment, indicating a narrowing of the size distribution. Lastly, the absorbance
peak shifted to a slightly higher wavelength 5 d and 10 d after treatment (Figure 4.25a),
the fluorescence peak red-shifted slightly (Figure 4.25b), and the Eg decreased slightly,
indicating a slight red-shift in emission. Figure 4.25 illustrates this increase in QY and
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red-shift, as the treated sample (right) is brighter and slightly more red than the untreated
sample (left).
Similar to treatment with CaH2 and NaBH4 as described in the preceding sections,
a possible explanation for the observed red-shift in emission is explained by the measured
increase in absorbance 10 d after treatment. Absorbance is related to the concentration of
QDs in solution, therefore an increase in absorbance is indicative of a higher density of
particles packed in the QD solution. When the space between QDs is small, it is possible
for the wave function of the electrons in an individual QD to ‘leak out’ and overlap with
the wave function of a neighboring QD.7 This formation of collective electronic states
due to electron overlap interactions results in a spectral red-shift of QD emission.7 In
conclusion, treatment of CdSe (OA & ODE) QDs dissolved in chloroform with C14H10O4
resulted in an 81.5 % increase in the QY of the QDs 5 d after treatment as well as a redshift in emission.
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Figure 4.25. Absorbance spectra (a) and fluorescence spectra (b) of a 6.43 x 10-7 M solution of CdSe (OA
& ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (1.29 x 10-4 molar ratio of QDs to
C14H10O4). Photos of untreated QDs (left) and QDs treated with 0.025 mmol C14H10O4 (right) excited with
365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

Table 4.17. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & ODE) QD and C14H10O4 solution dissolved in chloroform at a 1.29 x 10-4 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.081

182

2.23

Initial

0.116

176

2.25

1d

0.145

170

2.29

5d

0.147

156

2.20

10 d

0.074

168

2.20
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4.2.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene
Figure 4.26 displays the absorbance and fluorescence spectra of a CdSe (OA &
ODE) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at a 5.86 x 10-4
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table
4.18 below. From these values, it can be seen that the QY of the QDs steadily decreased
with time after treatment with C14H10O4. Additionally, the absorbance peak shifted to a
higher wavelength 5 d and 10 d after treatment indicating the QDs grew and size and
therefore a red-shift in emission is expected. Conversely, the fluorescence peak narrowed
and centered at a lower wavelength 5 d and 10 d after treatment indicating a blue-shift in
emission. Furthermore, Figure 4.26 illustrates that the QDs fluoresced pink 5 d and 10 d
after treatment. An explanation for these conflicting results is not known and it is
therefore recommended that this treatment be redone to ensure accuracy. In conclusion,
treatment of CdSe (OA & ODE) QDs dissolved in toluene with C14H10O4 resulted in a
decrease in the QY of the QDs.
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Figure 4.26. Absorbance spectra (a) and fluorescence spectra (b) of a 2.93 x 10-7 M solution of CdSe (OA
& ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with C14H10O4 (5.86 x 10-4 molar ratio of QDs to C14H10O4).
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 4.18. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & ODE) QD and C14H10O4 solution dissolved in toluene at a 5.86 x 10-4 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.186

156

2.50

Initial

0.185

156

2.50

1d

0.125

162

2.49

5d

0.034

84.6

2.66

10 d

0.037

60.6

2.64
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4.2.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform
Figure 4.27 displays the absorbance and fluorescence spectra of a CdSe (OA &
ODE) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in chloroform at a
2.06 x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table
4.19 below. From these values, it can be seen that the QY of the QDs decreased after
treatment with C4H10O2. Despite this measured decrease in fluorescence, the solution
appeared blue when excited by a 365 nm UV lamp (see pictures in Figure 4.27) because
the mixture of residual OA, ODE, and C4H10O2 in solution emits light at 450 nm upon
excitation (see Figure 4.28). Additionally, the broad fluorescence peak narrowed and
centered at a lower wavelength, resulting in a decreased FWHM and increased Eg. In
conclusion, treatment of CdSe (OA & ODE) QDs dissolved in chloroform with C4H10O2
resulted in a decrease in the QY of the QDs.
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Figure 4.27. Absorbance spectra (a) and fluorescence spectra (b) of a 6.43 x 10-7 M solution of CdSe (OA
& ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (2.06 x 10-6 molar ratio of QDs to
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

Table 4.19. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & ODE) QD and C4H10O2 solution dissolved in toluene at a 2.06 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.067

157

2.23

Initial

0.012

198

---

1d

0.013

158

2.31

5d

0.021

124

2.30

10 d

0.007

---

2.31
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Figure 4.28. Normalized fluorescence spectrum of a solution composed of chloroform, OA, ODE, and
C4H10O2.

4.2.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene
Figure 4.29 displays the absorbance and fluorescence spectra of a CdSe (OA &
ODE) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in toluene at a 9.39
x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, which are summarized in
Table 4.20 below, show that the QY of the QDs decreased after treatment with C4H10O2.
This decrease in QY was confirmed by the significant decrease in the fluorescence peak
(Figure 4.29b) as well from the pictures in Figure 4.29 where the treated QDs (right) are
less bright than the untreated QDs (left). Additionally, the broad fluorescence peak
narrowed and centered at a lower wavelength, resulting in a decreased FWHM and
increased Eg. These observations suggest an expected blue-shift in emission which was
confirmed in Figure 4.29 where the treated QD solution (right) is significantly bluer than
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the untreated solution (left). In conclusion, treatment of CdSe (OA & ODE) QDs
dissolved in toluene with C4H10O2 resulted in a decrease in the QY of the QDs.

Figure 4.29. Absorbance spectra (a) and fluorescence spectra (b) of a 2.93 x 10-6 M solution of CdSe (OA
& ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with C4H10O2 (9.39 x 10-6 molar ratio of QDs to C4H10O2).
Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 4.20. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & ODE) QD and C4H10O2 solution dissolved in toluene at a 9.39 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.173

156

2.52

Initial

0.002

198

---

1d

0.007

119

2.64

5d

0.013

100

2.68

10 d

0.012

110

2.67
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4.2.11 Summary of CdSe/OA & ODE Treatments
Figure 4.30 compares the effect of treating CdSe (OA & ODE) QDs with various
reducing and oxidizing agents in chloroform versus toluene. From these photographs, it
can be seen that the QDs dissolved in toluene were visibly brighter than those in
chloroform. This observation was confirmed as the QY of the QDs before treatment in
chloroform was approximately 0.067 while the QY in toluene was approximately 0.170.
Because both sets of QDs came from the same master batch of cores, this difference in
QY may be due to the solubility of OA in the various solvents. Thuy et al. have shown
that the QY is higher when the capping ligand is less soluble in a given solvent.13 From
our results, we found that the QY of the QDs was higher in toluene than chloroform
therefore implying that OA is less soluble in toluene than chloroform. The literature,
however, states that OA is more souble in toluene than chloroform, therefore disproving
this explanation. A possible explanation for this dependence on solvent may therefore be
due to the solubility of oxygen in each of the solvents. The Eg of the untreated QDs in
chloroform and toluene were 2.23 eV and 2.52 eV, respectively, which suggests that the
solvent does have an effect on QD size and color emitted. An explanation for this
phenomenon is not readily known, and will be explored via additional characterization
methods in the future work of this thesis.
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Figure 4.30. Photos of CdSe (OA & ODE) QDs that are from left to right: untreated, treated with NaBH4,
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were
suspended and treated in chloroform while those in the right column were suspended and treated in toluene.
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment.

The overall effect of reducing and oxidizing agents on the overall QY of CdSe
(OA & ODE) QDs was found to be independent of solvent for 3 of the 5 treatments.
More specifically, it was found that the QY of the QDs improved after treatment with
NaBH4 and worsened after treatment with N2H4 and C4H10O2 in both chloroform and
toluene. Treatment with CaH2 and C14H10O4, on the other hand, increased the QY of the
QDs when dissolved in chloroform, but not in toluene. Even though the QY of the QDs
increased after treatment with NaBH4 in both chloroform and toluene, the percent
increase in QY in chloroform was significantly higher than in toluene, 170 % compared
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to 0.05 %, respectively. These results clearly illustrate that the surface treatment of CdSe
(OA & ODE) QDs was more effective in chloroform than toluene.
The reason for this dependence on solvent is not known, however, a possible
explanation focuses on the solubility of the ligand (OA) in the dispersion solvent. In a
study by Bullen et al., it was concluded that desorption of the surface ligands may occur
if the ligand is more soluble in a given solvent, therefore resulting in decreased QY.21
Oleic acid is more soluble in toluene than chloroform as confirmed by comparing
Hildebrand solubility parameters. Specifically, the Hildebrand solubility parameter (δ)
provides a good estimation of the solubility of two substances as it is a numerical
estimate of the degree of interaction between materials. The closer the δ of two
substances, the better the degree of solubility. Furthermore, δOA = 15.95, δtoluene = 17.8,
and δchloroform = 19.0,22 therefore confirming that OA is more soluble in toluene than
chloroform. For this reason, it can be hypothesized that OA ligands will desorb from the
QD surface at a faster rate in toluene than chloroform, thereby explaining why surface
treatment is more effective in chloroform than toluene.
A second possible explanation for the observed results focuses on the solubility of
the reducing agent in the dispersion solvent. We hypothesize that when a
reducing/oxidizing agent it highly soluble in a given solvent, it reacts with the QDs at a
rate so fast desorption of the ligands and aggregation occur before forming a stable QD
with a CdO layer.7 The net result is an increase in the UV absorbance and a quenching of
the fluorescence resulting in a decrease in QY. As explained above, treatment of QDs
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dispersed in toluene resulted in a decreased QY, while treatment in chloroform enhanced
the QY. We therefore hypothesize that CaH2 is more soluble in toluene than chloroform,
resulting in a faster reduction rate of the QDs when dissolved and treated in the former
solvent. Unfortunately, information is not currently available regarding the solubility of
CaH2 in toluene versus chloroform. For this reason, it is recommended that future work
include a solubility study to determine the solubility of CaH2 in both chloroform and
toluene to confirm this theory.
Treatment with C14H10O4 also resulted in an enhanced QY when the QDs were
dispersed and treated in chloroform but not in toluene. This result is opposite of the
results obtained in the treatment of CdSe (oleylamine) QDs as detailed in section 4.1.11
above. When dissolved in toluene, treatment with C14H10O4 resulted in conflicting results.
Specifically, the absorbance spectrum showed a red-shift in emission while the
fluorescence spectrum showed a blue-shift in emission after treatment. An explanation
for these conflicting results is not known and it was therefore recommended that this
treatment be redone to ensure accuracy. It is expected that after retreating CdSe (OA &
ODE) QDs dissolved in toluene with C14H10O4 , a greater increase in QY will result than
the 81.5 % increase observed when the QDs were dissolved in chloroform. This
expectation is supported by the fact that C14H10O4 is more soluble in chloroform than
toluene, therefore the rate of reaction will be higher in chloroform than toluene. Because
an increase in QY was observed in chloroform, it can therefore be hypothesized that an
even greater increase in QY will be observed when the QDs are retreated in toluene.
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In Figure 4.30, it can clearly be seen that treatment with N2H4 and C4H10O2 had a
different effect in chloroform than toluene. Specifically, the QD solutions appeared very
bright when dissolved in chloroform but did not fluoresce when in toluene. Although the
QY was calculated to decrease after treatment in both solvents, the reason for the
observed decrease was very different. In the case of N2H4, as explained in detail in the
preceding sections, the reducing agent was nearly insoluble in chloroform and has poor
solubility in toluene. For this reason, an emulsion formed when the QDs were treated in
chloroform, causing the incident light to scatter, and the QD solution to appear purple.
When the QDs were treated in toluene, however, the N2H4 was soluble in toluene
therefore no emulsion formed. Instead, the QDs reacted with the reducing agent
immediately after treatment resulting in a quenched fluorescence. In the case of C4H10O2,
when added to QDs dispersed in chloroform, the solution appeared significantly brighter
than when added to toluene, even though the QY was calculated to decrease in both
cases. A reason for this decrease is not known, however, as explained above, the
increased solubility of OA in toluene over chloroform may be a potential reason.
In section 4.1.11 above, a fluorescence peak centered at approximately 450 nm
was observed in every measured fluorescence spectra. This peak was not observed in any
of the 10 preceding sections. Similar to the case of oleylamine, fluorescence spectroscopy
was performed on solutions consisting of each OA, ODE, solvent, and reducing/oxidizing
agent combination to account for the potential influence of the various reaction materials
on QD fluorescence. In these spectra, a peak at 450 nm was measured and was therefore
said to be representative of the reaction materials. Because this peak was not observed in
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the above spectra, we hypothesize that there was no residual OA present in the solvents.
In other words, if residual OA was present in the solution, we would expect to see a
fluorescence peak representing its interaction with the solvent it is dispersed in and added
reducing/oxidizing agent.

4.3 CdSe (OA and TOA) Quantum Dot Cores
4.3.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform
Figure 4.31 displays the absorbance and fluorescence spectra of a CdSe (OA &
TOA) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a 5.54 x
10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
4.21 below, show that the QY of the QDs steadily increased after treatment with NaBH4
until reaching a maximum 10 d after treatment. Figure 4.31e illustrates this increase in
QY 10 d after treatment, as the treated sample (right) is brighter than the untreated
sample (left). Additionally, no notable change in FWHM or Eg was observed therefore
ruling out a significant broadening of the QD size distribution or shift in QD emission
after treatment.
In calculating QY for this sample, the fluorescence peak centered at 620 nm was
determined to be representative of the QDs rather than the negative peak centered at
430 nm because the QDs fluoresced red in color (see pictures in Figure 4.31) which
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indicates a higher wavelength. To account for the potential influence of the various
reaction materials on the negative fluorescence peak, fluorescence spectroscopy was
performed on a solution of chloroform, OA, TOA and NaBH4. The normalized
fluorescence spectrum of this solution is included in Figure 4.32. From this spectrum it
can be seen that a significant fluorescence peak centered at 450 nm resulted, however, no
negative peak was measured. An explanation for this negative peak is therefore not
known and will be explored further in future work. In conclusion, treatment of CdSe (OA
& TOA) QDs dissolved in chloroform with NaBH4 resulted in a 133 % increase in the
QY of the QDs 10 d after treatment.

Figure 4.31. Absorbance spectra (a) and fluorescence spectra (b) of a 2.88 x 10-7 M solution of CdSe (OA
& TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (5.54 x 10-5 molar ratio of QDs to NaBH4).
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.
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Table 4.21. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & TOA) QD and NaBH4 solution dissolved in chloroform at a 5.54 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.003

53.5

1.92

Initial

0.005

56.4

1.91

1d

0.005

53.0

1.91

5d

0.004

50.6

1.92

10 d

0.007

53.3

1.93

Figure 4.32. Normalized fluorescence spectrum of a solution composed of chloroform, OA, TOA and
NaBH4.

4.3.2 Treatment with Sodium Borohydride (NaBH4) in Toluene
Figure 4.33 displays the absorbance and fluorescence spectra of a CdSe (OA &
TOA) QD and sodium borohydride (NaBH4) solution dissolved in toluene at a 5.83 x 10-5
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
4.22 below, show that the QY of the QDs steadily decreased with time after treatment
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with NaBH4. From the pictures in Figure 4.33, however, an increase in the QY was
observed as the treated QDs (right) appeared more bright than the untreated QDs (left). In
fact, the untreated QD solution appeared to decrease in brightness with time. This result
leads to the hypothesis that CdSe (OA & TOA) QDs are not stable with time.
Furthermore, this decrease in the QY of the untreated QDs over time may explain why
the QY calculated after treatment with NaBH4 decreased with time even though an
increase in brightness was observed. Lastly, no noticeable change in FWHM or Eg was
observed, therefore ruling out a significant change in the size distribution or size of the
QDs. In conclusion, treatment of CdSe (OA & TOA) QDs dissolved in toluene with
NaBH4 resulted in an increase in the QY of the QDs.
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Figure 4.33. Absorbance spectra (a) and fluorescence spectra (b) of a 3.03 x 10-7 M solution of CdSe (OA
& TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with NaBH4 (5.83 x 10-5 molar ratio of QDs to NaBH4).
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 4.22. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & TOA) QD and NaBH4 solution dissolved in toluene at a 5.83 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.073

61.1

1.92

Initial

0.072

60.7

1.92

1d

0.040

55.2

1.93

5d

0.040

56.1

1.93

10 d

0.038

56.7

1.93
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4.3.3 Treatment with Calcium Hydride (CaH2) in Chloroform
Figure 4.34 displays the absorbance and fluorescence spectra of a CdSe (OA &
TOA) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 6.00 x 10-5
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
4.23 below, show that the QY of the QDs decreased immediately after treatment with
CaH2 and the QDs stopped fluorescing 5 d after treatment. Additionally, the absorbance
value increased after treatment. In a study by Mandal et al., an increase in absorbance
was found to be indicative of aggregation because absorbance measurements are sensitive
to scattering from colloidal suspensions that form as QD aggregates grow in size.6
Furthermore, they found that a decrease in QD fluorescence also resulted from
aggregation.6 Similar to treatment of CdSe (OA & ODE) QDs with CaH2 as described in
section 4.2.3 above, the observed increase in absorbance and flattening of the
fluorescence peak (see Figure 4.34) therefore indicate that the QDs began to aggregate
5 d after treatment. In Figure 4.34d, a decrease in the QY was observed as the treated
QDs (right) are less bright than the untreated QDs (left).
The absorbance continued to increase 10 d after treatment (see purple line in
Figure 4.34a) which indicates that the QD aggregates continued to grow between 5 d and
10 d after treatment. Furthermore, because in Figure 4.34e the fluorescence of the treated
QDs solution is quenched, it can be hypothesized that the aggregates grew large enough
that the QDs precipitated out of solution at this time.7 Lastly, as explained in section
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4.3.1, a reason for the observed negative peak centered at 430 nm is not readily known
and will be explored further in future work. In conclusion, treatment of CdSe (OA &
TOA) QDs dissolved in chloroform with CaH2 resulted in a quenching of the QD
fluorescence 10 d after treatment due to aggregation.

Figure 4.34. Absorbance spectra (a) and fluorescence spectra (b) of a 2.88 x 10-7 M solution of CdSe (OA
& TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with CaH2 (6.00 x 10-5 molar ratio of QDs to CaH2).
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.
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Table 4.23. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & TOA) QD and CaH2 solution dissolved in chloroform at a 6.00 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.003

53.5

1.92

Initial

0.002

56.7

1.90

1d

0.002

54.0

1.91

5d

---

---

---

10 d

---

---

---

4.3.4 Treatment with Calcium Hydride (CaH2) in Toluene
Figure 4.35 displays the absorbance and fluorescence spectra of a CdSe (OA &
TOA) QD and calcium hydride (CaH2) solution dissolved in toluene at a 6.31 x 10-5
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
4.24 below, show that the QY of the QDs steadily decreased with time after treatment
with CaH2. This decrease in QY after treatment was confirmed by both the flattening of
the fluorescence peak and pictures included in Figure 4.35 where the treated QDs (right)
appeared less bright than the untreated QDs (left). Additionally, a slightly broader
fluorescence peak, increased FWHM, and less refined absorption peak indicate
broadening of the QD size distribution after treatment. In conclusion, treatment of CdSe
(OA & TOA) QDs dissolved in toluene with CaH2 resulted in a decrease in the QY of the
QDs.
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Figure 4.35. Absorbance spectra (a) and fluorescence spectra (b) of a 3.03 x 10-7 M solution of CdSe (OA
& TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with CaH2 (6.31 x 10-5 molar ratio of QDs to CaH2). Photos of
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.

Table 4.24. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & TOA) QD and CaH2 solution dissolved in toluene at a 6.31 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.047

61.8

1.92

Initial

0.034

64.7

1.91

1d

0.038

64.2

1.92

5d

0.012

74.2

1.90

10 d

0.002

75.3

1.88
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4.3.5 Treatment with Hydrazine (N2H4) in Chloroform
Figure 4.36 displays the absorbance and fluorescence spectra of a CdSe (OA &
TOA) QD and hydrazine (N2H4) solution dissolved in chloroform at a 3.04 x 10-7 molar
ratio. From these spectra, quantum yield (QY), full-width half-maximum (FWHM), and
bandgap energy (Eg) were calculated before treatment, as well as immediately, 1 d, 5 d,
and 10 d after treatment. These results are summarized in Table 4.25 below. Similar to
treatment of CdSe (OA & ODE) QDs in chloroform (as described in section 4.2.5 above),
treatment of CdSe (OA & TOA) QDs with N2H4 resulted in an emulsion due to the near
insolubility of N2H4 in chloroform. Although it was previously concluded that OA was a
good surfactant in chloroform due to its low HLB value, large, poorly dispersed droplets
of N2H4 formed in the treatment of CdSe (OA & TOA) QDs in chloroform (see pictures
in Figure 4.36).
Octadecene does not have surfactant-like properties because it does not contain
both polar and non-polar groups, therefore it was not a factor in the emulsion described in
section 4.2.5. Tricoctylamine, on the other hand, does contain polar and non-polar groups
and was therefore a factor in the emulsion. More specifically, the nitrogen in TOA forms
three bonds, leaving a single lone pair of electrons. We hypothesize that this lone pair of
electrons is repelled by the lone pair of electrons of N2H4, preventing all of the reducing
agent from reacting with the QDs. Instead, immediately after adding N2H4 to the
chloroform, a small amount of soluble N2H4 reacted with the QDs and reduced their
surface to etch and destroy the QDs thereby quenching the QD fluorescence. The
fluorescence spectrum included in Figure 4.36b confirms this quenching of the
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fluorescence as the peak completely flattened immediately after treatment. The remainder
of the N2H4 formed large, unevenly dispersed N2H4 droplets stabilized by the residual OA
and TOA. The solution appeared blue-green when excited by a 365 nm UV lamp because
the mixture of chloroform, OA, and TOA emits light at 450 nm upon excitation (see
Figure 4.37). After 10 d a visible layer formed at the top of the chloroform solution,
presumably due to instability of the emulsion (see Figure 4.36e). This result is consistent
with the result of treating CdSe (oleylamine) QDs in chloroform with N2H4 as explained
in section 4.1.5 above.

Figure 4.36. Absorbance spectra (a) and fluorescence spectra (b) of a 2.88 x 10-7 M solution of CdSe (OA
& TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with N2H4 (3.04 x 10-7 molar ratio of QDs to N2H4).
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.
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Table 4.25. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & TOA) QD and N2H4 solution dissolved in chloroform at a 3.04 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.003

53.5

1.92

Initial

---

---

---

1d

0.004

103

---

5d

0.074

101

2.33

10 d

---

---

---

Figure 4.37. Normalized fluorescence spectrum of a solution composed of chloroform, OA, TOA, and
N2H4.

It is unclear why the fluorescence spectrum of the QDs 5 d after treatment is not
similar to that of the 10 d spectrum. A possible explanation is that the cuvette in which
the fluorescence was measured was contaminated. Lastly, as explained in section 4.3.1, a
reason for the observed negative peak centered at 430 nm is not readily known and will
be explored further in future work. Figure 4.36b shows a second negative peak centered
at 650 nm that appeared 10 d after treatment. This too will be explored in future work. In
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conclusion, treatment of CdSe (OA & TOA) QDs dissolved in chloroform with N2H4
resulted in a quenching of the QD fluorescence.

4.3.6 Treatment with Hydrazine (N2H4) in Toluene
Figure 4.38 displays the absorbance and fluorescence spectra of a CdSe (OA &
TOA) QD and hydrazine (N2H4) solution dissolved in toluene at a 3.20 x 10-7 molar ratio.
From these spectra, quantum yield (QY), full-width half-maximum (FWHM), and
bandgap energy (Eg) were calculated before treatment, as well as immediately, 1 d, 5 d,
and 10 d after treatment. These results, as summarized in Table 4.26 below, show that the
QY of the QDs decreased immediately after treatment with N2H4. Although N2H4 is
soluble in toluene, residual TOA in the QD solution prevented all of the reducing agent
from reacting with the QDs, similar to treatment in chloroform as described in section
4.2.5 above. Instead, immediately after adding N2H4 to the toluene, a small amount of
N2H4 reacted with the QDs and reduced their surface to etch and destroy the QDs thereby
quenching the QD fluorescence. The fluorescence spectrum included in Figure 4.38b
confirms this quenching of the fluorescence as the peak completely flattened immediately
after treatment. The remainder of the N2H4 formed large, unevenly dispersed N2H4
droplets stabilized by the residual OA and TOA. The solution appeared blue-green when
excited by a 365 nm UV lamp because the mixture of toluene, OA, and TOA emits light
at 450 nm upon excitation (see Figure 4.39). After 10 d, unreacted N2H4 would visibly be
seen in the toluene solution (see Figure 4.38e). A distinct N2H4 layer did not form in this
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case because N2H4 is more dense than toluene. In conclusion, treatment of CdSe (OA &
TOA) QDs dissolved in toluene with N2H4 resulted in a quenching of the QD
fluorescence.

Figure 4.38. Absorbance spectra (a) and fluorescence spectra (b) of a 3.03 x 10-7 M solution of CdSe (OA
& TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with N2H4 (3.20 x 10-7 molar ratio of QDs to N2H4). Photos of
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.

146
Table 4.26. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & TOA) QD and N2H4 solution dissolved in toluene at a 3.20 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.054

61.2

1.92

Initial

0.007

164

2.43

1d

0.001

137

---

5d

0.005

116

2.43

10 d

0.005

151

2.43

Figure 4.39. Normalized fluorescence spectrum of a solution composed of toluene, OA, TOA, and N2H4.

4.3.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform
Figure 4.40 displays the absorbance and fluorescence spectra of a CdSe (OA &
TOA) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a 1.20 x
10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
4.27 below, show that the QY of the QDs increased slightly 1 d after treatment with
C14H10O4 before decreasing to below that of the untreated QY 10 d later. Additionally, no
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notable change in FWHM or Eg was observed therefore ruling out a significant
broadening of the QD size distribution or change in QD size after treatment. Furthermore,
as explained in section 4.3.1, a reason for the observed negative peak centered at 430 nm
is not readily known and will be explored further in future work. In conclusion, treatment
of CdSe (OA & TOA) QDs dissolved in chloroform with C14H10O4 resulted in a 66.7 %
increase in the QY of the QDs 1 d after treatment.

Figure 4.40. Absorbance spectra (a) and fluorescence spectra (b) of a 2.88 x 10-7 M solution of CdSe (OA
& TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (1.20 x 10-4 molar ratio of QDs to
C14H10O4). Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.
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Table 4.27. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & TOA) QD and C14H10O4 solution dissolved in chloroform at a 1.20 x 10-4 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.003

53.5

1.92

Initial

0.003

54.3

1.93

1d

0.005

52.8

1.93

5d

0.003

54.0

1.93

10 d

0.002

54.7

1.95

4.3.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene
Figure 4.41 displays the absorbance and fluorescence spectra of a CdSe (OA &
TOA) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at a 1.26 x 10-4
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
4.28 below, show that the QY of the QDs steadily decreased with time after treatment
with C14H10O4. This decrease in QY after treatment was confirmed by the flattening of
the fluorescence peak and by the pictures in Figure 4.41 where the treated QDs (right)
were less bright than the untreated QDs (left). Additionally, no notable change in FWHM
or Eg was observed therefore ruling out a significant broadening of the QD size
distribution or change in QD size after treatment. In conclusion, treatment of CdSe (OA
& TOA) QDs dissolved in toluene with C14H10O4 resulted in a decrease in the QY of the
QDs.
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Figure 4.41. Absorbance spectra (a) and fluorescence spectra (b) of a 3.03 x 10-7 M solution of CdSe (OA
& TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with C14H10O4 (1.26 x 10-4 molar ratio of QDs to C14H10O4).
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 4.28. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & TOA) QD and C14H10O4 solution dissolved in toluene at a 1.26 x 10-4 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.051

63.3

1.92

Initial

0.050

63.0

1.92

1d

0.029

61.3

1.92

5d

0.004

67.7

1.93

10 d

0.001

56.2

1.95
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4.3.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform
Figure 4.42 displays the absorbance and fluorescence spectra of a CdSe (OA &
TOA) QD and tert-Butyl Hydroperoxide (C4H10O2) solution dissolved in chloroform at a
1.38 x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
4.29 below, show that the QY of the QDs decreased immediately after treatment with
C4H10O2. In fact, the QDs stopped fluorescing 5 d after treatment as confirmed by both
the flattening of the fluorescence spectrum and Figure 4.42 where the treated QDs (right)
no longer fluoresced. Furthermore, as seen in the fluorescence spectra of each of the
treatments completed in chloroform, a negative peak centered at 430 nm was measured.
A second negative peak centered at 650 nm was also measured 10 d after treatment with
N2H4 as mentioned in section 4.3.5 above. As seen in Figure 4.42b below, both of these
negative peaks were observed after treatment with C4H10O2. An explanation for these
negative peaks is not readily known and will be explored further in future work. In
conclusion, treatment of CdSe (OA & TOA) QDs dissolved in chloroform with C4H10O2
resulted in a quenching of the QD fluorescence.
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Figure 4.42. Absorbance spectra (a) and fluorescence spectra (b) of a 2.88 x 10-7 M solution of CdSe (OA
& TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (1.38 x 10-6 molar ratio of QDs to
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

Table 4.29. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & TOA) QD and C4H10O2 solution dissolved in chloroform at a 1.38 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.003

53.5

1.92

Initial

0.001

56.1

1.92

1d

0.001

65.0

---

5d

---

---

---

10 d

---

---

---
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4.3.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene
Figure 4.43 displays the absorbance and fluorescence spectra of a CdSe (OA &
TOA) QD and tert-Butyl Hydroperoxide (C4H10O2) solution dissolved in toluene at a 1.46
x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
4.30 below, show that the QY of the QDs decreased immediately after treatment with
C4H10O2. A significant increase in absorbance was also observed immediately after
treatment (see orange line in Figure 4.43a). In a study by Mandal et al., an increase in
absorbance was found to be indicative of aggregation because absorbance measurements
are sensitive to scattering from colloidal suspensions that form as QD aggregates grow in
size.6 Furthermore, they found that a significant decrease in QD fluorescence also
resulted from aggregation.6 It can therefore be concluded that the flattening of the
fluorescence peak coupled with the significant increase in absorbance observed
immediately after treatment with C4H10O2, indicates that the QDs began to aggregate at
this time. Eventually, the aggregates grew to a size that allowed them to be clearly visible
in the solution, causing the solution to appear cloudy in visible light. When excited with a
365 nm UV light, as seen in the pictures in Figure 4.43, the aggregates scattered the
incident light and caused the solution to appear pink. As time progressed, the aggregates
continued to grow until the QDs precipitated out of solution 5 d after treatment as seen by
the quenching of the QD fluorescence in Figure 4.43d.
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Figure 4.43. Absorbance spectra (a) and fluorescence spectra (b) of a 3.03 x 10-7 M solution of CdSe (OA
& TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with C4H10O2 (1.46 x 10-6 molar ratio of QDs to C4H10O2).
Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 4.30. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdSe
(OA & TOA) QD and C4H10O2 solution dissolved in toluene at a 1.46 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.029

64.1

1.92

Initial

---

---

---

1d

0.002

62.4

1.90

5d

0.002

71.5

2.46

10 d

0.010

69.5

2.44
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Similar to treatment of CdSe (oleylamine) QDs with C4H10O2 in chloroform (as
described in section 4.1.9 above), the fluorescence peak centered at 600 nm in Figure
4.43 represents the emission of the QDs. The peak measured 10 d (purple) after
treatment, on the other hand, is centered at 450 nm and is therefore representative of the
mixture of toluene, OA, TOA, and C4H10O2, not the QDs (see Figure 4.44 below). For
this reason, it can be confirmed that the fluorescence of the QDs died 5 d after treatment.
In conclusion, treatment of CdSe (OA & TOA) QDs dissolved in toluene with C4H10O2
resulted in a decrease in the QY of the QDs due to aggregation.

Figure 4.44. Normalized fluorescence spectrum of a solution composed of toluene, OA, TOA, and
C4H10O2.

4.3.11 Summary of CdSe/OA & TOA Treatments
Figure 4.45 compares the effect of treating CdSe (OA & TOA) QDs with various
reducing and oxidizing agents in chloroform versus toluene. The quality of this batch of
QDs was significantly less than that of the previous 2 batches described above, as seen
from these photographs. The QY of the QDs before treatment in chloroform was
approximately 0.003 while the QY in toluene was approximately 0.049. Because both
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sets of QDs came from the same master batch of cores, this difference in QY may be due
to the solubility of OA in the various solvents. Thuy et al. have shown that the QY is
higher when the capping ligand is less soluble in a given solvent.13 From our results, we
found that the QY of the QDs was higher in toluene than chloroform therefore implying
that OA is less soluble in toluene than chloroform. The literature, however, states that OA
is more soluble in toluene than chloroform, therefore disproving this explanation. A
possible explanation for this dependence on solvent may therefore be due to the solubility
of oxygen in each of the solvents. This hypothesis is consistent with the results
summarized in section 4.2.11. The Eg of the untreated QDs in chloroform and toluene
were both 1.92 eV, which suggests that the solvent does not have an effect on QD size
and color emitted.
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Figure 4.45. Photos of CdSe (OA & TOA) QDs that are from left to right: untreated, treated with NaBH4,
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were
suspended and treated in chloroform while those in the right column were suspended and treated in toluene.
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment.

The overall effect of reducing and oxidizing agents on the QY of CdSe (OA &
TOA) QDs was found to be independent of solvent for 4 of the 5 treatments. More
specifically, it was found that the quality of the QDs worsened after treatment with CaH2,
N2H4, and C4H10O2 and improved after treatment with NaBH4 in both chloroform and
toluene. Treatment with C14H10O4, on the other hand, increased the quality of the QDs
when dissolved in chloroform, but not in toluene. Even though the QY of the QDs
increased after treatment with NaBH4 in both chloroform and toluene, in chloroform a
133 % increase was calculated whereas the increased QY was only qualitative in toluene.

157
Similar to treatment of CdSe (OA & ODE) QDs, as discussed in section 4.2.11 above,
these results clearly illustrate that the surface treatment of CdSe (OA & ODE) QDs was
more effective in chloroform than toluene.
The reason for this dependence on solvent is not known, however, the two
possible explanations discussed in detail in section 4.2.11 above can be applied to this
system because the capping ligand is still OA. The first explanation focuses on the
solubility of the ligand (OA) in the dispersion solvent. Specifically, it is hypothesized that
because OA is more soluble in toluene than chloroform, OA ligands will desorb from the
QD surface at a faster rate in toluene than chloroform. As the ligands continue to detach
from the QD surface, the QDs are unable to remain dispersed in the solvent and the QY
decreases. The second explanation focuses on the solubility of the reducing agent in the
dispersion solvent. Specifically, if a given reducing/oxidizing agent is more soluble is a
particular solvent, it will react at a much faster rate than when the treatment occurs in a
solvent to which it is less soluble. If the reaction happens too fast, the ligands will detach
from the QD surface before oxygen is able to diffuse to the QD surface to form a CdO
layer and therefore will not be able to passivate the surface defect sites. To confirm either
of these explanations, future work is required.
As mentioned above, treatment of CdS (OA & TOA) QDs with NaBH4 resulted in
an enhanced QY, while treatment with CaH2 decreased the QY of the QDs. This same
result was observed in the treatment of CdSe (oleylamine QDs). As explained in section
4.1.11 above, we hypothesize that this result can be explained by a difference in the
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reducing agents reactivity with water. Specifically, we hypothesize that the reducing
agents react with the residual water present in each of the solvents to form hydrogen. The
hydrogen then reacts with the surface ligands, causing them to detach from the QD
surface, and allowing oxygen from the atmospheric air to diffuse to the exposed
cadmium. The resulting CdO layer around the QDs serves to passivate the defect sites
located on the QD surface and therefore improves the QY of the QDs. If the reducing
agent reacts too fast with the residual water, the QDs will aggregate and the QY will be
quenched. In a study by Kong et al., the reaction rate of NaBH4 with water vapor was
found to be ten times slower than that of CaH2.16 For this reason, it is hypothesized that
CaH2 reacted very fast with the residual water present in the QD solution, causing the
QDs to aggregate, and the QY to be quenched. This aggregation was confirmed by an
increase in the measured absorbance. NaBH4, on the other hand, reacted with the water at
a slow enough rate that the hydrogen produced was able to effectively detach ligands on
the QD surface and allow for the formation of the CdO layer.
In the previous summary sections, the observation of a fluorescence peak centered
at approximately 450 nm was discussed. Fluorescence spectroscopy was performed on
solutions consisting of each ligand, solvent, and reducing/oxidizing agent combination to
confirm that this peak was not representative of the QDs. In the case of CdSe
(oleylamine) QDs, this peak was observed in each of the 10 treatments, however it was
only observed in 2 of the 10 treatments in the case of CdSe (OA & ODE) QDs.
Specifically, this peak was seen in the treatment of the QDs in toluene with N2H4 and
C4H10O2. Although it is not clear why this peak was only measured for 2 of the 5
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treatments performed in toluene, the trend was consistent with the theory provided above.
In both of these cases, the peak increased with time which further supports that the
reaction solution evaporated with time.
From the spectra seen in the above 10 sections representing CdSe (OA & TOA)
QDs, a negative peak centered at approximately 450 nm was measured when the QDs
were dissolved in chloroform. Fluorescence spectroscopy was performed on solutions
consisting of OA, TOA, chloroform, and each reducing/oxidizing agent to account for
this negative peak, however, these combinations yielded positive fluorescence peaks
centered at 450 nm, similar to those included in the previous sections. An explanation for
this negative peak is therefore not known. Munro et al. reported that chloroform contains
impurities23 which may explain this unusual result, however because it was not observed
in all chloroform solutions, no conclusions can be made. It is therefore recommended that
in future work of this thesis, additional batches of CdSe (OA & TOA) QDs dissolved in
chloroform be tested to see if a negative fluorescence peak results. If the negative peak is
observed in these new batches, it is recommended that further characterizations be
performed to determine its cause.

160
4.4 References

(1) Zezza, F.; Comparelli, R.; Striccoli, M.; Curri, M.; Tommasi, R.; Agostiano, A.; Della
Monica, M. Synth. Met. 2003, 139, 597-600.
(2) Bullen, C. R.; Mulvaney, P. Nano Lett 2004, 4, 2303-2307.
(3) Kampel, I. J. In Semiconductors - Basic Theory and Devices; Newnes-Butterworths: London,
1971; , pp 264.
(4) Grayson, M. In Encyclopedia of Semiconductor Technology; John Wiley & Sons: New York,
1984; , pp 941.
(5) Nirmal, M.; Brus, L. Acc. Chem. Res. 1999, 32, 407-414.
(6) Mandal, A.; Tamai, N. The Journal of Physical Chemistry C 2008, 112, 8244-8250.
(7) Zhang, Y.; Mi, L.; Wang, P. N.; Ma, J.; Chen, J. Y. J Lumin 2008, 128, 1948-1951.
(8) AnonymousDetermination of Noncancer Chronic Reference Exposure Levels 2000, .
(9) Jasper, J. J. J.Phys.Chem.Ref.Data 1972, 1, 841-1009.
(10) Simovic, S.; Prestidge, C. A. Langmuir 2008, 24, 7132-7137.
(11) Pasquali, R. C.; Sacco, N.; Bregni, C. Lat.Am.J.Pharm 2009, 28, 313-317.
(12) Park, J.; Lee, K. H.; Galloway, J. F.; Searson, P. C. 2008, 112, 17854.
(13) Thuy, U. T. D.; Liem, N. Q.; Thanh, D. X.; Protiere, M.; Reiss, P. Appl. Phys. Lett. 2007, 91,
241908-241908.
(14) Jang, E.; Jun, S.; Chung, Y.; Pu, L. J Phys Chem B 2004, 108, 4597-4600.
(15) Chellquist, E. M.; Gorman, W. G. Pharm. Res. 1992, 9, 1341-1346.
(16) Kong, V.; Foulkes, F.; Kirk, D.; Hinatsu, J. Int J Hydrogen Energy 1999, 24, 665-675.
(17) Kagan, C.; Murray, C.; Bawendi, M. Physical Review B 1996, 54, 8633.
(18) Artemyev, M.; Woggon, U.; Jaschinski, H.; Gurinovich, L.; Gaponenko, S. The Journal of
Physical Chemistry B 2000, 104, 11617-11621.
(19) Mićić, O. I.; Ahrenkiel, S.; Nozik, A. J. Appl. Phys. Lett. 2001, 78, 4022.

161
(20) Morales, M.; Jain, T. K.; Labhasetwar, V.; Leslie-Pelecky, D. J. Appl. Phys. 2005, 97,
10Q905.
(21) Bullen, C.; Mulvaney, P. Langmuir 2006, 22, 3007-3013.
(22) Tantishaiyakul, V.; Worakul, N.; Wongpoowarak, W. Int. J. Pharm. 2006, 325, 8-14.
(23) Munro, A. M.; Jen-La Plante, I.; Ng, M. S.; Ginger, D. S. 2007.
(24) Tansakul, C.; Lilie, E.; Walter, E.; Rivera, A. J Phys Chem C Nanomater Interfaces. 2010,
114, 7793–7805.

162

Chapter 5. Results and Discussion: CdS
Chapter 5 will present and discuss the results of the experimental work performed
on CdS QDs. This chapter will be divided into three sections: (1) CdS QDs synthesized
with oleylamine, (2) CdS QDs synthesized with oleic acid (OA) and octadecene (ODE),
and (3) CdS QDs synthesized with OA and trioctylamine (TOA). Following the same
model as Chapter 4, each section will summarize the effect of treating the surface of the
various QD batches with three reducing and two oxidizing agents. More specifically, the
effect of each treatment on the quantum yield (QY), size distribution, and bandgap
energy (Eg) of the QDs will be evaluated. The reducing agents to be investigated include:
sodium borohydride (NaBH4), calcium hydride (CaH2), and hydrazine (N2H4), while the
oxidizing agents include: benzoyl peroxide (C14H10O4) and tert-butyl hydroperoxide
(C4H10O2).

5.1 CdS (Oleylamine) Quantum Dot Cores
5.1.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform
Figure 5.1 displays the absorbance and fluorescence spectra of a CdS
(oleylamine) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a
6.11 x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.1 below, show that the QY of the QDs reached a maximum 10 d after treatment with
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NaBH4. Additionally, the Eg decreased and fluorescence peak shifted to a lower
wavelength 5 d and 10 d after treatment indicating a blue-shift in emission. This increase
in QY and blue-shift in emission are illustrated in Figure 5.1e as the treated solution
(right) is brighter and more blue than the untreated solution (left). Lastly, the FWHM
decreased slightly 5 d and 10 d after treatment, indicating a narrowing of the QD size
distribution. In conclusion, treatment of CdS (oleylamine) QDs dissolved in chloroform
with NaBH4 resulted in a 3.85 % increase in the QY of the QDs 10 d after treatment.

Figure 5.1. Absorbance spectra (a) and fluorescence spectra (b) of a 9.65 x 10-8 M solution of CdS
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1
d (red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (6.11 x 10-6 molar ratio of QDs to
NaBH4). Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light
(c) 1 d, (d) 5 d, and (e) 10 d after treatment.
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Table 5.1. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(oleylamine) QD and NaBH4 solution dissolved in chloroform at a 6.11 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.078

194

2.42

Initial

0.076

195

2.42

1d

0.076

194

2.42

5d

0.074

146

2.49

10 d

0.081

134

2.50

5.1.2 Treatment with Sodium Borohydride (NaBH4) in Toluene
Figure 5.2 displays the absorbance and fluorescence spectra of a CdS
(oleylamine) QD and sodium borohydride (NaBH4) solution dissolved in toluene at a
4.18 x 10-6 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.2 below, show that the QY of the QDs reached a maximum 5 d after treatment with
NaBH4 before decreasing to below that of the untreated QY 10 d later. This increase in
QY 5 d after treatment is illustrated in Figure 5.2d as the treated sample (right) is brighter
than the untreated sample (left). In Figure 5.2e, however, the treated sample (right) is less
bright than the untreated sample (left) confirming the QY calculations. Additionally, the
FWHM decreased slightly 5 d and 10 d after treatment, indicating a narrowing of the QD
size distribution. In conclusion, treatment of CdS (oleylamine) QDs dissolved in toluene
with NaBH4 resulted in a 23.4 % increase in QY of the QDs 5 d after treatment.
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Figure 5.2. Absorbance spectra (a) and fluorescence spectra (b) of a 6.60 x 10-8 M solution of CdS
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with NaBH4 (4.18 x 10-6 molar ratio of QDs to NaBH4).
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 5.2. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(oleylamine) QD and NaBH4 solution dissolved in toluene at a 4.18 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.448

174

2.40

Initial

0.440

175

2.40

1d

0.450

174

2.40

5d

0.553

158

2.48

10 d

0.391

148

2.50
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5.1.3 Treatment with Calcium Hydride (CaH2) in Chloroform
Figure 5.3 displays the absorbance and fluorescence spectra of a CdS
(oleylamine) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 2.01 x
10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 5.3
below, show that the QY of the QDs decreased after treatment with CaH2. The spectra in
Figure 5.3 illustrate that the fluorescence peak flattened and the absorbance increased
immediately after treatment. In a study by Mandal et al., an increase in absorbance was
found to be indicative of aggregation because absorbance measurements are sensitive to
scattering from colloidal suspensions that form as QD aggregates grow in size.1
Furthermore, they found that a significant decrease in QD fluorescence also resulted from
aggregation.1 It can therefore be hypothesized that the flattening of the fluorescence peak
coupled with the significant increase in absorbance observed immediately after treatment
with CaH2, indicates that the QDs began to aggregate at this time.
Figure 5.3d shows that 5 d after treatment, a slight red-shift was observed as the
treated QDs (right) appear more red than the untreated QDs (left). This red-shift is
attributed to the tight packing of the QDs contained in the aggregates. When the QDs are
tightly packed, the wave function of the electrons in an individual QD is believed to ‘leak
out’ and overlap with the wave function of a neighboring QD.2 This formation of
collective electronic states due to electron overlap interactions results in a spectral red
shift of QD emission.2 Between 5 d and 10 d after treatment, the aggregates continued to
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grow until the QDs precipitated out of solution, as seen in Figure 5.3e where the QD
solution no longer fluoresced. Rather than confirming this quenching of the QY by
completely flattening, the fluorescence peak blue-shifted to a wavelength of 450 nm (see
purple peak in Figure 5.3).
As seen in the CdSe (oleylamine) treatments, the same peak was observed at
450 nm (see section 4.2). After performing fluorescence spectroscopy on a solution of
each oleylamine, chloroform, and reducing/oxidizing agent combination, the peak was
determined to represent the precursor solution, not the QDs. To verify that the peak
measured 10 d after treatment of CdS (oleylamine) QDs with CaH2 was also
representative of the precursor solution, fluorescence spectroscopy was performed on a
solution consisting of oleylamine, chloroform, and CaH2. This normalized fluorescence
spectrum can be seen in Figure 5.4 below. A peak centered at 450 nm was clearly
measured, therefore confirming that the blue fluorescence peak centered at 510 nm was
representative of the QDs. For this reason, it can be confirmed that the CdS (oleylamine)
QDs stopped fluorescing 10 d after treatment with CaH2 due to precipitation of the QDs.
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Figure 5.3. Absorbance spectra (a) and fluorescence spectra (b) of a 9.65 x 10-8 M solution of CdS
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1
d (red), 5 d (green), and 10 d (purple) after treatment with CaH2 (2.01 x 10-5 molar ratio of QDs to CaH2).
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.

Table 5.3. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(oleylamine) QD and CaH2 solution dissolved in chloroform at a 2.01 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.087

197

2.42

Initial

0.012

194

2.41

1d

0.032

158

2.42

5d

0.049

181

2.43

10 d

0.037

63.9

2.51
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Figure 5.4. Normalized fluorescence spectrum of a solution composed of chloroform, oleylamine, and
CaH2.

5.1.4 Treatment with Calcium Hydride (CaH2) in Toluene
Figure 5.5 displays the absorbance and fluorescence spectra of a CdS
(oleylamine) QD and calcium hydride (CaH2) solution dissolved in toluene at a 1.38 x
10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 5.4
below, show that the QY of the QDs decreased after treatment with CaH2. This decrease
in QY was confirmed by both the fluorescence spectrum and pictures included in Figure
5.5 as the treated sample (right) is less bright than the untreated sample (left).
Additionally, no notable change in FWHM or Eg was observed therefore ruling out a
significant broadening of the QD size distribution or change in QD size after treatment.
In conclusion, treatment of CdS (oleylamine) QDs dissolved in toluene with CaH2
resulted in a decrease in the QY of the QDs.
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Figure 5.5. Absorbance spectra (a) and fluorescence spectra (b) of a 6.60 x 10-8 M solution of CdS
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with CaH2 (1.38 x 10-5 molar ratio of QDs to CaH2).
Photos of untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.

Table 5.4. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(oleylamine) QD and CaH2 solution dissolved in toluene at a 1.38 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.471

174

2.40

Initial

0.193

174

2.42

1d

0.210

170

2.42

5d

0.442

183

2.40

10 d

0.212

187

2.41

171
5.1.5 Treatment with Hydrazine (N2H4) in Chloroform
Figure 5.6 displays the absorbance and fluorescence spectra of a CdS
(oleylamine) QD and hydrazine (N2H4) solution dissolved in chloroform at a 1.02 x 10-7
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table 5.5
below. From these values, it can be seen that the QY of the QDs decreased after treatment
with N2H4. Similar to treatment of CdSe (oleylamine) QDs in chloroform (as described in
section 4.1.5), the addition of N2H4 resulted in an emulsion. Oleylamine was again
identified as the surfactant, as its surface tension (31.4 mN/m3) was in between that of
N2H4 (66.39 mN/m3) and chloroform (27.5 mN/m3).
Immediately after treatment, a small amount of soluble N2H4 reacted with the
QDs and reduced their surface to etch and destroy the QDs thereby quenching the QD
fluorescence. The remainder of the N2H4 formed large, unevenly dispersed N2H4 droplets
stabilized by the residual oleylamine. Because the large droplets could clearly be seen in
the solution, similar to the corresponding CdSe case, I shook the solution. Agitation
enabled the large N2H4 droplets to break up and disperse in the solution temporarily,
thereby scattering the 365 nm UV light and causing the solution to appear purple (see
Figure 5.6c). Five days after treatment, the N2H4 droplets returned to their original size
and again were clearly separated from the chloroform. Figure 5.6d confirms this
observation as large, poorly dispersed N2H4 droplets were again visible. After 10 d a
visible layer formed at the top of the chloroform solution, presumably due to instability
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of the emulsion (see Figure 5.6e). The solution appeared blue-green when excited by a
365 nm UV lamp because the oleylamine emits light at 450 nm upon excitation (see
Figure 4.6 in Chapter 4). In conclusion, the fluorescence of CdS (oleylamine) QDs
dissolved in chloroform died immediately after treatment with N2H4.

Figure 5.6. Absorbance spectra (a) and fluorescence spectra (b) of a 9.65 x 10-8 M solution of CdS
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1
d (red), 5 d (green), and 10 d (purple) after treatment with N2H4 (1.02 x 10-7 molar ratio of QDs to N2H4).
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.
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Table 5.5. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(oleylamine) QD and N2H4 solution dissolved in chloroform at a 1.02 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.071

197

2.42

Initial

0.008

---

2.55

1d

0.005

---

---

5d

0.011

75.0

2.56

10 d

0.029

66.2

2.57

5.1.6 Treatment with Hydrazine (N2H4) in Toluene
Figure 5.7 displays the absorbance and fluorescence spectra of a CdS
(oleylamine) QD and hydrazine (N2H4) solution dissolved in toluene at a 6.96 x 10-8
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table 5.6
below, show that the QY of the QDs was quenched immediately after treatment with
N2H4. This decrease in QY was confirmed by the pictures included in Figure 5.3 as the
treated sample (right) is less bright than the untreated sample (left). Similar to several of
the treatments described previously, the fluorescence peak centered at 510 nm in Figure
5.7b represents the emission of the QDs. The peaks measured 5 d (green) and 10 d
(purple) after treatment, on the other hand, are centered at approximately 440 nm and are
therefore representative of the mixture of toluene, oleylamine, and N2H4, not the QDs
(see Figure 5.8 below). Focusing on the peak representing the QDs, it can therefore be
seen that the fluorescence of the QDs was quenched immediately after treatment.
Hydrazine is soluble in toluene, therefore it was assumed that all of the reducing agent
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reacted with the QDs immediately after treatment and the concerns discussed in section
5.1.5 above were not applicable. In conclusion, treatment of CdS (oleylamine) QDs
dissolved in toluene with N2H4 resulted in a quenching of the fluorescence of the QDs.

Figure 5.7. Absorbance spectra (a) and fluorescence spectra (b) of a 6.60 x 10-8 M solution of CdS
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with N2H4 (6.96 x 10-8 molar ratio of QDs to N2H4).
Photos of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d)
5 d, and (e) 10 d after treatment.
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Table 5.6. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(oleylamine) QD and N2H4 solution dissolved in toluene at a 6.96 x 10-8 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.458

174

2.40

Initial

0.026

150

---

1d

0.003

---

---

5d

0.082

90.0

2.57

10 d

0.074

96.0

2.57

Figure 5.8. Normalized fluorescence spectrum of a solution composed of toluene, oleylamine, and N2H4.

5.1.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform
Figure 5.9 displays the absorbance and fluorescence spectra of a CdS
(oleylamine) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a
1.21 x 10-4 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These results are summarized in Table
5.7 below. From these values, it can be seen that the QY of the QDs steadily decreased
with time after treatment with C14H10O4. Additionally, the Eg increased 5 d and 10 d after

176
treatment, indicating a blue-shift in emission. Rather than confirming this expected blueshift, however, pictures d and e in Figure 5.9 illustrate that the QDs fluoresced pink after
treatment.
A possible explanation for these conflicting results may be explained by a change
in the QD size distribution after treatment. More specifically, prior to treatment, the
solution of QDs contained a very broad size distribution as illustrated by the wide
fluorescence peak (blue) centered at 510 nm (see Figure 5.9b) as well as the high FWHM
value. Five (green) and ten (purple) days after treatment, however, the fluorescence peaks
transformed from a wide peak to a bimodal peak. This bimodal peak indicates that the
QD solution was comprised of two distinct populations of QDs: one set of smaller QDs
centered at 440 nm and one larger set of QDs centered at 650 nm. Additionally, 5 d and
10 d after treatment, a slight increase in absorbance was observed representing an
increase in concentration. In a study by Kagan et al.4, it was concluded that in a system
composed of small and large QDs, electronic energy transfer from the small to the large
QDs is observed as fluorescence quenching of the small dots, and fluorescence
enhancement of the large QDs. In other words, electronic energy transfer in close-packed
QD systems arises from dipole-dipole interactions between proximal QDs resulting in an
observed red-shift in emission.4 In conclusion, treatment of CdS (oleylamine) QDs
dissolved in chloroform with C14H10O4 resulted in a red-shift in emission as well as a
decrease in the QY of the QDs.
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Figure 5.9. Absorbance spectra (a) and fluorescence spectra (b) of a 9.65 x 10-8 M solution of CdS
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1
d (red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (1.21 x 10-4 molar ratio of QDs to
C14H10O4). Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

Table 5.7. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(oleylamine) QD and C14H10O4 solution dissolved in chloroform at a 1.21 x 10-4 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.075

197

2.40

Initial

0.063

201

2.42

1d

0.058

196

2.42

5d

0.041

75.7

2.52

10 d

0.043

80.9

2.51
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5.1.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene
Figure 5.10 displays the absorbance and fluorescence spectra of a CdS
(oleylamine) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at an
8.25 x 10-5 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.8 below, show that the QY of the QDs decreased immediately after treatment with
C14H10O4 before increasing to above that of the untreated QY 10 d later. This increase in
QY 10 d after treatment is illustrated in Figure 5.10e where the treated QDs (right) are
brighter than the untreated cores (left). Additionally, the FWHM decreased and Eg
increased 10 d after treatment, indicating a narrowing of the size distribution and blueshift in emission. In conclusion, treatment of CdS (oleylamine) QDs dissolved in toluene
with C14H10O4 resulted in a 25.0 % increase in the QY of the QDs 10 d after treatment.
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Figure 5.10. Absorbance spectra (a) and fluorescence spectra (b) of a 6.60 x 10-8 M solution of CdS
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with C14H10O4 (8.25 x 10-5 molar ratio of QDs to
C14H10O4). Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

Table 5.8. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(oleylamine) QD and C14H10O4 solution dissolved in toluene at a 8.25 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.404

174

2.42

Initial

0.338

194

2.41

1d

0.078

98.5

2.54

5d

0.293

99.1

2.50

10 d

0.505

71.0

2.49
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5.1.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform
Figure 5.11 displays the absorbance and fluorescence spectra of a CdS
(oleylamine) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in
chloroform at a 3.09 x 10-7 molar ratio. From these spectra, quantum yield (QY), fullwidth half-maximum (FWHM), and bandgap energy (Eg) were calculated before
treatment, as well as immediately, 1 d, 5 d, and 10 d after treatment. These results are
summarized in Table 5.9 below. From these values, it can be seen that the QY of the QDs
decreased immediately after treatment with C4H10O2 before ceasing to fluoresce 1 d later.
This quenching of the QD fluorescence was confirmed by the pictures in Figure 5.11
where the treated QDs (right) were not fluorescent. Similar to treatment of CdSe
(oleylamine) QDs in chloroform with C4H10O2 (as described in section 4.1.9), the wide
fluorescence peak centered at 540 nm in Figure 5.11 represents the emission of the QDs.
The peaks measured after treatment, on the other hand, are centered at 450 nm and are
therefore representative of the mixture of chloroform, oleylamine, and C4H10O2, not the
QDs. For this reason, the quenching of the fluorescence of the QDs 1 d after treatment
was confirmed. In conclusion, treatment of CdS (oleylamine) QDs dissolved in
chloroform with C4H10O2 resulted in a quenching of the QD fluorescence 1 d after
treatment.
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Figure 5.11. Absorbance spectra (a) and fluorescence spectra (b) of a 9.65 x 10-8 M solution of CdS
(oleylamine) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1
d (red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (3.09 x 10-7 molar ratio of QDs to
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

Table 5.9. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(oleylamine) QD and C4H10O2 solution dissolved in chloroform at a 3.09 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.085

188

2.42

Initial

0.037

140

2.52

1d

0.021

97.8

2.53

5d

0.079

50.8

2.56

10 d

0.024

68.1

2.54
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5.1.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene
Figure 5.12 displays the absorbance and fluorescence spectra of a CdS
(oleylamine) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in toluene at
a 2.12 x 10-7 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.10 below, show that the QY of the QDs decreased immediately after treatment with
C4H10O2. This decrease in QY was confirmed by the pictures included in Figure 5.12 as
the treated sample (right) is less bright than the untreated sample (left). Similar to
treatment in chloroform, as explained in the previous section, the fluorescence peaks
measured after treatment were centered at 440 nm and were therefore representative of
the mixture of toluene, oleylamine, and C4H10O2, not the QDs (see Figure 4.15 in Chapter
4). For this reason, the quenching of the fluorescence of the QDs immediately after
treatment was confirmed. In conclusion, treatment of CdS (oleylamine) QDs dissolved in
toluene with C4H10O2 resulted in a quenching of the QD fluorescence immediately after
treatment.
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Figure 5.12. Absorbance spectra (a) and fluorescence spectra (b) of a 6.60 x 10-8 M solution of CdS
(oleylamine) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d
(red), 5 d (green), and 10 d (purple) after treatment with C4H10O2 (2.12 x 10-7 molar ratio of QDs to
C4H10O2). Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV
light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

Table 5.10. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(oleylamine) QD and C4H10O2 solution dissolved in toluene at a 2.12 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.384

162

2.40

Initial

0.030

91.0

2.55

1d

0.019

98.2

2.55

5d

0.104

96.6

2.53

10 d

0.064

89.9

2.54
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5.1.11 Summary of CdS/Oleylamine Treatments
Figure 5.13 compares the effect of treating CdS (oleylamine) QDs with various
reducing and oxidizing agents in chloroform versus toluene. From these photographs, it
can be seen that the QDs dissolved in toluene were visibly brighter than those in
chloroform. This observation was confirmed as the QY of the QDs before treatment in
chloroform was approximately 0.085 while the QY in toluene was approximately 0.475.
Because both sets of QDs came from the same master batch of cores, this difference in
QY may be due to the solubility of oleylamine in the various solvents. Thuy et al. have
shown that the QY is higher when the capping ligand is less soluble in a given solvent.13
Because the QY was higher in toluene than chloroform, we therefore hypothesize that
oleylamine is less soluble in toluene than chloroform. This result is consistent with the
results summarized in section 4.1.11 regarding the QY of CdSe (oleylamine) QDs in each
solvent. The Eg of the untreated QDs in chloroform and toluene were 2.42 eV and
2.40 eV, respectively, which suggests the solvent does not have an effect on QD size and
therefore color emitted.
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Figure 5.13. Photos of CdS (oleylamine) QDs that are from left to right: untreated, treated with NaBH4,
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were
suspended and treated in chloroform while those in the right column were suspended and treated in toluene.
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment.

The effect of reducing and oxidizing agents on the QY of CdS (oleylamine) QDs
was found to be independent of solvent for 4 of the 5 treatments. More specifically, it was
found that the QY of the QDs declined after treatment with CaH2, N2H4, and C4H10O2 and
improved after treatment with NaBH4 in both chloroform and toluene. Treatment with
C14H10O4, on the other hand, increased the QY of the QDs when dissolved in toluene, but
not in chloroform. These exact trends were observed when treating CdSe (oleylamine)
QDs as discussed in detail in section 4.1. For this reason, we hypothesize that the effect
of treating QDs capped with oleylamine with various reducing/oxidizing agents is
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independent of chalcogenide (Se or S). Furthermore, the theory proposed to explain the
dependence on solvent is applicable to this batch of QDs as well.
Treatment of QDs with a reducing/oxidizing agent is expected to reduce the
surface ligands thereby causing them to lose their coordinating properties and detach
from the QD surface.6 Oxygen from atmospheric air is then able to diffuse to the exposed
cadmium on the QD surface to form a cadmium oxide (CdO) layer around the QDs.6 This
CdO layer serves to passivate defects on the QD surface, thereby enhancing the QY of
the QDs.6 A possible explanation for the observed decrease of the QY after treatment
with C14H10O4 in chloroform is that the oxidizing agent reacted with the QDs at a rate so
fast that oxygen was not able to diffuse to the QD surface and form a CdO layer. Instead,
C14H10O4 caused the oleylamine ligands to quickly detach from the QD surface and
therefore caused aggregation in chloroform (as measured by the increase in absorbance),
and resulted in a quenched QY.2 In toluene, however, the reaction rate was slowed down
significantly because C14H10O4 is less soluble in toluene than chloroform.7 Because the
reaction rate was slowed, after the C14H10O4 reduced the oleylamine on the QD surface,
oxygen was able to form the CdO layer and therefore passivate the defect sites on the QD
surface. To confirm this theory, additional testing is required. A possible experiment
involves treating the QDs with a lower concentration of C14H10O4 in chloroform to see if
the reaction rate slows enough to allow for the formation of a CdO layer and therefore
increased QY.
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As mentioned above, treatment of CdS (oleylamine) QDs with NaBH4 resulted in
an enhanced QY, while treatment with CaH2 decreased the QY of the QDs. We
hypothesize that this result can be explained by a difference in the reducing agents
reactivity with water. Specifically, we hypothesize that the reducing agents react with the
residual water present in each of the solvents to form hydrogen. The hydrogen then reacts
with the surface ligands, causing them to detach from the QD surface, and allowing
oxygen from the atmospheric air to diffuse to the exposed cadmium. The resulting CdO
layer around the QDs serves to passivate the defect sites located on the QD surface and
therefore improves the QY of the QDs. If the reducing agent reacts too fast with the
residual water, the QDs will aggregate and the QY will be quenched. In a study by Kong
et al., the reaction rate of NaBH4 with water vapor was found to be ten times slower than
that of CaH2.8 For this reason, it is hypothesized that CaH2 reacted very fast with the
residual water present in the QD solution, causing the QDs to aggregate, and the QY to
be quenched. This aggregation was confirmed by an increase in the measured absorbance.
NaBH4, on the other hand, reacted with the water at a slow enough rate that the hydrogen
produced was able to effectively detach ligands on the QD surface and allow for the
formation of the CdO layer.
In several of the 10 preceding subsections, a fluorescence peak centered at
approximately 440 nm was observed. To account for this peak, fluorescence spectroscopy
was

performed

on

solutions

consisting

of

each

oleylamine,

solvent,

and

reducing/oxidizing agent combination. Several of these spectra are included in the above
section. From these spectra, the peak at 440 nm was consistently found to represent the
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ligand, solvent, and reducing/oxidizing agent combination, not the QDs. Often, an
increase in this peak was observed with time. A possible explanation for this increase is
that the solvent evaporated over time, as seen by the decrease in solution volume in the
pictures included in the figures above. As the solvent evaporated, the concentration of the
precursor solution increased, and an increase in fluorescence was therefore observed.
This observation is consistent with the results obtained for the treatment of CdSe
(oleylamine) QDs.

5.2 CdS (OA and ODE) Quantum Dot Cores
The following 11 sections discuss the effect of treating CdS (OA & ODE) QDs
with each of the investigated reducing/oxidizing agents. This batch of QDs was different
from the previous 4 batches of QDs in two ways: (1) the untreated QDs yielded a bimodal
fluorescence peak in both solvents, and (2) a different batch of QDs was used in
chloroform than toluene. These two differences make this set of results unique and help
to explain the results obtained.
A bimodal fluorescence peak indicates that either there are two separate size
populations of QDs in the solution or that the peaks represent multiple things present in
the QD solution. For example, if there is residual ligand present in the solution, one peak
may correspond to the combination of solvent and ligand while the other represents the
QDs. Similar to in previous sections, fluorescence spectroscopy was performed on
solutions of each ligand, solvent, and reducing/oxidizing agent combination to account
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for their influence on the measured fluorescence spectra. Figure 5.14 below illustrates the
fluorescence spectra of the combination of OA, ODE, and chloroform as well as the
combination of OA, ODE, and toluene. From these fluorescence spectra, it can clearly be
seen that a peak centered at 450 nm was measured in both solvents that represents the
mixture of the ligand, non-coordinating solvent, and dispersion solvent. We therefore
hypothesize that because the bimodal fluorescence peaks representing the untreated QD
solution contain one peak centered at 450 nm and one centered at approximately 620 nm,
the latter peak is representative of the QDs. For this reason, the 620 nm peak will be the
focus of the following sections to evaluate the effect of each surface treatment.
Furthermore, the QYs calculated for each treatment only accounted for the area under the
peak corresponding to the QDs. The reported Eg and FWHM values are also only
representative of the QD peak.

Figure 5.14. Normalized fluorescence spectrum of a solution composed of chloroform, OA, and ODE
(solid) and a solution composed of toluene, OA, and ODE (dashed).
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5.2.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform
Figure 5.15 displays the absorbance and fluorescence spectra of a CdS (OA &
ODE) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a 5.62 x
10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.11 below, show that the QY of the QDs increased slightly after treatment with NaBH4
and reached a maximum 1 d after treatment before decreasing to below that of the
untreated QY 5 d later. Additionally, the absorbance value increased significantly 5 d and
10 d after treatment. In a study by Mandal et al., an increase in absorbance was found to
be indicative of aggregation because absorbance measurements are sensitive to scattering
from colloidal suspensions that form as QD aggregates grow in size.1 Furthermore, they
found that a decrease in QD fluorescence also resulted from aggregation.1 The observed
increase in absorbance and decrease of the fluorescence peak measured 5 d and 10 d after
treatment therefore imply that the QDs began to aggregate 5 d after treatment. Lastly, no
notable change in FWHM or Eg was observed therefore ruling out a significant
broadening of the QD size distribution or change in QD size after treatment. In
conclusion, treatment of CdS (OA & ODE) QDs dissolved in chloroform with NaBH4
resulted in a 45.8 % increase in QY of the QDs 1 d after treatment.
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Figure 5.15. Absorbance spectra (a) and fluorescence spectra (b) of a 8.99 x 10-8 M solution of CdS (OA &
ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with NaBH4 (5.62 x 10-6 molar ratio of QDs to NaBH4).
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 5.11. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & ODE) QD and NaBH4 solution dissolved in chloroform at a 5.62 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.024

122

2.65

Initial

0.030

131

2.65

1d

0.035

144

2.65

5d

0.019

185

2.65

10 d

0.017

188

2.66
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5.2.2 Treatment with Sodium Borohydride (NaBH4) in Toluene
Figure 5.16 displays the absorbance and fluorescence spectra of a CdS (OA &
ODE) QD and sodium borohydride (NaBH4) solution dissolved in toluene at a 7.69 x 10-6
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.12 below, show that the QY of the QDs decreased after treatment with NaBH4.
Furthermore, 5 d and 10 d after treatment, the peak centered at 450 nm that was
representative of the combination of OA, ODE, toluene, and NaBH4 increased
significantly. The normalized fluorescence peak of this solution as well as a picture of the
solution excited by a 365 nm UV light is shown in Figure 5.17 below. As seen in the
picture, this solution fluoresces bright blue. Because the fluorescence of the QD solution
decreased and the fluorescence of the precursor solution increased, a blue-shift in
emission is expected. Figure 5.16d and e illustrate this expected blue-shift as the treated
QDs (right) appear more blue than the untreated QDs (left). In conclusion, treatment of
CdS (OA & ODE) QDs dissolved in toluene with NaBH4 resulted in a decrease in the QY
of the QDs.
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Figure 5.16. Absorbance spectra (a) and fluorescence spectra (b) of a 1.23 x 10-7 M solution of CdS (OA &
ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d
(green), and 10 d (purple) after treatment with NaBH4 (7.69 x 10-6 molar ratio of QDs to NaBH4). Photos of
untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.

Table 5.12. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & ODE) QD and NaBH4 solution dissolved in toluene at a 7.69 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.117

152

2.60

Initial

0.099

151

2.60

1d

0.103

151

2.60

5d

0.051

---

2.62

10 d

0.062

---

2.62
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Figure 5.17. Normalized fluorescence spectrum and picture (inset) of a solution composed of chloroform,
OA, ODE, and NaBH4.

5.2.3 Treatment with Calcium Hydride (CaH2) in Chloroform
Figure 5.18 displays the absorbance and fluorescence spectra of a CdS (OA &
ODE) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 1.87 x 10-5
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.13 below, show that the QY of the QDs decreased immediately after treatment with
CaH2. An increase in absorbance was also observed after treatment (see Figure 5.18a). In
a study by Mandal et al., an increase in absorbance was found to be indicative of
aggregation because absorbance measurements are sensitive to scattering from colloidal
suspensions that form as QD aggregates grow in size.1 Furthermore, they found that a
significant decrease in QD fluorescence also resulted from aggregation.1 It can therefore
be concluded that the flattening of the fluorescence peak coupled with the significant
increase in absorbance observed immediately after treatment with CaH2, indicates that the
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QDs began to aggregate at this time. The aggregates grew to a size that allowed them to
be clearly visible in the solution, causing the solution to appear cloudy in visible light.
When excited with a 365 nm UV light, as seen in the pictures in Figure 5.18, the
aggregates scattered the incident light and caused the solution to appear pink. With time,
the aggregates continued to grow which explains why the absorbance continued to
increase and fluorescence peak continued to flatten with time. In conclusion, treatment of
CdS (OA & ODE) QDs dissolved in chloroform with CaH2 resulted in aggregation and a
decrease in the QY of the QDs.

Figure 5.18. Absorbance spectra (a) and fluorescence spectra (b) of a 8.99 x 10-8 M solution of CdS (OA &
ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with CaH2 (1.87 x 10-5 molar ratio of QDs to CaH2). Photos of
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.
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Table 5.13. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & ODE) QD and CaH2 solution dissolved in chloroform at a 1.87 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.024

122

2.65

Initial

0.005

188

2.66

1d

0.007

190

2.66

5d

0.002

---

2.66

10 d

0.001

---

2.66

5.2.4 Treatment with Calcium Hydride (CaH2) in Toluene
Figure 5.19 displays the absorbance and fluorescence spectra of a CdS (OA &
ODE) QD and calcium hydride (CaH2) solution dissolved in toluene at a 2.56 x 10-5
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.14 below, show that the QY of the QDs decreased after treatment with CaH2.
Furthermore, 5 d and 10 d after treatment, the peak centered at 450 nm that was
representative of the combination of OA, ODE, toluene, and CaH2 increased
significantly. The normalized fluorescence peak of this solution as well as a picture of the
solution excited by a 365 nm UV light is shown in Figure 5.20 below. As seen in the
picture, this solution fluoresces bright blue. Because the fluorescence of the QD solution
decreased and the fluorescence of the precursor solution increased, a blue-shift in
emission is expected. Figure 5.19d and e illustrate this expected blue-shift as the treated
QDs (right) appear more blue than the untreated QDs (left). This same result was
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observed after treatment with NaBH4, as detailed in section 5.2.2 above. In conclusion,
treatment of CdS (OA & ODE) QDs dissolved in toluene with CaH2 resulted in a
decrease in the QY of the QDs.

Figure 5.19. Absorbance spectra (a) and fluorescence spectra (b) of a 1.23 x 10-7 M solution of CdS (OA &
ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d
(green), and 10 d (purple) after treatment with CaH2 (2.56 x 10-5 molar ratio of QDs to CaH2). Photos of
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.
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Table 5.14. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & ODE) QD and CaH2 solution dissolved in toluene at a 2.56 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.084

152

2.60

Initial

0.032

---

2.60

1d

0.063

---

2.60

5d

0.039

---

2.59

10 d

0.032

---

2.59

Figure 5.20. Normalized fluorescence spectrum and picture (inset) of a solution composed of chloroform,
OA, ODE, and CaH2.

5.2.5 Treatment with Hydrazine (N2H4) in Chloroform
Figure 5.21 displays the absorbance and fluorescence spectra of a CdS (OA &
ODE) QD and hydrazine (N2H4) solution dissolved in chloroform at a 2.84 x 10-7 molar
ratio. Because the fluorescence of the QDs was quenched immediately after treatment, it
was not possible to calculate the quantum yield (QY), full-width half-maximum (FWHM)
or bandgap energy (Eg) of the QDs. Similar to treatment of CdSe (OA & ODE) QDs in
chloroform (as described in section 4.2.5), the addition of N2H4 resulted in an emulsion.
We hypothesize that OA was able to act as a surfactant and stabilize the hydrazine
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droplets, as its surface tension (32.5 mN/m3) was in between that of N2H4 (66.39 mN/m3)
and chloroform (27.5 mN/m3). The hydrophilic-lipophilic balance (HLB) of OA was
found to be 19, indicating that it is a hydrophobic surfactant.10 Chloroform is a
hydrophobic solvent, therefore OA was found to be a good surfactant that yielded a stable
emulsion with small, evenly dispersed droplets of N2H4.
Immediately after adding N2H4 to the chloroform, a small amount of soluble N2H4
reacted with the QDs and reduced their surface to etch and destroy the QDs thereby
quenching the QD fluorescence. The fluorescence spectrum included in Figure 5.21b
confirms this quenching of the fluorescence as the peak completely flattened immediately
after treatment. The residual OA in the solution then stabilized the remaining N2H4 into
small, evenly dispersed N2H4 droplets. These droplets scattered the light, causing the
solution to appear cloudy in visible light. When a 365 nm UV lamp was used as the
incident light, the evenly dispersed droplets of N2H4 in the QD solution scattered the light
causing the solution to appear purple (see pictures in Figure 5.21). In conclusion,
treatment of CdS (OA & ODE) QDs dissolved in chloroform with N2H4 caused the QDs
to stop fluorescing immediately after treatment.
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Figure 5.21. Absorbance spectra (a) and fluorescence spectra (b) of a 8.99 x 10-8 M solution of CdS (OA &
ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with N2H4 (2.84 x 10-7 molar ratio of QDs to N2H4). Photos of
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.

Table 5.15. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & ODE) QD and N2H4 solution dissolved in chloroform at a 2.84 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.024

122

2.65

Initial

---

---

---

1d

---

---

---

5d

---

---

---

10 d

---

---

---
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5.2.6 Treatment with Hydrazine (N2H4) in Toluene
Figure 5.22 displays the absorbance and fluorescence spectra of a CdS (OA &
ODE) QD and hydrazine (N2H4) solution dissolved in toluene at a 3.89 x 10-7 molar ratio.
From these spectra, quantum yield (QY), full-width half-maximum (FWHM), and
bandgap energy (Eg) were calculated before treatment, as well as immediately, 1 d, 5 d,
and 10 d after treatment. These results are summarized in Table 5.16 below. As
illustrated in Figure 5.22b, immediately after treatment with N2H4, the fluorescence peak
corresponding to the QDs flattened completely. The peak corresponding to the solution of
toluene, OA, ODE, andN2H4, on the other hand, was still measured. We therefore
hypothesize that immediately after treatment the fluorescence of the QD solution was
quenched. The blue color observed in the pictures included in Figure 5.22 is therefore
representative of the precursor solution, not the QDs. Because N2H4 is soluble in toluene,
the issues explained in section 5.2.5 above are not applicable to this system. Lastly, these
results are consistent with those observed in the treatment of CdSe (OA & ODE) QDs
with N2H4 as detailed in section 4.2.6. In conclusion, treatment of CdS (OA & ODE) QDs
dissolved in toluene with N2H4 resulted in the quenching of the QD fluorescence
immediately after treatment.
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Figure 5.22. Absorbance spectra (a) and fluorescence spectra (b) of a 1.23 x 10-7 M solution of CdS (OA &
ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d
(green), and 10 d (purple) after treatment with N2H4 (3.89 x 10-7 molar ratio of QDs to N2H4). Photos of
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.

Table 5.16. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & ODE) QD and N2H4 solution dissolved in toluene at a 3.89 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.062

152

2.60

Initial

---

---

---

1d

---

---

---

5d

---

---

---

10 d

---

---

---
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5.2.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform
Figure 5.23 displays the absorbance and fluorescence spectra of a CdS (OA &
ODE) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a 3.75 x
10-5 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.17 below, show that the QY of the QDs increased after treatment with C14H10O4 and
reached a maximum 10 d after treatment. Figure 5.23e illustrates this increase in QY 10 d
after treatment as the treated sample (right) is significantly brighter than the untreated
sample (left). Additionally, the FWHM decreased slightly and the absorbance peak
became more sharp (see Figure 5.23a) 10 d after treatment, indicating a significant
narrowing of the QD size distribution. In conclusion, treatment of CdS (OA & ODE)
QDs dissolved in chloroform with C14H10O4 resulted in a 62.5 % increase in the QY of
the QDs 10 d after treatment.

204

Figure 5.23. Absorbance spectra (a) and fluorescence spectra (b) of a 8.99 x 10-8 M solution of CdS (OA &
ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with C14H10O4 (3.75 x 10-5 molar ratio of QDs to C14H10O4).
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 5.17. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & ODE) QD and C14H10O4 solution dissolved in chloroform at a 3.75 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.024

122

2.65

Initial

0.025

124

2.65

1d

0.030

125

2.66

5d

0.019

139

2.65

10 d

0.039

146

2.63
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5.2.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene
Figure 5.24 displays the absorbance and fluorescence spectra of a CdS (OA &
ODE) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at a 5.13 x 10-5
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.18 below, show that the QY of the QDs reached a maximum 10 d after treatment with
C14H10O4. Figure 5.24e illustrates this increase in QY 10 d after treatment as the treated
sample (right) is significantly brighter than the untreated sample (left). In conclusion,
treatment of CdS (OA & ODE) QDs dissolved in toluene with C14H10O4 resulted in a
6.84 % increase in the QY of the QDs 10 d after treatment.
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Figure 5.24. Absorbance spectra (a) and fluorescence spectra (b) of a 1.23 x 10-7 M solution of CdS (OA &
ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d
(green), and 10 d (purple) after treatment with C14H10O4 (5.13 x 10-5 molar ratio of QDs to C14H10O4).
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 5.18. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & ODE) QD and C14H10O4 solution dissolved in toluene at a 5.13 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.117

152

2.60

Initial

0.117

153

2.60

1d

0.099

155

2.60

5d

0.089

155

2.60

10 d

0.125

---

2.60
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5.2.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform
Figure 5.25 displays the absorbance and fluorescence spectra of a CdS (OA &
ODE) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in chloroform at a
4.32 x 10-7 molar ratio. From these spectra, quantum yield (QY), full-width halfmaximum (FWHM), and bandgap energy (Eg) were calculated before treatment, as well
as immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.19 below, show that the QY of the QDs decreased immediately after treatment with
C4H10O2. An increase in absorbance was also observed immediately after treatment (see
Figure 5.25a). In a study by Mandal et al., an increase in absorbance was found to be
indicative of aggregation because absorbance measurements are sensitive to scattering
from colloidal suspensions that form as QD aggregates grow in size.1 Furthermore, they
found that a significant decrease in QD fluorescence also resulted from aggregation.1 It
can therefore be concluded that the flattening of the fluorescence peak coupled with the
significant increase in absorbance observed immediately after treatment with C4H10O2,
indicates that the QDs began to aggregate at this time. One day after treatment, the
aggregates grew to a size that allowed them to be clearly visible in the solution, causing
the solution to appear cloudy in visible light. When excited with a 365 nm UV light, as
seen in Figure 5.25c, the aggregates scattered the incident light and caused the solution to
appear pink.
In previous cases of aggregation, the aggregates grew to a large enough size that
they precipitated out of solution and caused the fluorescence of the QD solution to
quench. In this case, however, a fluorescence peak centered at 510 nm increased 5 d and
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10 d after treatment. Additionally, the QDs blue-shifted in color and increased in
brightness, as illustrated in Figure 5.25d and e. These observations are unlike any of the
others and have no obvious explanation.

Figure 5.25. Absorbance spectra (a) and fluorescence spectra (b) of a 8.99 x 10-8 M solution of CdS (OA &
ODE) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with C4H10O2 (4.32 x 10-7 molar ratio of QDs to C4H10O2).
Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.
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Table 5.19. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & ODE) QD and C4H10O2 solution dissolved in chloroform at a 4.32 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.024

122

2.65

Initial

---

---

---

1d

---

---

---

5d

0.008

149

2.71

10 d

0.015

141

2.72

5.2.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene
Figure 5.26 displays the absorbance and fluorescence spectra of a CdS (OA &
ODE) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in toluene at a 5.91
x 10-7 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.20 below, show that the QY of the QDs decreased after treatment with C4H10O2. This
decrease in QY was confirmed as the fluorescence peak corresponding to the QDs
decreased after treatment. Furthermore, the pictures in Figure 5.26 illustrate that the
treated sample (right) is less bright than the untreated sample (left). In conclusion,
treatment of CdS (OA & ODE) QDs dissolved in toluene with C4H10O2 resulted in a
decline in the QY of the QDs.
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Figure 5.26. Absorbance spectra (a) and fluorescence spectra (b) of a 1.23 x 10-7 M solution of CdS (OA &
ODE) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d
(green), and 10 d (purple) after treatment with C4H10O2 (5.91 x 10-7 molar ratio of QDs to C4H10O2). Photos
of untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d,
and (e) 10 d after treatment.

Table 5.20. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & ODE) QD and N2H4 solution dissolved in toluene at a 5.91 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.086

152

2.60

Initial

0.020

---

2.61

1d

0.026

---

2.61

5d

0.021

---

2.61

10 d

0.028

---

2.60
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5.2.11 Summary of CdS/OA & ODE Treatments
Figure 5.27 compares the effect of treating CdS (OA & ODE) QDs with various
reducing and oxidizing agents in chloroform and toluene. From these photographs, it can
be seen that the QDs dissolved in toluene were visibly brighter than those in chloroform.
This observation was confirmed as the QY of the QDs before treatment in chloroform
was approximately 0.024 while the QY in toluene was approximately 0.085. A different
batch of QDs was used for treatments in chloroform than toluene due to low yield
therefore it is unclear if this difference in QY is attributed to differences in the batch
quality or to QD solubility in each solvent. In each of the other 2 batches of QDs capped
with OA, it was hypothesized that the QDs exhibited a higher QY in toluene over
chloroform because of the difference in dissolved oxygen concentration in each solvent.5
The Eg of the untreated QDs in chloroform and toluene were 2.65 eV and 2.60 eV,
respectively, which suggests the solvent does not have a significant effect on QD size and
therefore color emitted.
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Figure 5.27. Photos of CdS (OA & ODE) QDs that are from left to right: untreated, treated with NaBH4,
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were
suspended and treated in chloroform while those in the right column were suspended and treated in toluene.
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment.

The effect of reducing and oxidizing agents on the QY of CdS (OA & ODE) QDs
was found to be independent of solvent for 3 of the 5 treatments. More specifically, it was
found that the quality of the QDs worsened after treatment with N2H4 and CaH2, and
improved after treatment with C14H10O4 in both chloroform and toluene. Treatment with
NaBH4 and C4H10O2, on the other hand, increased the quality of the QDs when dissolved
in chloroform, but not toluene. Even though the QY of the QDs increased after treatment
with C14H10O4 in both chloroform and toluene, the percent increase in QY in chloroform
was significantly higher than in toluene, 62.5 % compared to 6.84 %, respectively. These
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results clearly illustrate that the surface treatment of CdS (OA & ODE) QDs was more
effective in chloroform than toluene. This is consistent with the CdSe (OA & ODE) case
where surface treatment was also more effective in chloroform than toluene.
The reason for this dependence on solvent is not known, however, a possible
explanation focuses on the solubility of the ligand (OA) in the dispersion solvent. In a
study by Bullen et al., it was concluded that desorption of the surface ligands may occur
if the ligand is more soluble in a given solvent, therefore resulting in decreased QY.11
Oleic acid is more soluble in toluene than chloroform as confirmed by comparing
Hildebrand solubility parameters. Specifically, the Hildebrand solubility parameter (δ)
provides a good estimation of the solubility of two substances as it is a numerical
estimate of the degree of interaction between materials. The closer the δ of two
substances, the better the degree of solubility. Furthermore, δOA = 15.95, δtoluene = 17.8,
and δchloroform = 19.012, therefore confirming that OA is more soluble in toluene than
chloroform. For this reason, it can be hypothesized that OA ligands will desorb from the
QD surface at a faster rate in toluene than chloroform, thereby explaining why surface
treatment is more effective in chloroform than toluene.
A second possible explanation for the observed results focuses on the solubility of
the reducing agent in the dispersion solvent. It is hypothesized that NaBH4 is more
soluble in toluene than chloroform. For this reason, the reducing agent reacts with the
QDs at a faster rate when dissolved in toluene than chloroform. It is therefore
hypothesized that when dispersed and treated in toluene, oxygen was not able to diffuse
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to the QD surface to form a CdO layer and therefore was not able to passivate the surface
defect sites. Instead, NaBH4 caused the OA ligands to detach from the QD surface and
destroyed the QDs dispersibility in toluene, thereby resulting in a decreased QY.2
Unfortunately, information is not currently available regarding the solubility of NaBH4 in
toluene versus chloroform. For this reason, it is recommended that future work include a
solubility study to determine the solubility of NaBH4 in both chloroform and toluene to
confirm this theory.
Treatment with C4H10O2 also resulted in an enhanced QY when the QDs were
dispersed and treated in chloroform but not in toluene. As detailed in section 5.2.9 above,
the observed increase in QY was unlike any other C4H10O2 treatment. Furthermore, the
measured fluorescence and absorbance spectra indicate that the QDs aggregated
immediately after treatment before increasing significantly in brightness. Due to the
uniqueness of this result, it is recommended that the treatment be redone to validate
accuracy.
In each of the 10 preceding sections, a bimodal fluorescence peak was measured
to represent the untreated QDs. As previously explained, the fluorescence peak centered
at 450 nm was believed to be representative of the mixture of OA, ODE, and solvent,
whereas the peak centered at 620 nm was representative of the QDs. We hypothesize that
measurement of a fluorescence peak at 450 nm indicates that residual ligand is present in
the QD solution after washing. As explained in section 4.2.11 where the treatment of
CdSe (OA & ODE) QDs is summarized, no peak at 450 nm was measured. It is unclear
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why residual OA and ODE were found to be present in the case of CdS QDs but not
CdSe QDs. Furthermore, in previous cases where residual ligand was present in solution
after washing, a peak centered at 450 nm was only observed after treatment. This leads to
another interesting difference between CdS (OA & ODE) QDs and the other batches: a
peak representing the precursor solution was measured prior to treatment. A reason for
this observation is not readily known.

5.3 CdS (OA and TOA) Quantum Dot Cores
Each of the previous 5 QD batches were treated with various reducing and
oxidizing agents at an initial absorbance between 0.08 a.u. and 0.10 a.u.. This starting
absorbance value was chosen to ensure accurate QY calculations. CdS (OA & TOA) QD
solutions with this same concentration did not fluoresce. Furthermore, treatment of these
poor quality QDs with each of the reducing and oxidizing agents failed to improve the
quality. Appendix B illustrates these results. Jang et al.6 report an increase in QY of CdS
(OA & TOA) QDs after treatment with NaBH4. For their study, a starting absorbance of
0.35 a.u. was reported. For this reason, the CdS (OA & TOA) QD treatments described in
the following section had an initial absorbance of 0.35 a.u..
Similar to CdS (OA & ODE) QDs, the untreated CdS (OA & TOA) QDs yielded
a bimodal fluorescence peak in both solvents. As explained in section 5.2 above, we
hypothesize that this bimodal fluorescence peak indicates that there is residual ligand
present in the solution. Similar to in previous sections, fluorescence spectroscopy was
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performed on solutions of each ligand, solvent, and reducing/oxidizing agent combination
to account for their influence on the measured fluorescence spectra. Figure 5.28 below
illustrates the fluorescence spectra of the combination of OA, TOA, and chloroform as
well as the combination of OA, TOA, and toluene. From these fluorescence spectra, it
can clearly be seen that a peak centered at 460 nm was measured in both solvents that
represents the mixture of the ligand, non-coordinating solvent, and dispersion solvent.
We therefore hypothesize that because the bimodal fluorescence peaks representing the
untreated QD solution contain one peak centered at 460 nm and one centered at
approximately 650 nm, the latter peak is representative of the QDs. For this reason, the
650 nm peak will be the focus of the following sections to evaluate the effect of each
surface treatment. Furthermore, the QYs calculated for each treatment only accounted for
the area under the peak corresponding to the QDs. The reported Eg and FWHM values are
also only representative of the QD peak.

Figure 5.28. Normalized fluorescence spectrum of a solution composed of chloroform, OA, and TOA
(solid) and a solution composed of toluene, OA, and TOA (dashed).
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5.3.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform
Figure 5.29 displays the absorbance and fluorescence spectra of a CdS (OA &
TOA) QD and sodium borohydride (NaBH4) solution dissolved in chloroform at a 9.19 x
10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.21 below, show that the QY of the QDs decreased after treatment with NaBH4.
Additionally, the absorbance value increased 1 d after treatment. In a study by Mandal et
al., an increase in absorbance was found to be indicative of aggregation because
absorbance measurements are sensitive to scattering from colloidal suspensions that form
as QD aggregates grow in size.1 Furthermore, they found that a decrease in QD
fluorescence also resulted from aggregation.1 The observed increase in absorbance and
flattening of the fluorescence peak (see Figure 5.29) therefore indicate that the QDs
began to aggregate 1 d after treatment.
Similar to in the fluorescence spectra of CdSe (OA & TOA) QDs dissolved in
chloroform as described in section 4.3, a negative peak was measured after treatment (see
Figure 5.29b). This peak was found to represent the combination of OA, TOA,
chloroform, and NaBH4 (see Figure 4.27 in Chapter 4), however it is unclear why the
peak is negative. An explanation for this negative peak is therefore not known and will be
explored further in future work. In conclusion, treatment of CdS (OA & TOA) QDs
dissolved in chloroform with NaBH4 resulted in a decrease in the QY of the QDs.
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Figure 5.29. Absorbance spectra (a) and fluorescence spectra (b) of a 2.94 x 10-7 M solution of CdS (OA &
TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with NaBH4 (9.19 x 10-6 molar ratio of QDs to NaBH4).
Photos of untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 5.21. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & TOA) QD and NaBH4 solution dissolved in chloroform at a 9.19 x 10-6 molar ratio.

QY x 10-3

FWHM (nm)

Eg (eV)

Untreated

1.00

198

2.45

Initial

1.00

198

2.45

1d

0.80

196

2.45

5d

0.30

---

2.45

10 d

0.50

195

2.45
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5.3.2 Treatment with Sodium Borohydride (NaBH4) in Toluene
Figure 5.30 displays the absorbance and fluorescence spectra of a CdS (OA &
TOA) QD and sodium borohydride (NaBH4) solution dissolved in toluene at an 8.16 x
10-6 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.22 below, show that the QY of the QDs increased immediately after treatment with
NaBH4. Additionally, a significant increase in the fluorescence peak corresponding to the
precursor solution was seen over time (see Figure 5.30b). In conclusion, treatment of CdS
(OA & TOA) QDs dissolved in toluene with NaBH4 resulted in a 200 % increase in the
QY of the QDs immediately after treatment.
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Figure 5.30. Absorbance spectra (a) and fluorescence spectra (b) of a 2.61 x 10-7 M solution of CdS (OA &
TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d
(green), and 10 d (purple) after treatment with NaBH4 (8.16 x 10-6 molar ratio of QDs to NaBH4). Photos of
untreated QDs (left) and QDs treated with NaBH4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.

Table 5.22. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & TOA) QD and NaBH4 solution dissolved in toluene at a 8.16 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.002

198

2.45

Initial

0.006

150

2.46

1d

0.003

197

2.47

5d

0.001

---

2.47

10 d

0.003

195

2.47
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5.3.3 Treatment with Calcium Hydride (CaH2) in Chloroform
Figure 5.31 displays the absorbance and fluorescence spectra of a CdS (OA &
TOA) QD and calcium hydride (CaH2) solution dissolved in chloroform at a 2.10 x 10-5
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.23 below, show that the QY of the QDs decreased after treatment with CaH2.
Additionally, the absorbance value increased after treatment. In a study by Mandal et al.,
an increase in absorbance was found to be indicative of aggregation because absorbance
measurements are sensitive to scattering from colloidal suspensions that form as QD
aggregates grow in size.1 Furthermore, they found that a decrease in QD fluorescence
also resulted from aggregation.1 Similar to treatment of CdSe (OA & TOA) QDs with
CaH2 as described in section 4.3.3, the observed increase in absorbance and flattening of
the fluorescence peak (see Figure 5.31) therefore indicate that the QDs began to
aggregate after treatment.
The absorbance continued to increase 10 d after treatment (see purple line in
Figure 5.31a) which indicates that the QD aggregates continued to grow with time. Ten
days after treatment, the aggregates grew to a size that allowed them to be clearly visible
in the solution, causing the solution to appear cloudy in visible light. When a 365 nm UV
lamp was used as the incident light (as in the case in Figure 5.31e) the QD aggregates
scattered the incident light causing the solution to appear pink. In conclusion, treatment
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of CdS (OA & TOA) QDs dissolved in chloroform with CaH2 resulted in a decrease in
the QY of the QDs due to aggregation.

Figure 5.31. Absorbance spectra (a) and fluorescence spectra (b) of a 2.94 x 10-7 M solution of CdS (OA &
TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with CaH2 (2.10 x 10-5 molar ratio of QDs to CaH2). Photos of
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.

Table 5.23. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & TOA) QD and CaH2 solution dissolved in chloroform at a 2.10 x 10-5 molar ratio.

QY x 10-3

FWHM (nm)

Eg (eV)

Untreated

0.70

198

2.45

Initial

0.50

---

2.45

1d

0.50

---

2.45

5d

0.20

---

---

10 d

0.20

---

---
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5.4.4 Treatment with Calcium Hydride (CaH2) in Toluene
Figure 5.32 displays the absorbance and fluorescence spectra of a CdS (OA &
TOA) QD and calcium hydride (CaH2) solution dissolved in toluene at a 1.86 x 10-5
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.24 below, show that the QY of the QDs decreased after treatment with CaH2.
Additionally, a significant increase in the fluorescence peak corresponding to the
precursor solution was seen over time (see Figure 5.32b). In conclusion, treatment of CdS
(OA & TOA) QDs dissolved in toluene with CaH2 resulted in a decrease in the QY of the
QDs.
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Figure 5.32. Absorbance spectra (a) and fluorescence spectra (b) of a 2.61 x 10-7 M solution of CdS (OA &
TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d
(green), and 10 d (purple) after treatment with CaH2 (1.86 x 10-5 molar ratio of QDs to CaH2). Photos of
untreated QDs (left) and QDs treated with CaH2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.

Table 5.24. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & TOA) QD and CaH2 solution dissolved in toluene at a 1.86 x 10-5 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.006

197

2.45

Initial

0.002

191

2.45

1d

0.004

193

2.45

5d

0.002

192

2.45

10 d

0.005

180

2.45
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5.3.5 Treatment with Hydrazine (N2H4) in Chloroform
Figure 5.33 displays the absorbance and fluorescence spectra of a CdS (OA &
TOA) QD and hydrazine (N2H4) solution dissolved in chloroform at a 9.30 x 10-7 molar
ratio. Because the fluorescence of the QDs was quenched immediately after treatment, it
was not possible to calculate the quantum yield (QY), full-width half-maximum (FWHM)
or bandgap energy (Eg) of the QDs. Similar to treatment of CdSe (OA & TOA) QDs with
N2H4, the fluorescence of the QDs was quenched and an emulsion resulted immediately
after treatment due to the near insolubility of N2H4 in chloroform. Figure 5.33c illustrates
this emulsion 1 d after treatment as an uneven distribution of N2H4 droplets can clearly be
seen in the solution. Immediately after adding N2H4 to the chloroform, a small amount of
N2H4 reacted with the QDs and reduced their surface to etch and destroy the QDs thereby
quenching the QD fluorescence. The fluorescence spectrum included in Figure 5.33b
confirms this quenching of the fluorescence as the peak completely flattened immediately
after treatment. The remainder of the N2H4 formed large, unevenly dispersed N2H4
droplets stabilized by the residual OA and TOA. The solution appeared blue-green when
excited by a 365 nm UV lamp because the mixture of toluene, OA, and TOA emits light
at 450 nm upon excitation (see Figure 4.36 in Chapter 4). By 10 d after treatment, two
distinct layers were clearly visible presumably due to instability of the emulsion, so I
shook the vial. Agitation enabled the N2H4 layer to break up and disperse in the solution
temporarily, thereby causing the solution to appear bright (see Figure 5.33e) even though
the fluorescence of the QDs had been quenched prior.
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Similar to in the fluorescence spectra of the same batch of QDs dissolved in
chloroform after treatment with NaBH4, the peak fell negative at 450 nm. This peak was
found to represent the combination of OA, TOA, chloroform, and N2H4 (see Figure 4.36
in Chapter 4), however it is unclear why the peak is negative. An explanation for this
negative peak is therefore not known and will be explored further in future work. In
conclusion, the fluorescence of CdS (OA & TOA) QDs dissolved in chloroform died
immediately after treatment with N2H4.

Figure 5.33. Absorbance spectra (a) and fluorescence spectra (b) of a 2.94 x 10-7 M solution of CdS (OA &
TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with N2H4 (9.30 x 10-7 molar ratio of QDs to N2H4). Photos of
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.
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Table 5.25. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & TOA) QD and N2H4 solution dissolved in chloroform at a 9.30 x 10-7 molar ratio.

QY x 10-3

FWHM (nm)

Eg (eV)

Untreated

1.00

195

2.45

Initial

---

---

---

1d

---

---

---

5d

---

---

---

10 d

---

---

---

5.3.6 Treatment with Hydrazine (N2H4) in Toluene
Figure 5.34 displays the absorbance and fluorescence spectra of a CdS (OA &
TOA) QD and hydrazine (N2H4) solution dissolved in toluene at an 8.26 x 10-7 molar
ratio. Because the fluorescence of the QDs was quenched immediately after treatment, it
was not possible to calculate the quantum yield (QY), full-width half-maximum (FWHM)
or bandgap energy (Eg) of the QDs. Although N2H4 is soluble in toluene, residual TOA in
the QD solution prevented all of the reducing agent from reacting immediately with the
QDs, similar to treatment in chloroform, as detailed in section 5.3.5 above. Instead,
immediately after adding N2H4 to the toluene, a small amount of N2H4 reacted with the
QDs and reduced their surface to etch and destroy the QDs thereby quenching the QD
fluorescence. The fluorescence spectrum included in Figure 5.34b confirms this
quenching of the fluorescence as the peak corresponded to the QDs completely flattened
immediately after treatment. The remainder of the N2H4 formed two clearly separate
phases in the solution stabilized by the residual OA and TOA (see pictures in Figure
5.34). The solution appeared blue-green when excited by a 365 nm UV lamp because the
mixture of toluene, OA, and TOA emits light at 450 nm upon excitation (see Figure 4.38
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in Chapter 4). In conclusion, the fluorescence of CdS (OA & TOA) QDs dissolved in
toluene died immediately after treatment with N2H4.

Figure 5.34. Absorbance spectra (a) and fluorescence spectra (b) of a 2.61 x 10-7 M solution of CdS (OA &
TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d
(green), and 10 d (purple) after treatment with N2H4 (8.26 x 10-7 molar ratio of QDs to N2H4). Photos of
untreated QDs (left) and QDs treated with N2H4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and
(e) 10 d after treatment.

Table 5.26. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & TOA) QD and N2H4 solution dissolved in toluene at a 8.26 x 10-7 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.006

195

2.45

Initial

---

---

---

1d

---

---

---

5d

---

---

---

10 d

---

---

---
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5.3.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform
Figure 5.35 displays the absorbance and fluorescence spectra of a CdS (OA &
TOA) QD and benzoyl peroxide (C14H10O4) solution dissolved in chloroform at a 3.68 x
10-4 molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.27 below, show that the QY of the QDs decreased after treatment with C14H10O4.
Additionally, the fluorescence peak corresponding to the QDs (centered at 650 nm)
flattened completely 5 d and 10 d after treatment, indicating that the fluorescence of the
QDs was quenched at this time. Furthermore, the absorbance value increased 5 d and
10 d after treatment. In a study by Mandal et al., an increase in absorbance was found to
be indicative of aggregation because absorbance measurements are sensitive to scattering
from colloidal suspensions that form as QD aggregates grow in size.1 Furthermore, they
found that a decrease in QD fluorescence also resulted from aggregation.1 The observed
increase in absorbance and flattening of the fluorescence peak (see Figure 5.35) therefore
indicate that the QDs began to aggregate 5 d after treatment.
The absorbance continued to increase 10 d after treatment (see purple line in
Figure 5.35a) which indicates that the QD aggregates continued to grow with time. Ten
days after treatment, the aggregates grew to a size that allowed them to be clearly visible
in the solution, causing the solution to appear cloudy in visible light. When a 365 nm UV
lamp was used as the incident light (as in the case in Figure 5.35e) the QD aggregates
scattered the incident light causing the solution to appear pink. Lastly, 5 d and 10 d after
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treatment, a measurable fluorescence peak centered at 450 nm was observed. This peak
was found to represent the combination of OA, TOA, chloroform, and C14H10O4 (see
Figure 5.36 below). In conclusion, treatment of CdS (OA & TOA) QDs dissolved in
chloroform with C14H10O4 resulted in a quenching of the fluorescence of the QDs 5 d
after treatment.

Figure 5.35. Absorbance spectra (a) and fluorescence spectra (b) of a 2.94 x 10-7 M solution of CdS (OA &
TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with C14H10O4 (3.68 x 10-4 molar ratio of QDs to C14H10O4).
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.
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Table 5.27. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & TOA) QD and C14H10O4 solution dissolved in chloroform at a 3.68 x 10-4 molar ratio.

QY x 10-3

FWHM (nm)

Eg (eV)

Untreated

1.00

198

2.45

Initial

0.90

198

2.45

1d

0.90

198

2.45

5d

---

---

---

10 d

---

---

---

Figure 5.36. Normalized fluorescence spectrum of a solution composed of chloroform, OA, TOA, and
C14H10O4.

5.3.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene
Figure 5.37 displays the absorbance and fluorescence spectra of a CdS (OA &
TOA) QD and benzoyl peroxide (C14H10O4) solution dissolved in toluene at a 3.26 x 10-4
molar ratio. From these spectra, quantum yield (QY), full-width half-maximum
(FWHM), and bandgap energy (Eg) were calculated before treatment, as well as
immediately, 1 d, 5 d, and 10 d after treatment. These results, as summarized in Table
5.28 below, show that the QY of the QDs decreased immediately after treatment with
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C14H10O4. The peak corresponding to the QDs (centered at 650nm) flattened completely
1 d after treatment, indicating that the fluorescence of the QDs was quenched at this time
(see Figure 5.37b). Additionally, a significant increase in the fluorescence peak
corresponding to the precursor solution was seen over time (centered at 450 nm). In
conclusion, treatment of CdS (OA & TOA) QDs dissolved in toluene with C14H10O4
resulted in a quenching of the QD fluorescence 1 d after treatment.

Figure 5.37. Absorbance spectra (a) and fluorescence spectra (b) of a 2.61 x 10-7 M solution of CdS (OA &
TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d
(green), and 10 d (purple) after treatment with C14H10O4 (3.26 x 10-4 molar ratio of QDs to C14H10O4).
Photos of untreated QDs (left) and QDs treated with C14H10O4 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.
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Table 5.28. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & TOA) QD and C14H10O4 solution dissolved in toluene at a 3.26 x 10-4 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.005

198

2.45

Initial

0.004

197

2.45

1d

---

---

---

5d

---

---

---

10 d

---

---

---

5.3.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform
Figure 5.38 displays the absorbance and fluorescence spectra of a CdS (OA &
TOA) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in chloroform at a
1.41 x 10-6 molar ratio. Because the fluorescence of the QDs was quenched immediately
after treatment, it was not possible to calculate the quantum yield (QY), full-width halfmaximum (FWHM) or bandgap energy (Eg) of the QDs. The fluorescence peak
corresponding to the QDs (centered at 650nm) flattened immediately after treatment,
indicating that the fluorescence of the QDs was quenched at this time (see Figure 5.38b).
The fluorescence peak corresponding to the precursor solution (centered at 450 nm), on
the other hand, increased significantly 5 d and 10 d after treatment. In conclusion,
treatment of CdS (OA & TOA) QDs dissolved in chloroform with C4H10O2 resulted in a
quenching of the QD fluorescence immediately after treatment.
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Figure 5.38. Absorbance spectra (a) and fluorescence spectra (b) of a 2.94 x 10-7 M solution of CdS (OA &
TOA) QDs dissolved in chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red),
5 d (green), and 10 d (purple) after treatment with C4H10O2 (1.41 x 10-6 molar ratio of QDs to C4H10O2).
Photos of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV light (c) 1 d,
(d) 5 d, and (e) 10 d after treatment.

Table 5.29. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & TOA) QD and C4H10O2 solution dissolved in chloroform at a 1.41 x 10-6 molar ratio.

QY x 10-3

FWHM (nm)

Eg (eV)

Untreated

0.70

198

2.45

Initial

---

---

---

1d

---

---

---

5d

---

---

---

10 d

---

---

---
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5.3.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene
Figure 5.39 displays the absorbance and fluorescence spectra of a CdS (OA &
TOA) QD and tert-butyl hydroperoxide (C4H10O2) solution dissolved in toluene at a 1.25
x 10-6 molar ratio. Because the fluorescence of the QDs was quenched immediately after
treatment, it was not possible to calculate the quantum yield (QY), full-width halfmaximum (FWHM) or bandgap energy (Eg) of the QDs. The fluorescence peak
corresponding to the QDs (centered at 650 nm) flattened immediately after treatment,
indicating that the fluorescence of the QDs was quenched at this time (see Figure 5.39b).
The fluorescence peak corresponding to the precursor solution (centered at 450 nm), on
the other hand, increased significantly 5 d and 10 d after treatment. In conclusion,
treatment of CdS (OA & TOA) QDs dissolved in toluene with C4H10O2 resulted in a
quenching of the QD fluorescence immediately after treatment.
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Figure 5.39. Absorbance spectra (a) and fluorescence spectra (b) of a 2.61 x 10-7 M solution of CdS (OA &
TOA) QDs dissolved in toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d
(green), and 10 d (purple) after treatment with C4H10O2 (1.25 x 10-6 molar ratio of QDs to C4H10O2). Photos
of untreated QDs (left) and QDs treated with C4H10O2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d,
and (e) 10 d after treatment.

Table 5.30. Quantum yield (QY), full-width half-maximum (FWHM), and bandgap energy (Eg) of a CdS
(OA & TOA) QD and C4H10O2 solution dissolved in toluene at a 1.25 x 10-6 molar ratio.

QY

FWHM (nm)

Eg (eV)

Untreated

0.005

198

2.45

Initial

---

---

---

1d

---

---

---

5d

---

---

---

10 d

---

---

---
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5.3.11 Summary of CdS/OA & TOA Treatments
Figure 5.40 compares the effect of treating CdS (OA & TOA) QDs with various
reducing and oxidizing agents in chloroform and toluene. From these photographs, it can
be seen that the initial quality of these QDs were not as high as the other batches
described in the preceding sections. This observation was confirmed as the QY of the
QDs before treatment was only 0.001 in chloroform and 0.005 in toluene. This batch,
therefore, did not have a strong dependence on solvent as seen in the other QD batches.
The Eg of the untreated QDs in chloroform and toluene were both 2.45 eV, which
suggests the solvent does not have a significant effect on QD size and therefore color
emitted.
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Figure 5.40. Photos of CdS (OA & TOA) QDs that are from left to right: untreated, treated with NaBH4,
C14H10O4, CaH2, N2H4, and C4H10O2 excited with 365 nm UV light. The QDs in the left column were
suspended and treated in chloroform while those in the right column were suspended and treated in toluene.
Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom row) after treatment.

The effect of reducing and oxidizing agents on the QY of CdS (OA & TOA) QDs
was found to be independent of solvent for 4 of the 5 treatments. More specifically, the
QY of the QDs decreased after treatment with CaH2, N2H4, C14H10O4, and C4H10O2 in
both chloroform and toluene. The latter three treatments resulted in a quenched
fluorescence after treatment. Sodium borohydride, on the other hand, resulted in an
increased QY immediately after treatment in toluene, however the QY decreased after
treatment in chloroform. Although treatment with NaBH4 seems to have a dependence on
solvent, the initial quality of the QDs was so poor that it is difficult to form a concrete
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conclusion to explain these results. Furthermore, due to the difference in starting
concentration for this set of treatments, laterally comparing these results to the other 5
systems is not consistent. For these reasons, a recommendation for the future work of this
thesis is to develop a more robust procedure to synthesize higher quality CdS (OA &
TOA) QDs. Once this procedure is developed, it is recommended that the QDs be treated
with each of the reducing/oxidizing agents discussed in this thesis.
An important result stemming from the above results is consistent with the CdS
(OA & ODE) QD results (see section 5.2.11 above). Specifically, in each of the 10
preceding sections, a bimodal fluorescence peak was measured to represent the untreated
QDs. As previously explained, the fluorescence peak centered at 450 nm was believed to
be representative of the mixture of OA, TOA, and solvent, whereas the peak centered at
650 nm was representative of the QDs. We hypothesize that measurement of a
fluorescence peak at 450 nm indicates that residual ligand is present in the QD solution
after washing. A reason for this observation is not readily known.
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Chapter 6. Results and Discussion: Concentration Dependence on QY
The previous 2 chapters thoroughly present and discuss the effect of various
reducing/oxidizing agents on the optical properties of QDs after treatment. Treatment of
QDs with a reducing/oxidizing agent is expected to reduce the surface ligands thereby
causing them to lose their coordinating properties and detach from the QD surface.1
Oxygen from atmospheric air is then able to diffuse to the exposed cadmium on the QD
surface to form a cadmium oxide (CdO) layer around the QDs.1 This CdO layer serves to
passivate defects on the QD surface, thereby enhancing the QY of the QDs.1 As
explained in the previous results chapters, however, only 18 of the 50 investigated
treatments resulted in an enhanced QY of the QDs. Two possible explanations for the
observed decrease of the QY after the majority of the surface treatments involve the
reaction rate. Specifically, we hypothesize that when a reducing/oxidizing agent it too
soluble in a given solvent, it will lead to the formation of QD aggregates and an eventual
decrease in the QY of the QDs. Instead, the reducing/oxidizing agent will cause the
ligands to quickly detach from the QD surface and destroy the QDs dispersibility in the
solvent, and result in a quenched QY.2
A second possible hypothesis to explain the observed decrease in QY of the QDs
after several treatments also focuses on the reaction rate. Specifically, we hypothesize
that the reducing/oxidizing agents react with the residual water present in each of the
solvents to form hydrogen. The hydrogen then reacts with the surface ligands, causing
them to detach from the QD surface, and allowing oxygen from the atmospheric air to
diffuse to the exposed cadmium. The resulting CdO layer around the QDs serves to
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passivate the defect sites located on the QD surface and therefore improves the QY of the
QDs. If the reducing/oxidizing agents react too fast with the residual water, the QDs will
aggregate and the QY will be quenched. Based on this hypothesis, the amount of water
present in each of the solvents may be responsible for the dependence of solvent on the
effectiveness of the various surface treatments.
These theories can also be applied to explain why specific treatments were
successful in improving the QY of the QDs. For example, 10 of the 18 observed increases
in QY resulted after surface treatment with sodium borohydride (NaBH4). Consistent
with the theory presented above, it is believed that NaBH4 was effective as a reducing
agent because it is only slightly soluble in the two dispersion solvents. Because NaBH4 is
only slightly soluble in chloroform and toluene, we hypothesize that the reducing agent
diffused through the solvent to react with the QDs at a slow enough reaction rate that the
QDs surface was effectively reduced. In the case of reducing/oxidizing agents that were
completely soluble in the dispersion solvents, the reaction often happened so fast that the
QDs aggregated and the fluorescence of the QD solution was completely quenched. A
second possible explanation involves the reactivity of NaBH4 with water. In a study by
Kong et al., the reaction rate of NaBH4 with water vapor was found to be ten times
slower than that of CaH2.3 For this reason, we hypothesize that NaBH4 reacted with the
residual water in each solvent at a slow enough rate that the hydrogen produced was able
to effectively detach ligands on the QD surface and allow for the formation of the CdO
layer.
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Unlike NaBH4, surface treatment with tert-butyl hydroperoxide (C4H10O2)
resulted in a decline in the QY of the QDs in 11 of the 12 treatments. Eight of those
treatments led to a total quenching of the QD fluorescence. It is hypothesized that
because C4H10O2 is a liquid that was miscible in both solvents, all of the oxidizing agent
was able to react with each batch of QDs immediately after addition. Consistent with the
theory explained above, we hypothesize that because all of the C4H10O2 was able to react
with the QDs, the reaction rate was too fast for the formation of the CdO layer due to
either its solubility in the solvents or its reactivity with water. Regardless of explanation,
the fast reaction rate led to a decrease in QY. To test this theory, an additional set of
experiments was performed to investigate whether treatment with a lower concentration
of C4H10O2 would slow the reaction rate down enough to allow for proper passivation of
surface defects and therefore enhancement of the QY.

6.1 Effect of tert-Butyl Hydroperoxide (C4H10O2) Concentration on QY of QDs
Appendix C contains the results from treating each of the 6 batches of QDs with
lower concentrations of C4H10O2 in both chloroform and toluene. The new concentrations
investigated were: 0.006 M, 0.010 M, and 0.015 M. It is important to note that these
concentrations were significantly lower than those evaluated in determining the optimum
reducing/oxidizing agent concentration (as summarized in Appendix A). In Appendix A,
results for treatment with 0.104 M, 0.208 M, and 0.312 M C4H10O2 are presented.
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From these results, a clear dependence on C4H10O2 concentration was observed on
the QY of the QDs. Specifically, the fluorescence of the QDs was never quenched
immediately after treatment with lower concentrations of C4H10O2, as was seen after
treatment with higher concentrations. Instead, the fluorescence often decreased gradually
over the 10 d period, indicating a significantly slower reaction rate. Figure 6.1 below
illustrates this dependence on concentration as the fluorescence of the CdSe (oleylamine)
QDs dissolved in chloroform was quenched immediately after treatment with 0.1038 M
C4H10O2 (6.14 x 10-6 molar ratio of QDs to C4H10O2), but not after treatment with
0.0062 M C4H10O2 (1.37 x 10-4 molar ratio of QDs to C4H10O2). The same trend was
observed when the QDs were dispersed and treated in toluene, as illustrated in Figure 6.2.
Each of the photos was taken 1 d after the respective treatments.

Figure 6.1. Photos of a (a) 6.39 x 10-7 M solution of CdSe (oleylamine) QDs dissolved in chloroform before
treatment (left) and 1 d after treatment with C4H10O2 (6.14 x 10-6 molar ratio of QDs to C4H10O2) (right),
and (b) 8.51 x 10-7 M solution of CdSe (oleylamine) QDs dissolved in chloroform before treatment (left)
and 1 d after treatment with C4H10O2 (1.37 x 10-4 molar ratio of QDs to C4H10O2) (right).
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Figure 6.2. Photos of a (a) 1.04 x 10-6 M solution of CdSe (oleylamine) QDs dissolved in toluene before
treatment (left) and 1 d after treatment with C4H10O2 (1.00 x 10-5 molar ratio of QDs to C4H10O2) (right),
and (b) 1.04 x 10-6 M solution of CdSe (oleylamine) QDs dissolved in toluene before treatment (left) and
1 d after treatment with C4H10O2 (1.68 x 10-4 molar ratio of QDs to C4H10O2) (right).

Although only 1 of the 5 reducing/oxidizing agents investigated in this thesis was
evaluated as a function of concentration, it is expected that the lower the concentration of
reducing/oxidizing agent, the slower the rate of reaction and therefore the better the
treatment. Future work based on this thesis will investigate the effect of concentration of
the other 4 reducing/oxidizing agents on the QY of the QDs after treatment.
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Chapter 7. Conclusions
Quantum dots are nanoscale semiconductors that exhibit fascinating optical and
electrical properties not observed in bulk semiconductors. Specifically, the size and shape
of QDs can be tuned by varying reaction conditions therefore making QDs advantageous
for a variety of applications ranging from electronics to the medical field.
This thesis focused on producing QDs with a high quantum yield (QY) by
investigating the effect of treating QDs with either reducing or oxidizing agents to
enhance the QY. The reducing agents investigated include: sodium borohydride (NaBH4),
calcium hydride (CaH2), and hydrazine (N2H4); and the oxidizing agents investigated are:
benzoyl peroxide (C14H10O4) and tert-butylhydroperoxide (C4H10O2). To correlate what
effect the reducing and oxidizing agents were having on the optical properties of the
QDs, we investigated these treatments on the following factors: chalcogenide (Se vs. S),
ligand (oleylamine vs. OA), coordinating solvent (ODE vs. TOA), and dispersant solvent
(chloroform vs. toluene) on the overall optical properties of the QDs.

The main

conclusions from the work of this thesis are presented below.

•

The ability of the various reducing/oxidizing agents to enhance the QY of the
QDs was independent of the chalcogenide. No clear trend was observed to indicate
that the surface treatments were more effective in treating CdSe QDs versus CdS
QDs. In fact, the exact same results were obtained when oleylamine was used as the
capping ligand. The initial QY of CdSe QDs, however, was higher than that of CdS
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QDs when capped with oleylamine. Conversely, the initial QY of CdS QDs was
higher than that of CdSe QDs when capped with oleic acid (regardless of noncoordinating solvent used). A reason for this difference is not known, however, we
hypothesize that a possible explanation involves the coverage of ligands on the
surface of the QDs. To estimate ligand surface coverage, thermogravimetric analysis
(TGA) data coupled with data regarding the geometry of the QD can be used.
Specifically, TGA measures the weight change of a sample as it is heated to the
temperature at which it degrades. After performing TGA on the QD samples, it is
believed that the mass remaining after heating is that of the metal core without the
ligands. TGA was performed on each batch of QDs used in this thesis (see Appendix
D). Coupling this TGA data with information regarding the size and shape of the QDs
would allow for the estimate of ligand surface coverage and therefore provide an
explanation as to why the QY of the untreated QDs was higher when CdSe QDs were
capped with oleylamine and CdS QDs were capped with OA. To estimate the size and
shape of the QDs, it is recommended that transmission electron microscopy (TEM) or
dynamic light scattering (DLS) be performed in the future work of this thesis.

•

The QY of the QDs was calculated to be higher when octadecene (ODE) was
used as the non-coordinating solvent versus trioctylamine (TOA). The QY of the
QDs synthesized with OA as the ligand and ODE as the non-coordinating solvent
were visibly brighter and yielded a higher QY than those with TOA as the noncoordinating solvent. This was observed regardless of chalcogenide or dispersion

249
solvent. The primary difference between the two investigated solvents is that ODE is
a non-coordinating solvent whereas TOA is a weakly-coordinated solvent. Because
TOA has both polar and non-polar groups, it may have coordinated to the QD surface
and interfered with the OA coverage of the QD surface, therefore leading to a reduced
QY. Further characterization of the QDs is required before a definitive conclusion can
be made.
In terms of surface treatment, the QY of the QDs was enhanced after treatment
with the various reducing/oxidizing agents more often when ODE was used as the
non-coordinating solvent than TOA. More specifically, 8 of the 20 treatments
performed on QDs with ODE as the non-coordinating solvent resulted in an increased
QY, whereas only 4 of the 20 treatments increased in the presence of TOA. Similar to
the effect of the chalcogenide, it is believed that the difference in coverage of the
ligands on the QD surface is responsible for this observation. As mentioned above, it
is possible that the TOA may have interfered with the OA coverage of the QD
surface, therefore preventing the reducing/oxidizing agents from effectively
passivating the surface defects on the QDs surface. To determine the effect the noncoordinating solvent has on the ability of OA to bind to the QD surface, it is
recommended that further characterization techniques be performed. Specifically,
TEM or DLS should be performed to determine the size and shape of the QDs.
Coupling this geometry data with the TGA data summarized in Appendix D of this
thesis would allow for the estimate of OA coverage in the presence of the 2 noncoordinating solvents. Furthermore, this data would provide an explanation about
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why the surface treatment of the QDs was more effective at increasing the QY of the
QDs when ODE was used instead of TOA.

•

The QY of the QDs was calculated to be higher when the QDs were dispersed in
toluene versus chloroform. Regardless of chalcogenide, ligand, non-coordinating
solvent, or treatment, QDs were visibly brighter and yielded a higher QY when
dissolved in toluene than chloroform. This result is consistent with the work of Bullen
et al. who concluded that when capping ligands are very soluble in a solvent, the
ligands detach from the QD surface, therefore resulting in a quenched QY.1
Conversely, if the ligands are less soluble in a solvent, they will tend to adsorb onto
the surface of the QDs from solution which may enhance the QY even further.1
Because oleylamine is more soluble in chloroform than toluene, the higher QY of
QDs capped with oleylamine in toluene than chloroform was therefore justified. Oleic
acid, on the other hand, is more soluble in toluene than chloroform therefore the
dependence of solvent is hypothesized to be due to the difference in dissolved oxygen
concentration in each solvent.
In terms of surface treatment, the QY of the QDs capped with OA was enhanced
after treatment with the various reducing/oxidizing agents more often when the QDs
were dispersed and treated in chloroform than toluene. When oleylamine was used as
the capping ligand, no difference in solvent was observed. To explain the dependence
on solvent in the presence of OA, we present 2 possible explanations. First, we
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hypothesize that if the reducing/oxidizing agent is more soluble in a given solvent it
will react at a significantly faster rate than in a poor solvent. If the reaction happens
too fast, the QDs will begin to aggregate, and the QY will be quenched. To test this
theory, a solubility study to determine the solubility of each reducing/oxidizing agent
in both chloroform and toluene should be conducted. Based on the results presented
in this thesis, we expect that the reducing/oxidizing agents will be more soluble in
toluene than chloroform, therefore explaining our results.
A second possible explanation for the observed results also focuses on the
reaction rate. Specifically, we hypothesize that the reducing/oxidizing agents react
with the residual water present in each of the solvents to form hydrogen. The
hydrogen then reacts with the surface ligands, causing them to detach from the QD
surface, and allowing oxygen from the atmospheric air to diffuse to the exposed
cadmium. The resulting CdO layer around the QDs serves to passivate the defect sites
located on the QD surface and therefore improves the QY of the QDs. If the
reducing/oxidizing agents react too fast with the residual water, the QDs will
aggregate and the QY will be quenched. Based on this hypothesis, the amount of
water present in each of the solvents may be responsible for the dependence of
solvent on the effectiveness of the various surface treatments. To test this theory, the
hydrogen concentration emitted from the reaction of each reducing/oxidizing agent
with both chloroform and toluene should be measured and compared.
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•

Surface treatment of QDs with sodium borohydride (NaBH4) resulted in an
enhanced QY in 10 of the 12 treatments. Sodium borohydride (NaBH4) was found
to be the most effective reducing agent at improving the QY of the as-synthesized
QDs. Of the 12 batches of QDs investigated, NaBH4 effectively improved the QY of
all but 2 after treatment (including CdS (OA & TOA) in chloroform, and CdS (OA &
ODE) in toluene). One potential explanation for the success of NaBH4 in enhancing
the QY of the QDs is due to the slight solubility of NaBH4 in the two dispersion
solvents. Because NaBH4 is only slightly soluble in chloroform and toluene, we
hypothesize that the reducing agent diffused through the solvent to react with the QDs
at a slow enough reaction rate that the QDs surface was effectively reduced. In the
case of reducing/oxidizing agents that were completely soluble in the dispersion
solvents, the reaction often happened so fast that the QDs aggregated and the
fluorescence of the QD solution was completely quenched.
A second possible explanation involves the reactivity of NaBH4 with water. In a
study by Kong et al., the reaction rate of NaBH4 with water vapor was found to be ten
times slower than that of CaH2.2 For this reason, we hypothesize that NaBH4 reacted
with the residual water in each solvent at a slow enough rate that the hydrogen
produced was able to effectively detach ligands on the QD surface and allow for the
formation of the CdO layer. As explained above, if a reducing/oxidizing agent reacts
too fast with the residual water, the QDs will aggregate and the QY will be quenched.
It is therefore hypothesized that CaH2 reacted with the residual water at too fast a rate,
therefore explaining the observed aggregation and decrease in QY.
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•

Surface treatment of QDs with hydrazine (N2H4) in chloroform resulted in poor
dispersion of the hydrazine which quenched the QY. Hydrazine is a liquid that is
nearly insoluble in chloroform. When hydrazine was added to the QD solution an
emulsion formed. We hypothesize that OA and oleylamine were able to act as
surfactants and stabilize the N2H4 droplets in their respective emulsions. In the
presence of oleylamine, large, poorly dispersed droplets of N2H4 formed, indicating
that oleylamine is not a good surfactant for N2H4 in chloroform. However, OA
seemed to be a better surfactant for N2H4 in chloroform because small, evenly
dispersed droplets of N2H4 could be seen in the chloroform. Figure 7.2 illustrates this
difference in droplet suspension when oleylamine was used as opposed to OA.
We hypothesized the emulsions had two effects on the QD solutions. For the
oleylamine QDs, a small amount of soluble N2H4 reacts with the QDs and reduces
their surface to etch and destroy the QDs thereby quenching the QD fluorescence.
The remainder of the N2H4 forms large, unevenly dispersed N2H4 droplets stabilized
by the residual oleylamine. The solution appears blue-green when excited by a
365 nm UV lamp because the oleylamine emits light at 450 nm upon excitation. After
10 d a visible layer forms at the top of the chloroform solution, presumably due to
instability of the emulsion. A similar effect was observed with the OA/TOA QDs
presumably because residual TOA is a poor surfactant for N2H4 in chloroform.
In the case of the OA QDs, when the N2H4 is added to the chloroform a small
amount of soluble N2H4 reacts with the QDs and reduces their surface to etch and
destroy the QDs thereby quenching the QD fluorescence. The residual OA then
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stabilized the remaining N2H4 into small, evenly dispersed N2H4 droplets. These
droplets scatter light, causing the solution to appear cloudy in visible light. When a
365 nm UV lamp was used as the incident light, the evenly dispersed droplets of
N2H4 in the QD solution scattered the light causing the solution to appear purple (see
Figure 7.1).

Figure 7.1. Schematic illustrating effect of ligand on N2H4 dispersion in chloroform.

Regardless of ligand, the fluorescence of the OA/TOA QDs was quenched
immediately after treatment with N2H4.

•

The effectiveness of QD surface treatment with various reducing/oxidizing
agents is dependent on concentration. As explained above, often the
reduction/oxidation of the QD surface happened so fast that the fluorescence of the
QD solution was quenched after treatment. We hypothesize that when a
reducing/oxidizing agent it highly soluble in a given solvent or very reactive with
water, it reacts with the QDs at a rate so fast desorption of the ligands and
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aggregation occur before forming a stable QD with a CdO layer.3 The net result is an
increase in the UV absorbance and a quenching of the fluorescence resulting in a
decrease in QY. This theory was investigated by treating each of the 6 batches of QDs
with tert-butylhydroperoxide (C4H10O2) in both chloroform and toluene at several
concentrations. From this set of treatments, a clear dependence on the oxidizing
agent’s concentration was observed. Specifically, at lower concentrations of the
oxidizing agent, the reaction rate slowed significantly, and the fluorescence was not
quenched. Although this theory was only tested for 1 of the 5 reducing/oxidizing
agents, it is expected the concentration dependence on the reactivity effect the other 4
treatments as well.
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Chapter 8. Future Work
The work detailed in this thesis was aimed at surveying the effect of oxidizing and
reducing agents on the quantum yield of CdSe and CdS QDs. Future work focuses on
expanding on these results to include additional characterization methods to gather more
information about the effect of the reducing and oxidizing agents on the structure of the
QDs. Additional future work involves investigating the solubility and reactivity of each
reducing/oxidizing agent to support the conclusion that the effectiveness of each agent
was dependent on reaction rate. Specific recommendations for future work of this thesis
are presented below.

•

Characterization methods should be performed to quantify the size and shape of
the QDs. Specifically, transmission electron microscopy (TEM), atomic force
microscopy (AFM) or dynamic light scattering (DLS) should be performed to
measure the size and shape of the QDs before and after treatment. Knowledge of the
morphology of the QDs would help to quantitatively determine what effect the
oxidizing and reducing agents have on the size of the QDs due to etching or
aggregation. For example, increases in absorbance and flattening of the fluorescence
peak seem to indicate aggregation had occurred after treating several of the QD
batches with calcium hydride (CaH2). Information regarding the size of the QDs
before treatment and at each time interval after treatment with CaH2 could quantify
what fraction of the QDs aggregated with time. TEM images would also provide
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information about the shape of the QDs. The size and shape of the QDs could be used
in conjunction with thermogravitational analysis (TGA) results to determine the
ligand surface coverage of the various QD batches. The ligand surface coverage could
be used to determine if there is a correlation between coverage of the ligands on the
QDs surface and effectiveness of a reducing/oxidizing agent.

•

The dependence of concentration on the effectiveness of QD surface treatment
should be investigated for each reducing/oxidizing agent. One of the main
conclusions of this thesis is that the effectiveness of QD surface treatments on the QY
of the QDs is dependent on concentration. This conclusion was explored by retreating
each of the 6 batches of QDs with a lower concentration of tert-butylhydroperoxide
(C4H10O2) in both chloroform and toluene. From this set of treatments, a clear
dependence on the oxidizing agent’s concentration was observed. Specifically, lower
oxidizing agent concentrations resulted in slower reaction rates and greater increases
in QY. Given these results, the concentration dependence of the remaining surface
treatments (sodium borohydride (NaBH4), hydrazine (N2H4), calcium hydride (CaH2),
and benzoyl peroxide (C14H10O2)) on the QY should be explored.

•

A solubility study should be performed to determine the solubility of each
reducing/oxidizing agent in chloroform and toluene. As explained in the results
sections of this thesis, little information is available regarding the solubility of each
reducing/oxidizing agent in toluene versus chloroform. We hypothesize that if a given

259
reducing/oxidizing agent is more soluble is a particular solvent, it will react at a much
faster rate than in a poor solvent. The result of the faster reaction rate leads to the
ligands detaching from the QD surface at a rate that favors aggregation of the QDs.
For this reason, information concerning the solubility of each agent in the dispersion
solvents is crucial to confirming this hypothesis. It is therefore recommended that a
solubility study be conducted on each of the 5 reducing/oxidizing agents in both
toluene and chloroform.

•

Additional testing should be performed to test the hypothesis that water
contained in the solvents reacted with each reducing/oxidizing agent to
reduce/oxidize the QD surface. As explained in Chapter 7, we hypothesize that
water contained in the solvents reacted with each reducing/oxidizing agent to produce
hydrogen. This hydrogen then reacted with the surface ligands, causing them to
detach from the QD surface, and allowing oxygen from the atmospheric air to diffuse
to the exposed cadmium. The resulting CdO layer around the QDs served to passivate
the defect sites located on the QD surface and resulted in an enhanced QY. To test
this hypothesis, it is recommended that each of the QDs be dispersed and treated in
dried chloroform and toluene. If our hypothesis is correct, the QDs will not be
reduced/oxidized and no change in the QY of the QDs will be observed.
This hypothesis was also applied as a possible explanation as to why NaBH4
was an effective reducing agent but CaH2 was not. Specifically, CaH2 reacts with
water vapor at a significantly faster rate (10 X) than NaBH4.1 For this reason, it is
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believed that because the reduction of the QDs happened so fast when treated with
CaH2, the QDs often aggregated, resulting in reduced QY. To further test this
hypothesis, the hydrogen concentration emitted from the reaction of each solvent,
ligand, and CaH2 reaction can be compared to that of each solvent, ligand, and
NaBH4 reaction. If our hypothesis is correct, the amount of hydrogen produced from
the reaction with CaH2 will be significantly higher than the amount produced from the
NaBH4 reaction.

•

It is recommended that techniques to synthesize better quality CdS (OA & TOA)
QDs be investigated. Of the 6 batches of QDs synthesized in the work of this thesis,
CdS (OA & TOA) QDs had the lowest initial QY. It is therefore recommended that
techniques to synthesize better quality CdS (OA & TOA) QDs be investigated. A
potential modification to the existing procedure involves heating the precursor
solution to a higher temperature prior to injection into the reaction solution.
Currently, the precursor solution is heated to 120 °C prior to injection into the
reaction solution which is then heated to 175 °C. It is recommended that the precursor
solution be preheated to temperatures between 120 °C and 175 °C to determine the
influence, if any, that this temperature has on the QY of the synthesized QDs.
Another potential modification involves exploring other cadmium sources. In this
thesis, cadmium acetate was used as the cadmium source for each of the batches,
however, several research groups report the use of cadmium oxide (CdO) to produce
high quality CdS QDs.2 It is therefore recommended that CdO be investigated.
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•

Methods to quench the QD synthesis reaction should be explored. The procedure
followed to synthesize QDs in this thesis involved heating the reaction mixture in a
microwave to a specific temperature. After the reaction was complete, the reaction
solution slowly cooled to room temperature. As seen from the fluorescence spectra
included in the results of this thesis, the as-synthesized QDs yielded a broad
fluorescence peak indicating a wide size distribution of particles. Specifically, an
average full-width half-maximum (FWHM) of 90 nm was reported for CdSe QDs and
170 nm for CdS QDs. The literature, on the other hand, reports CdSe FWHM values
as low as 25 nm3,4, and CdS values of 18 nm.3 A recommendation for future work
involves quenching the reaction immediately after heating to prevent any further
reaction. It is expected that by quenching the reaction, a more uniform size
distribution of particles will be achieved. A possible technique to explore involves
adding a small amount of ethanol to the reaction solution immediately after the
reaction is complete.5

•

It is recommended that the negative fluorescence peak observed in the
fluorescence spectra of CdSe (OA & TOA) and CdS (OA & TOA) QDs dissolved
in chloroform be investigated further. Fluorescence spectroscopy was performed
on solutions consisting of each ligand, non-coordinating solvent, dispersion solvent,
and reducing/oxidizing agent combination to account for the potential influence of the
various reaction materials on QD fluorescence. Each spectra yielded a similar peak at
450 nm, therefore this peak was said to be representative of the reaction materials.
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Although this peak was observed in several of the QD batches, in the case of both
CdSe (OA & TOA) and CdS (OA & TOA) QDs dissolved in chloroform, this
fluorescence peak was negative. Because a positive peak centered at 450 nm was
observed in the fluorescence spectra of OA, TOA, and chloroform (no negative peak),
it is unclear why this negative peak was seen. The final recommendation for future
work of this thesis is that additional batches of CdSe (OA & TOA) and CdS (OA &
TOA) QDs dissolved in chloroform be tested to confirm this result. If the negative
peak is observed in these new batches, it is recommended that further
characterizations be performed to determine its cause.

•

A method to purify the QDs after treatment should be explored. As explained in
Chapter 4, the measured absorbance and fluorescence spectra presented in this thesis
(and therefore calculated quantum yield values) were representative of the QD
mixture, not just the QDs. For this reason, it is unclear what led to the quenching of
the QD solutions. Developing a method to purify the QDs after treatment may remove
the quenching agent and enable us to measure the absorbance and fluorescence of just
the QDs. Furthermore, if the quenching is reversible, purification may allow for the
restoration of the QD fluorescence after quenching. For example, if excess free ligand
led to the quenching of the fluorescence, purifying the QDs would remove the
residual ligand, and, if the quenching is reversible, restore the fluorescence. Future
work should also focus on determining the specific effect of the ligands on QD
quenching as well as determining the extinction coefficient of the QD mixture.
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A1

Appendix A . Determining the Optimum Concentration of
Reducing/Oxidizing Agents for Experiments
Included in this appendix are plots and pictures that led to the determination of the
optimal concentration of each the 5 reducing/oxidizing agents used in this thesis. The
agents investigated include: (1) sodium borohydride (NaBH4), (2) calcium hydride
(CaH2), (3) hydrazine (N2H4), (4) benzoyl peroxide (C14H10O4), and (5) tert-butyl
hydroperoxide (C4H10O2). Preliminary results showed that QDs fluoresced brighter in
chloroform than toluene, therefore, chloroform was used as the solvent when determining
each reducing/oxidizing agent concentration.

A.1 CdSe Quantum Dot Cores Synthesized with Oleylamine
A.1.1 Sodium Borohydride (NaBH4)
Cadmium selenide QD cores synthesized with oleylamine were treated with 0.001
g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to determine
which concentration yielded the highest fluorescence peak. Figure A1 below shows the
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The
optimal concentration of NaBH4 for this batch type was found to be 0.006 g (0.159
mmol) as represented by the green line.
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Figure A.1. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (oleylamine) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g NaBH4 excited with 365 nm UV light.

A.1.2 Calcium Hydride (CaH2)
Cadmium selenide QD cores synthesized with oleylamine were treated with 0.001
g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to determine
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which concentration yielded the highest fluorescence peak. Figure A2 below shows the
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The
optimal concentration of CaH2 for this batch type was found to be 0.001 g (0.024 mmol)
as represented by the orange line.

Figure A.2. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (oleylamine) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g CaH2 excited with 365 nm UV light.

A4
A.1.3 Hydrazine (N2H4)
Cadmium selenide QD cores synthesized with oleylamine were treated with
0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to
determine which concentration yielded the highest fluorescence peak. Figure A3 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of N2H4 for this batch type was found to be 0.15 mL (4.74
mmol) as represented by the green line.

Figure A.3. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (oleylamine) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and
0.15 mL N2H4 excited with 365 nm UV light.
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A.1.4 Benzoyl Peroxide (C14H10O4)
Cadmium selenide QD cores synthesized with oleylamine were treated with 0.001
g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4 to determine
which concentration yielded the highest fluorescence peak. Figure A4 below shows the
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The
optimal concentration of C14H10O4 for this batch type was found to be 0.001 g (0.004
mmol) as represented by the orange line.

Figure A.4. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (oleylamine) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g C14H10O4 excited with 365 nm UV light.

A6
A.1.5 tert-Butyl Hydroperoxide (C4H10O2)
Cadmium selenide QD cores synthesized with oleylamine were treated with
0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to
determine which concentration yielded the highest fluorescence peak. Figure A5 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
Although the QDs stopped fluorescing after the addition of C4H10O2 as seen in Figure
A5c, the optimal concentration of C4H10O2 for this batch type was assumed to be 0.05
mL (orange line).

Figure A.5. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (oleylamine) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL,
and 0.15 mL C4H10O2 excited with 365 nm UV light.
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A.2 CdSe Quantum Dot Cores Synthesized with Oleic Acid and ODE
A.2.1 Sodium Borohydride (NaBH4)
Cadmium selenide QD cores synthesized with oleic acid and ODE were treated
with 0.001 g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to
determine which concentration yielded the highest fluorescence peak. Figure A6 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of NaBH4 for this batch type was found to be 0.006 g (0.159
mmol) as represented by the green line.
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Figure A.6. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & ODE) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g NaBH4 excited with 365 nm UV light.

A.2.2 Calcium Hydride (CaH2)
Cadmium selenide QD cores synthesized with oleic acid and ODE were treated
with 0.001 g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to
determine which concentration yielded the highest fluorescence peak. Figure A7 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
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The optimal concentration of CaH2 for this batch type was found to be 0.001 g (0.024
mmol) as represented by the orange line.

Figure A.7. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & ODE) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g CaH2 excited with 365 nm UV light.

A10
A.2.3 Hydrazine (N2H4)
Cadmium selenide QD cores synthesized with oleic acid and ODE were treated
with 0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to
determine which concentration yielded the highest fluorescence peak. Figure A8 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
Although the QDs stopped fluorescing after the addition of N2H4, the optimal
concentration of N2H4 for this batch type was assumed to be 0.05 mL (orange line).

Figure A.8. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & ODE) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and
0.15 mL N2H4 excited with 365 nm UV light.

A11
A.2.4 Benzoyl Peroxide (C14H10O4)
Cadmium selenide QD cores synthesized with oleic acid and ODE were treated
with 0.001 g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4
to determine which concentration yielded the highest fluorescence peak. Figure A9 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of C14H10O4 for this batch type was found to be 0.006 g (0.025
mmol) as represented by the green line.

Figure A.9. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & ODE) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g C14H10O4 excited with 365 nm UV light.
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A.2.5 tert-Butyl Hydroperoxide (C4H10O2)
Cadmium selenide QD cores synthesized with oleic acid and ODE were treated
with 0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to
determine which concentration yielded the highest fluorescence peak. Figure A10 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of C4H10O2 for this batch type was found to be 0.15 mL (1.56
mmol) as represented by the green line.

Figure A.10. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & ODE) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL,
and 0.15 mL C4H10O2 excited with 365 nm UV light.
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A.3 CdSe Quantum Dot Cores Synthesized with Oleic Acid and TOA
A.3.1 Sodium Borohydride (NaBH4)
Cadmium selenide QD cores synthesized with oleic acid and TOA were treated
with 0.001 g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to
determine which concentration yielded the highest fluorescence peak. Figure A11 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of NaBH4 for this batch type was found to be 0.001 g (0.026
mmol) as represented by the orange line.
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Figure A.11. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & TOA) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g NaBH4 excited with 365 nm UV light.

A.3.2 Calcium Hydride (CaH2)
Cadmium selenide QD cores synthesized with oleic acid and TOA were treated
with 0.001 g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to
determine which concentration yielded the highest fluorescence peak. Figure A12 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
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The optimal concentration of CaH2 for this batch type was found to be 0.001 g (0.024
mmol) as represented by the orange line.

Figure A.12. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & TOA) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g CaH2 excited with 365 nm UV light.
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A.3.3 Hydrazine (N2H4)
Cadmium selenide QD cores synthesized with oleic acid and TOA were treated
with 0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to
determine which concentration yielded the highest fluorescence peak. Figure A13 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
Although the QDs stopped fluorescing after the addition of N2H4, the optimal
concentration of N2H4 for this batch type was assumed to be 0.15 mL (green line).

Figure A.13. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & TOA) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and
0.15 mL N2H4 excited with 365 nm UV light.
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A.3.4 Benzoyl Peroxide (C14H10O4)
Cadmium selenide QD cores synthesized with oleic acid and TOA were treated
with 0.001 g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4
to determine which concentration yielded the highest fluorescence peak. Figure A14
below shows the absorbance spectrum, the fluorescence spectrum, and a picture of the
samples. The optimal concentration of C14H10O4 for this batch type was found to be 0.003
g (0.012 mmol) as represented by the red line.

Figure A.14. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & TOA) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g C14H10O4 excited with 365 nm UV light.

A18
A.3.5 tert-Butyl Hydroperoxide (C4H10O2)
Cadmium selenide QD cores synthesized with oleic acid and TOA were treated
with 0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to
determine which concentration yielded the highest fluorescence peak. Figure A15 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of C4H10O2 for this batch type was found to be 0.10 mL (1.04
mmol) as represented by the red line.

Figure A.15. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdSe (OA & TOA) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL,
and 0.15 mL C4H10O2 excited with 365 nm UV light.
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A.4 CdS Quantum Dot Cores Synthesized with Oleylamine
A.4.1 Sodium Borohydride (NaBH4)
Cadmium sulfide QD cores synthesized with oleylamine were treated with 0.001
g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to determine
which concentration yielded the highest fluorescence peak. Figure A16 below shows the
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The
optimal concentration of NaBH4 for this batch type was found to be 0.003 g (0.079
mmol) as represented by the red line.
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Figure A.16. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (oleylamine) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g NaBH4 excited with 365 nm UV light.

A.4.2 Calcium Hydride (CaH2)
Cadmium sulfide QD cores synthesized with oleylamine were treated with 0.001
g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to determine
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which concentration yielded the highest fluorescence peak. Figure A17 below shows the
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The
optimal concentration of CaH2 for this batch type was found to be 0.001 g (0.024 mmol)
as represented by the orange line.

Figure A.17. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (oleylamine) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g CaH2 excited with 365 nm UV light.
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A.4.3 Hydrazine (N2H4)
Cadmium sulfide QD cores synthesized with oleylamine were treated with
0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to
determine which concentration yielded the highest fluorescence peak. Figure A52 below
shows the absorbance spectrum, Figure A53 shows the fluorescence spectrum, and Figure
A54 includes a picture of the samples. The optimal concentration of N2H4 for this batch
type was found to be 0.15 mL (4.74 mmol) in Figure A53 (green line).

Figure A.18. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (oleylamine) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and
0.15 mL N2H4 excited with 365 nm UV light.
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A.4.4 Benzoyl Peroxide (C14H10O4)
Cadmium sulfide QD cores synthesized with oleylamine were treated with 0.001
g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4 to determine
which concentration yielded the highest fluorescence peak. Figure A19 below shows the
absorbance spectrum, the fluorescence spectrum, and a picture of the samples. The
optimal concentration of C14H10O4 for this batch type was found to be 0.001 g (0.004
mmol) as represented by the orange line.

Figure A.19. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (oleylamine) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g C14H10O4 excited with 365 nm UV light.
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A.4.5 tert-Butyl Hydroperoxide (C4H10O2)
Cadmium sulfide QD cores synthesized with oleylamine were treated with
0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to
determine which concentration yielded the highest fluorescence peak. Figure A20 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of C4H10O2 for this batch type was found to be 0.15 mL (1.56
mmol) as represented by the green line.

Figure A.20. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (oleylamine) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL,
and 0.15 mL C4H10O2 excited with 365 nm UV light.
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A.5 CdSe Quantum Dot Cores Synthesized with Oleic Acid and ODE
A.5.1 Sodium Borohydride (NaBH4)
Cadmium sulfide QD cores synthesized with oleic acid and ODE were treated
with 0.001 g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to
determine which concentration yielded the highest fluorescence peak. Figure A21 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of NaBH4 for this batch type was found to be 0.003 g (0.079
mmol) as represented by the red line.
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Figure A.21. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & ODE) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g NaBH4 excited with 365 nm UV light.

A.5.2 Calcium Hydride (CaH2)
Cadmium sulfide QD cores synthesized with oleic acid and ODE were treated
with 0.001 g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to
determine which concentration yielded the highest fluorescence peak. Figure A22 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
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The optimal concentration of CaH2 for this batch type was found to be 0.001 g (0.024
mmol) as represented by the orange line.

Figure A.22. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & ODE) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g CaH2 excited with 365 nm UV light.
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A.5.3 Hydrazine (N2H4)
Cadmium sulfide QD cores synthesized with oleic acid and ODE were treated
with 0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to
determine which concentration yielded the highest fluorescence peak. Figure A23 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
Although the QDs stopped fluorescing after the addition of N2H4, the optimal
concentration of N2H4 for this batch type was assumed to be 0.05 mL (orange line).

Figure A.23. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & ODE) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and
0.15 mL N2H4 excited with 365 nm UV light.

A29
A.5.4 Benzoyl Peroxide (C14H10O4)
Cadmium sulfide QD cores synthesized with oleic acid and ODE were treated
with 0.001 g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4
to determine which concentration yielded the highest fluorescence peak. Figure A24
below shows the absorbance spectrum, the fluorescence spectrum, and a picture of the
samples. The optimal concentration of C14H10O4 for this batch type was found to be 0.003
g (0.012 mmol) as represented by the red line.

Figure A.24. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & ODE) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g C14H10O4 excited with 365 nm UV light.
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A.5.5 tert-Butyl Hydroperoxide (C4H10O2)
Cadmium sulfide QD cores synthesized with oleic acid and ODE were treated
with 0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to
determine which concentration yielded the highest fluorescence peak. Figure A25 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of C4H10O2 for this batch type was found to be 0.10 mL (1.04
mmol) as represented by the red line.

Figure A.25. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & ODE) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL,
and 0.15 mL C4H10O2 excited with 365 nm UV light.
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A.6 CdS Quantum Dot Cores Synthesized with Oleic Acid and TOA
A.6.1 Sodium Borohydride (NaBH4)
Cadmium sulfide QD cores synthesized with oleic acid and TOA were treated
with 0.001 g (0.026 mmol), 0.003 g (0.079 mmol), and 0.006 g (0.159 mmol) NaBH4 to
determine which concentration yielded the highest fluorescence peak. Figure A26 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of NaBH4 for this batch type was found to be 0.006 g (0.159
mmol) as represented by the green line.

A32

Figure A.26. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & TOA) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g NaBH4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g NaBH4 excited with 365 nm UV light.

A.6.2 Calcium Hydride (CaH2)
Cadmium sulfide QD cores synthesized with oleic acid and TOA were treated
with 0.001 g (0.024 mmol), 0.003 g (0.071 mmol), and 0.006 g (0.143 mmol) CaH2 to
determine which concentration yielded the highest fluorescence peak. Figure A27 below
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shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of CaH2 for this batch type was found to be 0.003 g (0.071
mmol) as represented by the red line.

Figure A.27. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & TOA) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g CaH2. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g CaH2 excited with 365 nm UV light.

A34
A.6.3 Hydrazine (N2H4)
Cadmium sulfide QD cores synthesized with oleic acid and TOA were treated
with 0.05 mL (1.58 mmol), 0.10 mL (3.16 mmol), and 0.15 mL (4.74 mmol) N2H4 to
determine which concentration yielded the highest fluorescence peak. Figure A28 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of N2H4 for this batch type was found to be 0.05 mL (1.58
mmol) as represented by the orange line.

Figure A.28. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & TOA) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL N2H4. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL, and
0.15 mL N2H4 excited with 365 nm UV light.

A35
A.6.4 Benzoyl Peroxide (C14H10O4)
Cadmium sulfide QD cores synthesized with oleic acid and TOA were treated
with 0.001 g (0.004 mmol), 0.003 g (0.012 mmol), and 0.006 g (0.025 mmol) C14H10O4
to determine which concentration yielded the highest fluorescence peak. Figure A29
below shows the absorbance spectrum, the fluorescence spectrum, and a picture of the
samples. The optimal concentration of C14H10O4 for this batch type was found to be 0.001
g (0.004 mmol) as represented by the orange line.

Figure A.29. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & TOA) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.001 g (orange), 0.003 g (red), and
0.006 g C14H10O4. (c) Photo of QDs that are from left to right, untreated, treated with 0.001 g, 0.003 g, and
0.006 g C14H10O4 excited with 365 nm UV light.

A36
A.5.5 tert-Butyl Hydroperoxide (C4H10O2)
Cadmium sulfide QD cores synthesized with oleic acid and TOA were treated
with 0.05 mL (0.519 mmol), 0.10 mL (1.04 mmol), and 0.15 mL (1.56 mmol) C4H10O2 to
determine which concentration yielded the highest fluorescence peak. Figure A30 below
shows the absorbance spectrum, the fluorescence spectrum, and a picture of the samples.
The optimal concentration of C4H10O2 for this batch type was found to be 0.10 mL (1.04
mmol) as represented by the red line.

Figure A.30. Absorbance spectra (a) and fluorescence spectra (b) of a solution of CdS (OA & TOA) QDs
dissolved in chloroform before treatment (blue), after treatment with 0.05 mL (orange), 0.10 mL (red), and
0.15 mL C4H10O2. (c) Photo of QDs that are from left to right, untreated, treated with 0.05 mL, 0.10 mL,
and 0.15 mL C4H10O2 excited with 365 nm UV light.

B1

Appendix B . Determining the Effect of Reducing/Oxidizing Agents on
CdS (OA & TOA) QDs
Included in this appendix are plots and pictures that illustrate the effect of treating
CdS (OA & TOA) QDs with various reducing and oxidizing agents. The agents
investigated include: (1) sodium borohydride (NaBH4), (2) calcium hydride (CaH2), (3)
hydrazine (N2H4), (4) benzoyl peroxide (C14H10O4), and (5) tert-butyl hydroperoxide
(C4H10O2). The absorbance of the QD solution prior to treatment was ~ 0.08 a.u.

B2
B.1 Treatment with Sodium Borohydride (NaBH4) in Chloroform

Figure B.1. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.159 mmol NaBH4. Photos of untreated QDs (left) and QDs treated with
NaBH4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

B3
B.2 Treatment with Sodium Borohydride (NaBH4) in Toluene

Figure B.2. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.159 mmol NaBH4. Photos of untreated QDs (left) and QDs treated with
NaBH4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

B4
B.3 Treatment with Calcium Hydride (CaH2) in Chloroform

Figure B.3. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.071 mmol CaH2. Photos of untreated QDs (left) and QDs treated with CaH2
(right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

B5
B.4 Treatment with Calcium Hydride (CaH2) in Toluene

Figure B.4. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.071 mmol CaH2. Photos of untreated QDs (left) and QDs treated with CaH2
(right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

B6
B.5 Treatment with Hydrazine (N2H4) in Chloroform

Figure B.5. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 1.58 mmol N2H4. Photos of untreated QDs (left) and QDs treated with N2H4
(right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

B7
B.6 Treatment with Hydrazine (N2H4) in Toluene

Figure B.6. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 1.58 mmol N2H4. Photos of untreated QDs (left) and QDs treated with N2H4
(right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

B8
B.7 Treatment with Benzoyl Peroxide (C14H10O4) in Chloroform

Figure B.7. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.004 mmol C14H10O4. Photos of untreated QDs (left) and QDs treated with
C14H10O4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

B9
B.8 Treatment with Benzoyl Peroxide (C14H10O4) in Toluene

Figure B.8. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.004 mmol C14H10O4. Photos of untreated QDs (left) and QDs treated with
C14H10O4 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

B10
B.9 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Chloroform

Figure B.9. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 1.04 mmol C4H10O2. Photos of untreated QDs (left) and QDs treated with
C4H10O2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

B11
B.10 Treatment with tert-Butyl Hydroperoxide (C4H10O2) in Toluene

Figure B.10. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 1.04 mmol C4H10O2. Photos of untreated QDs (left) and QDs treated with
C4H10O2 (right) excited with 365 nm UV light (c) 1 d, (d) 5 d, and (e) 10 d after treatment.

B12
B.11 Summary of CdSe/OA & ODE Treatments

Figure B.11. Photos of CdS (OA & TOA) QDs that are from left to right: untreated, treated with 0.159
mmol NaBH4, 0.004 mmol C14H10O4, 0.071 mmol CaH2, 1.58 mmol N2H4, and 1.04 mmol C4H10O2 excited
with 365 nm UV light. The QDs in the left column were suspended and treated in chloroform while those
in the right column were in toluene. Photos were taken 1 d (top row), 5 d (middle row), and 10 d (bottom
row) after treatment.

C1

Appendix C . Determining the Effect of Concentration on the Surface
Treatment of QDs with tert-Butyl Hydroperoxide (C4H10O2)

Included in this appendix are plots and pictures that illustrate the effect of treating
each batch of QDs with varying concentrations of tert-butyl hydroperoxide (C4H10O2).

C2
C.1 CdSe/Oleylamine Quantum Dot Cores
C.1.1 Chloroform

Figure C1. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C3

Figure C2. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C4

Figure C3. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure C4. Photos of CdSe (oleylamine) QDs dissolved in chloroform that are from left to right: untreated,
treated with 0.0311 mmol, 0.0519 mmol, 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, (b)
5 d, and (c) 10 d after treatment..

C5
C.1.2 Toluene

Figure C5. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C6

Figure C6. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C7

Figure C7. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (oleylamine) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure C8. Photos of CdSe (oleylamine) QDs dissolved in toluene that are from left to right: untreated,
treated with 0.0311 mmol, 0.0519 mmol, 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, (b)
5 d, and (c) 10 d after treatment.

C8
C.2 CdSe/OA & ODE Quantum Dot Cores
C.2.1 Chloroform

Figure C9. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C9

Figure C10. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C10

Figure C11. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure C12. Photos of CdSe (OA & ODE) QDs dissolved in chloroform that are from left to right:
untreated, treated with 0.0311 mmol, 0.0519 mmol, 0.0.726 mmol C4H10O2 excited with 365 nm UV light
(a) 1 d, (b) 5 d, and (c) 10 d after treatment..

C11
C.2.2 Toluene

Figure C13. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C12

Figure C14. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C13

Figure C15. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & ODE) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure C16. Photos of CdSe (OA & ODE) QDs dissolved in toluene that are from left to right: untreated,
treated with 0.0311 mmol, 0.0519 mmol, 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, (b)
5 d, and (c) 10 d after treatment.

C14
C.3 CdSe/OA & TOA Quantum Dot Cores
C.3.1 Chloroform

Figure C17. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C15

Figure C18. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C16

Figure C19. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure C20. Photos of CdSe (OA & TOA) QDs dissolved in chloroform that are from left to right:
untreated, treated with 0.0311 mmol, 0.0519 mmol, 0.0.726 mmol C4H10O2 excited with 365 nm UV light
(a) 1 d, (b) 5 d, and (c) 10 d after treatment.

C17
C.3.2 Toluene

Figure C21. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C18

Figure C22. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C19

Figure C23. Absorbance spectra (a) and fluorescence spectra (b) of CdSe (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure C24. Photos of CdSe (OA & TOA) QDs dissolved in toluene that are from left to right: untreated,
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d,
(b) 5 d, and (c) 10 d after treatment.

C20
C.4 CdS/Oleylamine Quantum Dot Cores
C.4.1 Chloroform

Figure C25. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C21

Figure C26. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C22

Figure C27. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure C28. Photos of CdS (oleylamine) QDs dissolved in chloroform that are from left to right: untreated,
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d,
(b) 5 d, and (c) 10 d after treatment.

C23
C.4.2 Toluene

Figure C29. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C24

Figure C30. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C25

Figure C31. Absorbance spectra (a) and fluorescence spectra (b) of CdS (oleylamine) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure C32. Photos of CdS (oleylamine) QDs dissolved in toluene that are from left to right: untreated,
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d,
(b) 5 d, and (c) 10 d after treatment.

C26
C.5 CdS/OA & ODE Quantum Dot Cores
C.5.1 Chloroform

Figure C33. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C27

Figure C34. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C28

Figure C35. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure
C36. Photos of CdS (OA & ODE) QDs dissolved in chloroform that are from left to right: untreated, treated
with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d, (b) 5 d,
and (c) 10 d after treatment.

C29
C.5.2 Toluene

Figure C37. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C30

Figure C38. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C31

Figure C39. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & ODE) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure C40. Photos of CdS (OA & ODE) QDs dissolved in toluene that are from left to right: untreated,
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d,
(b) 5 d, and (c) 10 d after treatment.

C32
C.6 CdS/OA & TOA Quantum Dot Cores
C.6.1 Chloroform

Figure C41. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C33

Figure C42. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C34

Figure C43. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
chloroform before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure C44. Photos of CdS (OA & TOA) QDs dissolved in chloroform that are from left to right: untreated,
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d,
(b) 5 d, and (c) 10 d after treatment.

C35
C.6.2 Toluene

Figure C45. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0311 mmol C4H10O2.

C36

Figure C46. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0519 mmol C4H10O2.

C37

Figure C47. Absorbance spectra (a) and fluorescence spectra (b) of CdS (OA & TOA) QDs dissolved in
toluene before treatment (blue), immediately after treatment (yellow), 1 d (red), 5 d (green), and 10 d
(purple) after treatment with 0.0726 mmol C4H10O2.

Figure C48. Photos of CdS (OA & TOA) QDs dissolved in toluene that are from left to right: untreated,
treated with 0.0311 mmol, 0.0519 mmol, and 0.0.726 mmol C4H10O2 excited with 365 nm UV light (a) 1 d,
(b) 5 d, and (c) 10 d after treatment.

D1

Appendix D . Thermogravimetric Analysis (TGA)
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Figure D.1. TGA of CdSe (oleylamine) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min
under nitrogen.
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Figure D.2. TGA of CdSe (OA & ODE) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min
under nitrogen.
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Figure D.3. TGA of CdSe (OA & TOA) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min
under nitrogen.

3.00
2.50

Weight (mg)

2.00
1.50
1.00

wt % remaining = -0.057 5
0.50
0.00
0
-0.50

100

200

300

400

500

600

700

Temperature (°C)

Figure D.4. TGA of CdS (oleylamine) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min
under nitrogen.
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Figure D.5. TGA of CdS (OA & ODE) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min
under nitrogen.
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Figure D.6. TGA of CdS (OA & TOA) QDs heated from 30 °C to 600 °C at a constant rate of 10 °C/min
under nitrogen.

